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SUMMARY
Heat Shock proteins (hsps) are induced and expressed in response to cerebral ischaemia. 
Pre-conditioning and cell culture studies have indicated that hsp 70i (the major inducible 
hsp) may be involved in reducing ischaemic neuronal damage induced by cerebral 
ischaemia and simulated ischaemia, respectively. Moreover, genetically modified mice 
and viral vectors are being increasingly employed to investigate the roles of various genes 
and gene products in cerebral ischaemia. The studies of this thesis were designed to 
address two major themes. First, the influence of hsp 70i upon ischaemic neuronal damage 
following global cerebral ischaemia was investigated using transgenic mice over­
expressing hsp 70i and intrastriatal adenovirus (ad) hsp 70i gene transfer. Second, the 
functional consequences of transgene introduction into the brain were investigated, in 
transgenic mice over-expressing hsp 70i and in mice with intrastriatal ad enhanced green 
fluorescing protein (egfp, reporter gene) gene transfer.
Global cerebral ischaemia in MF1 and C57bl/6 strain mice
A mouse model of global cerebral ischaemia (bilateral common carotid artery occlusion, 
BCCAo) was established to investigate the influence of hsp 70i over-expression in the 
pathophysiology of cerebral ischaemia. The pathologic consequences of BCCAo in MF1 
mice (the background strain of the hsp 70i transgenic mice used in this thesis) were 
compared with those in C57bl/6 mice (the strain most susceptible to BCCAo). Ischaemic 
neuronal damage in MF1 strain mice was significantly less extensive and widespread than 
that observed in C57bl/6 strain mice (even after extended BCCAo in MF1 mice). 
Significantly increased posterior communicating artery (PcomA) plasticity in the circle of 
Willis and significantly increased mean arterial blood pressure (MABP) in MF1 strain 
mice during BCCAo were the most likely reasons for reduced susceptibility to BCCAo 
compared with C57bl/6 strain mice.
Ischaemic neuronal damage in transgenic mice over-expressing hsp 70i
Hsp 70i is induced in the brain by several stimuli (including cerebral ischaemia) and has 
been postulated to play a beneficial role in damaged cells. Following BCCAo, transgenic 
mice over-expressing hsp 70i displayed significantly reduced ischaemic neuronal damage 
in the medial caudate nucleus, lateral caudate nucleus and posterior thalamus than wild 
type littermate mice. PcomA plasticity and MABP during BCCAo were similar in hsp 70i 
transgenic and wild type littermate mice. These data indicate that transgenic hsp 70i over­
expression reduces ischaemic neuronal damage induced by BCCAo.
Ischaemic neuronal damage following ad hsp 70i and ad egfp gene transfer
Gene transfer of therapeutic molecules by viral vectors has been shown to reduce 
ischaemic neuronal damage induced by both global and focal cerebral ischaemia. 
Intrastriatal injection of ad hsp 70i and ad egfp significantly reduced ischaemic neuronal 
damage in ipsilateral caudate nucleus compared with contralateral nucleus following 20- 
minute BCCAo, but not 10-minute BCCAo. Although ad hsp 70i and ad egfp gene 
transfer reduced ischaemic neuronal damage following 20-miunte BCCAo it is unlikely 
that they did so by the same mechanism, although this could not be concluded.
Local cerebral glucose utilisation in transgenic mice over-expressing hsp 70i
To investigate the impact of hsp 70i over-expression on local cerebral glucose utilisation 
(LCGU), 14C-2-deoxyglucose autoradiography was employed. LCGU in transgenic mice 
over-expressing hsp 70i was not significantly different from LCGU in wild type littermate 
mice in any of 35 brain regions analysed (including brain regions known to over-express 
hsp 70i) in the basal state. Following metabolic activation with dizocilpine (1 mg/kg) 
however, LCGU in transgenic mice over-expressing hsp 70i was significantly increased in 
three brain regions (anterior thalamus, hippocampus CA1 stratum lacunosum molecularae 
and hippocampus CA1 stratum oriens) and significantly decreased in two brain regions
(superior olivary body and nucleus of the lateral lemniscus) compared to wild type 
littermate mice. These data suggest transgenic hsp 70i over-expression does not affect 
brain function in the basal state, but can influence brain function following metabolic 
activation.
Local cerebral glucose utilisation following intrastriatal ad egfp gene transfer
To investigate the impact of ad egfp gene transfer on LCGU, 14C-2-deoxyglucose 
autoradiography was employed. LCGU in areas of ad egfp transfection in ipsilateral 
caudate nucleus was significantly reduced compared to LCGU in the contralateral caudate 
nucleus at seven and 28-days post-injection. The absence of any significant differences in 
LCGU between hemispheres in saline injected mice at seven and 28-days post-injection, 
suggests that ad egfp transfer actively reduces LCGU.
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CHAPTER ONE : INTRODUCTION
1.1 Cerebral ischaemia
Only cardiovascular disease and cancer end more human lives than cerebrovascular disease 
(cerebral ischaemia) in the Western world today (Camamarta et al., 1994). Cerebral 
ischaemia is also the major cause of incapacity in adults (Camamarta, et al., 1994). It is 
estimated that approximately 500,000 people in the United Kingdom are severely 
debilitated by the neurological consequences of cerebral ischaemia (Bamford et al., 1990). 
The incidence of cerebral ischaemia and the impact of its sequelae upon society serve to 
highlight the importance of research into the understanding of the mechanisms involved in 
cerebral ischaemia. The studies, which constitute this thesis, were primarily designed and 
executed to investigate the influence of heat shock protein 70i (hsp 70i) in cerebral 
ischaemia and to explore and extend the use of transgenic mice and viral vectors in 
cerebral ischaemia research.
Ischaemia (from the Greek ischo, to hold back, and hamia, blood) is, by definition, the 
complete loss of blood flow in a region of a bodily organ. In cerebral ischaemia research 
however, ischaemia is generally defined as a decrease in cerebral blood flow to the point 
that metabolic substrate (chiefly oxygen and glucose) fails to meet the metabolic demand 
of the tissue, which perturbs function. The level of cerebral blood flow at which this 
occurs varies with brain region and the ischaemic insult involved (Siesjo et al., 1995). 
Anatomically, cerebral ischaemia can be classified as global (the loss or reduction of blood 
flow to the entire brain) or focal (the loss or reduction in blood flow to a specific vascular 
territory).
Clinically, global and focal cerebral ischaemia are very different. Global cerebral 
ischaemia in man is most frequently observed following cardiac arrest (stagnant hypoxia). 
Increased intracranial pressure, hypotension, hypoxia (hypoxic and histotoxic), 
hypoglycaemia and carbon monoxide can all also produce global cerebral ischaemic
1
damage to varying degrees. Permanent global cerebral ischaemia results in death. 
Prolonged global cerebral ischaemia (approximately 10 minutes or greater) is generally 
incompatible with survival beyond the vegetative state. Transient global cerebral 
ischaemia (less than 10 minutes) can go unnoticed or cause varying degrees of mental and 
physical disability. Focal cerebral ischaemia (stroke) in man is most frequently 
encountered following occlusion of a cerebral artery (in particular the middle cerebral 
artery, MCA) by thrombus or embolus. Cerebral haemorrhage can also induce focal 
cerebral ischaemia, although this is less common. Approximately 40% of first strokes are 
fatal (Camamarta et al., 1994). Increased duration of focal occlusion is intimately related 
to the volume of infarction (brain tissue in which all components die). Transient focal 
cerebral ischaemia (that is to say the source of occlusion has moved, been reduced or been 
removed) has wide-ranging effects depending upon the severity of the insult. Transient 
focal cerebral ischaemia, like global cerebral ischaemia, can pass unnoticed or cause 
varying degrees of mental and physical debilitation.
Pathologically, global and focal cerebral ischaemia are also very different (Figure 1). 
Global cerebral ischaemia results in cell death in selectively vulnerable brain regions (see 
Section 1.3.4). Classically, hippocampus, cortex, thalamus, basal ganglia, cerebellum and 
brainstem are affected in both humans and animals alike (Auer and Beneviste, 1997; Auer 
1998). Moreover, ischaemic neuronal damage following global cerebral ischaemia occurs 
over a period of a few hours to a few days (Ito et al., 1975; Pulsinelli and Brierly, 1979; 
Kirino, 1982; Kirino and Sano, 1984; Smith et al., 1984; Petito et al., 1987; Bonnekoh et 
al., 1990; Horn and Scholte, 1992). This maturation phenomenon is known as delayed 
neuronal death (see Section 1.3.4). Focal cerebral ischaemia results in infarction of brain 
tissue. The densely ischaemic core of infarction varies with the degree and duration of the 
ischaemic insult and matures quickly (a few hours). Surrounding the core of infarction is a 
margin of tissue known as the penumbra. Penumbra consists of neurones and glial cells
2
Figure 1 Global and focal cerebral ischaemia pathology
CA1
Y Y Y Y
CA2
Twenty-minutes of global cerebral ischaemia (BCCAo) in C57bl/6 mouse induced 
ischaemic neuronal damage in selectively vulnerable neurones in hippocampus CA1 and 
CA2 at 72-hours survival (A). Permanent distal MCAo (24-hour diathermy) produces 
ischaemic neuronal damage in the MCA territory including cortex and striatum (B, lighter 
pallor to left o f dotted line). (Original magnification A = X40, B = X8).
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subjected to varying degrees of ischaemia, which may or may not die; that is to say it 
might be possible to intervene and save some of these cellular components.
1.2 Animal models of cerebral ischaemia
Several large animal species have been used to model global and focal cerebral ischaemia 
(notably sub-human primates, dogs, cats, pigs and rabbits). Major advantages of using 
large animals are first, their homology with humans, and second, the ease with which they 
can be resuscitated and recovered. The major disadvantages to the use of large animals are 
their high cost and high associated costs (such as large volumes of anaesthesia, drugs, 
fixation materials, etcetera) and the considerable ethical and quasi-political concerns over 
the use of higher vertebrates as experimental models. Rodents have been employed to 
model cerebral ischaemia since the 1960’s. There are several major advantages of using 
rodents as models of cerebral ischaemia. First, their low cost and low associated costs (i.e., 
less reagents and drugs are required). Second, their small brain size is better suited to 
fixation procedures, such as in vivo and in vitro freezing. Third, ethical and quasi-political 
concerns over their use are less contentious than those raised about large animals. In this 
thesis bilateral common carotid artery occlusion (BCCAo) was established in the mouse as 
a model of global cerebral ischaemia. It should be made clear at this point, that BCCAo in 
mouse does not induce complete global cerebral ischaemia (as the vertebro-basilar arterial 
branches are not occluded). However, the term global cerebral ischaemia is used in this 
thesis to describe a loss or reduction in cerebral blood flow to the forebrain (as well as the 
entire brain). This thesis focuses predominantly upon the mechanisms and pathology of 
global cerebral ischaemia, with occasional consideration aspects involved in focal cerebral 
ischaemia.
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1.2.1 Rodent models of global cerebral ischaemia
Decapitation, cardiac arrest, increased intracranial pressure and most commonly, vascular 
occlusion (with and without systemic hypotension) have all been employed to induce 
global cerebral ischaemia in rodents. Lowry et al., (1964) induced global cerebral 
ischaemia in mice by decapitation to investigate the effects of ischaemia upon substrates 
and cofactors of the glycolytic pathway in the brain. More recently Woznicki and Walker 
(1980) investigated the utilisation of cyclocreatine phosphate during decapitation 
ischaemia in the mouse. Decapitation represents the simplest means of inducing global 
cerebral ischaemia. Xie et al., (1995) induced global cerebral ischaemia by cardiac arrest 
without resuscitation to investigate the role of ion channels in the early phase of global 
ischaemia in the rat. Decapitation and cardiac arrest without resuscitation are limited 
however, as there is no facility to investigate post-ischaemic recirculation. Cardiac arrest 
with resuscitation has also been used to induce global cerebral ischaemia in the rat and 
mouse (De Garavilla et al., 1984; Blomqvist et al., 1985; Kawai et al., 1992; Bottiger et 
al., 1995, 1999). Cardiac arrest with resuscitation enables investigation of post-ischaemic 
recirculation and more closely resembles global cerebral ischaemia in the clinical setting. 
However, cardiac arrest also damages systemic organs (especially the heart) and disturbs 
arterial blood gas and electrolyte concentrations. The effects of myocardial damage and 
disturbances in systemic physiologic parameters, such as, arterial blood gases and 
electrolytes on ischaemic neuronal damage are unknown (Tamura et al., 1995). Ljunggren 
et al., (1974) produced global cerebral ischaemia in rats by raising intracranial pressure 
such that cerebral blood flow was almost zero.
Vascular occlusion is the most common means by which global cerebral ischaemia can be 
induced in rodent models. The first report of reversible global cerebral ischaemia induced 
by vascular occlusion in a rodent was reported five decades ago. Levine and Payan (1966) 
described ischaemic neuronal damage in gerbils following ligation of the common carotid
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arteries. Levine and Sohn (1969) and Ito et al., (1975) later correlated ischaemic neuronal 
damage in gerbils following BCCAo with hypoplasticity in the circle of Willis. A large 
number of gerbils subjected to BCCAo of 15 minutes or more have post-ischaemic 
seizures which, can greatly influence ischaemic neuronal damage (Kuroiwa et al., 1990). 
The two classic models of global cerebral ischaemia in the rat were reported in the late 
1970s and early 1980s. Pulsinelli and Brierly (1979) produced severe global cerebral 
ischaemia in rat by bilateral occlusion of the vertebral arteries (day 0) followed by BCCAo 
(day 1). Smith et al., (1984) induced global cerebral ischaemia in rat by BCCAo with 
systemic hypotension (MABP circa 50mmHg). Production of global cerebral ischaemia in 
mouse by vascular occlusion dates from 1990. Himori et al., (1990, 1991) investigated the 
effects of BCCAo in mouse on learning deficits and mortality rates. Histological analysis 
of ischaemic neuronal damage following BCCAo in mouse was first reported by Barone et 
al., (1993). Since then several models of reversible global cerebral ischaemia (induced by 
vascular occlusion) have been reported in several strains of wild type mice (Panahian et al., 
1996, Fujii et al., 1997; Yang et al., 1997; Murakami et al., 1998a; Sheng et al., 1999; 
Section 3.1 in this thesis).
1.2.2 Rodent models of focal cerebral ischaemia
Rodent models of focal cerebral ischaemia, like rodent models of global cerebral 
ischaemia, can be induced permanently and transiently. The most commonly employed 
models of rodent focal cerebral ischaemia are based on occlusion of the middle cerebral 
artery (MCA). MCA occlusion (MCAo) in the rat has been in use since 1975 (Robinson et 
al., 1975). Tamura et al., (1981) induced permanent focal cerebral ischaemia in the rat by 
cauterising the MCA via a craniectomy. Zea Longa et al., (1989) described the induction 
of focal cerebral ischaemia in rat without craniectomy. Zea Longa et al., (1989) achieved 
permanent and transient focal cerebral ischaemia by advancing a suture (intraluminal 
thread) via the lumen of the carotid artery to the origin of the MCA, and either securing it
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in place or withdrawing it after a given duration. The intraluminal thread model has also 
been adapted for use in mice (Hara et al., 1996; Huang et al., 1996). Macrae et al., (1993) 
induced transient focal cerebral ischaemia by topical application of the vasoconstrictor 
peptide, endothelin 1. More recently, focal cerebral ischaemia has been induced in rat and 
mouse by embolic occlusion of the MCA (Zhang et al., 1997; Zhang et al., 1997).
1.3 Histopathology of cerebral ischaemia
1.3.1 Necrosis
Neuronal necrosis is commonly observed following cerebral ischaemia. The pathological 
hallmarks of necrosis are mitochondrial changes and increased influx of calcium across the 
cell membrane. Necrosis can essentially be regarded as a cytoplasmic event, as nuclear 
alterations are unclear. Briefly, the pathogenesis of ischaemic neuronal necrosis begins 
with ultrastructural changes in dendrites (Johansen et al., 1984; Olney, 1969a, 1969b, 
1971; Olney et al., 1971; Yamamoto et al., 1986, 1990). These dendritic abnormalities are 
thought to end in cell membrane breaks (Auer et al., 1985; Simon et al., 1985). 
Ultrastructural changes to ribosomes, cytoskeletal cell components and perturbation of 
cellular protein synthesis ensue (Kreutzberg et al., 1997). Necrosis induced by ischaemia 
(or other stimuli such as excitatory amino acids or hypoglycaemia) can be identified using 
light microscopy. These observable alterations are referred to as ischaemic cell changes. 
Shrunken cell body and pyknotic, shrunken nucleus, signal Ischaemic cell change. 
Moreover, ischaemic cells often become triangular in shape and demonstrate increased 
affinity for acid dies such as eosin (Figure 2). If ischaemic neuronal damage is 
irreversible, cells further shrink and finally undergo homogenising cell change followed by 
ghost cell change, resulting in shrunken, pyknotic and fragmented nuclei without 
recognisable cytoplasm (Adams and Graham, 1989). It should be noted that the light 
microscopic characteristics of ischaemic cell change might also be observed in apoptosis.
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Figure 2 Ischaemic cell change
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Haematoxylin and eosin histological staining to identify morphologically abnormal 
pyramidal neurones of hippocampus CA1 exhibiting features of ischaemic cell change (A) 
and morphologically normal pyramidal neurones of hippocampus CA1 exhibiting no 
features of ischaemic cell change (B). (Original magnification X200).
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However, necrotic cells generally die in large clusters, whereas apoptotic cells tend to die 
singly (Kerr et al., 1972; Majno et al., 1995).
1.3.2 Apoptosis
Apoptosis refers to cell death which can occur spontaeneously as a physiological event 
during life (Kerr et al., 1972; Wylie et al., 1990; Cohen, 1991; Sen, 1992; Hockenbery, 
1995; Majno et al., 1995) and can be triggered by a variety of insults including ischaemia 
(McManus et al., 1993). Apoptosis is essentially a nuclear event and can be divided into 
classic apoptotic cell death, autophagia and non-lysosomal vesiculate cell death (Clarke, 
1990). The pathophysiological hallmark of apoptotic cell death is inter-nucleosomal DNA 
fragmentation (DNA laddering), into fragments of approximately 180-200 base pairs 
(Arends et al., 1990). Apoptosis has a distinct morphology, which begins with changes to 
the outer membrane of the cell nucleus (Kerr et al., 1972). Light microscopic 
identification of apoptotic cells was facilitated by the establishment of terminal transferase 
mediated nick-end labelling (TUNEL) (Gavrieli et al., 1992). The TUNEL technique 
labels exposed DNA endings, on fragmented DNA, with labelled nucleotides. It should 
however be noted that DNA endbreaks are not specific to apoptosis, but may also occur 
during necrosis. Therefore, single-stranded DNA breaks require confirmation by 
ultrastructural identification.
1.3.3 Pan-necrosis
In pan-necrosis (infarction) all cellular elements of the CNS (neurones, glial cells and 
vascular components) die. Pan-necrosis is generally associated with focal, rather than 
global cerebral ischaemia, as cerebral blood flow to a specific territory is blocked 
permanently (or for a prolonged period). Several other conditions have also been reported 
to induce pan-necrosis including, lactic acidosis (Bogousslavsky et al., 1982; Kuriyama et
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al., 1984; Pavlakis et al., 1984; Mukoyama et al., 1986), status epilepticus (Nevander et 
al., 1985) and hypoglycaemic ischaemia (Inamura et al., 1987, 1988).
1.3.4 Selective vulnerability and delayed neuronal death
During global cerebral ischaemia the brain is deprived of blood flow. Blood represents the 
major source of oxygen and glucose, which are essential for brain function (see Section 
1.5). Following transient cessation of blood flow to the brain, damage is restricted to 
specific brain regions (Adams and Graham, 1989; Auer and Beneviste, 1997). Six major 
brain regions are classically reported to be selectively vulnerable to global cerebral 
ischaemia (hippocampus, cortex, thalamus, basal ganglia, cerebellum and brainstem) 
(Auer, 1998). Within each of these brain regions, hierarchies of vulnerability exist. That 
is to say, some cell types are highly vulnerable while others may not be affected. 
Pyramidal neurones of the hippocampus CA1 sub-field have been shown to be more 
vulnerable than other hippocampal cell types to mild global cerebral ischaemia in gerbil 
(Kirino, 1982; Araki et al., 1989) and rat (Smith et al., 1984) and humans (Adams and 
Graham, 1989). Although other cell types of the hippocampal formation, such as, 
subiculum and CA4 have been reported to have minor damage after such mild global 
ischaemic insults, the remainder of the hippocampus is relatively unscathed. Where the 
duration (or severity) of global cerebral ischaemia is increased, ischaemic neuronal damage 
is not only observed in CA1 but is also observed more frequently in subiculum, CA4, CA3 
and eventually in dentate gyrus (Smith et al., 1984).
Global cerebral ischaemia in humans and experimental animals produces ischaemic 
neuronal damage in hippocampus CA1 pyramidal neurones which matures over a period of 
a few hours to a few days (Ito et al., 1975; Pulsinelli and Brierly, 1979; Kirino, 1982; 
Kirino and Sano, 1984a; Smith et al., 1984; Petito et al., 1987; Bonnekoh et al., 1990; 
Horn and Scholte, 1992). Pulsinelli et al., (1982) investigated the relationship between
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ischaemic neuronal damage and survival time in rats subjected to 30 minutes of global 
cerebral ischaemia. Pulsinelli and colleagues reported that at three-hour survival 65% of 
rats had no ischaemic neuronal damage in CA1; at six-hour survival 57% of rats had no 
ischaemic neuronal damage in CA1; at 24-hour survival 40% of rats had no ischaemic 
neuronal damage in CA1; and at 72-hour survival 0% of rats had no ischaemic neuronal 
damage in CA1. This phenomenon is known as delayed neuronal death and occurs despite 
rapid restoration of hydrogen, sodium, potassium and water in cells and fairly rapid 
recovery of high energy phosphate levels following restoration of cerebral blood flow 
(Siesjo etal., 1995).
1.3.5 Delayed neuronal death: necrosis versus apoptosis
The time course with which delayed neuronal death occurs in hippocampus CA1 pyramidal 
neurones following global cerebral ischaemia (typically 24-72 hours post-ischaemia, lto et 
al., 1975; Pulsinelli and Brierly, 1979; Kirino, 1982; Kirino and Sano, 1984; Smith et al., 
1984; Petito et a l , 1987; Bonnekoh et al., 1990; Horn and Scholte, 1992) could be 
consistent with apoptosis (Colboume et al., 1999). Neurochemical analysis suggests 
delayed neuronal death in hippocampus CA1 pyramidal neurones is apoptotic (McManus 
et al., 1993, 1995; Okamoto et al., 1993; Kihara et al., 1994; Iwai et al., 1995; Honkaniemi 
et al., 1996; MacManus and Linnick, 1997; McManus et al., 1999). Ultrastructurally, 
necrosis and apoptosis have distinct morphologies, with necrosis being considered 
predominantly a cytomplasmic event (Colboume et al., 1999). Electron microscopy of 
hippocampus CA1 pyramidal neurones which displayed delayed neuronal death following 
global cerebral ischaemia predominantly highlights features of necrotic cell death (Kirino 
and Sano, 1984b; Johansen et al., 1984; Yamamoto et al., 1990; Desphande et al., 1992; 
Tomimoto et al., 1993; Colboume et al., 1999). Nitatori et al., (1995) however, describe 
features of apoptotic cell death in hippocampus CA1 pyramidal neurones following global 
cerebral ischaemia. The conclusions of Nitatori et al., (1995) have been questioned by
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Colboume et al., (1999) who claim to observe similar results which they say are markers 
of necrotic cell death. On balance, the compelling evidence from ultrastructural studies 
strongly suggests necrosis as a mechanism leading to delayed neuronal death in 
hippocampus CA1 pyramidal neurones following global cerebral ischaemia. However, the 
substantial neurochemical evidence and the ultrastructural evidence of Nitatori et al., 
(1995) also imply apoptosis, as a process leading to delayed neuronal death in 
hippocampus CA1 neurones following global cerebral ischaemia. It is likely that both 
necrotic and apoptotic mechanisms contribute to cellular death following global cerebral 
ischaemia. While both necrosis and apoptosis are recognised to contribute to CNS 
pathology following global cerebral ischaemia, this thesis studied necrotic ischaemic 
neuronal damage using haematoxylin and eosin histochemical staining (as described in 
Sections 1.3.1 and 2.6.3).
1.3.6 Cerebral vasculature
Theoretically, BCCAo in normal, healthy rodents should not be sufficient to induce 
widespread ischaemic cell change, because of increased collateral blood flow to the brain 
via the basilar artery. BCCAo alone however, is commonly employed as a model of global 
cerebral ischaemia in gerbils and mice whereas BCCAo in rats, is only employed as a 
model of global cerebral ischaemia when accompanied by haemorrhagic hypotension 
(Smith et al., 1984). However, BCCAo in gerbil and mouse is sufficient to induce 
considerable ischaemic damage in several forebrain structures. The reason for this is poor 
communication between anterior and posterior cerebral circulation. In gerbil, ischaemic 
neuronal damage following BCCAo was first correlated with hypoplasticity of the circle of 
Willis by Levine and Sohn (1969) and Ito et al., (1975). Since then BCCAo in the gerbil 
has been used extensively as a model of global cerebral ischaemia. In mouse, ischaemic 
neuronal damage following BCCAo was first correlated with hypoplasticity of the circle of 
Willis by Barone et al., (1993). Due largely to a growing availability of genetically
modified mice, a succession of studies have reported similar vascular anomalies in several 
mouse strains (Fujii et al., 1997; Yang et al., 1997; Murakami et al., 1998; Section 3.1 of 
this thesis).
1.3.7 Temperature
Brain temperature can influence the degree of neuronal damage induced by global cerebral 
ischaemia. Hypothermia has been shown to delay neuronal necrosis in experimental 
models of global cerebral ischaemia (Dietrich et al., 1993). Hypothermia has also been 
shown, in experimental models of global cerebral ischaemia, to reduce ischaemic damage 
(Busto et al., 1987; Colboume et al., 1994, 1995). Furthermore, hypothermia has been 
employed in neurosurgical and cardiac procedures requiring interruption of the cerebral 
circulation with some success (Ginsberg et al., 1992). In contrast, hyperthermia during 
global cerebral ischaemia has been shown to exacerbate ischaemic neuronal damage 
(Dietrich et a l, 1990). However, prolonged periods of hyperthermia before induction of 
global cerebral ischaemia, have been shown to reduce ischaemic neuronal damage 
(Kitagawa et al., 1992). These reductions in ischaemic neuronal damage following global 
cerebral ischaemia after hyperthermic pre-conditioning have been associated with 
expression ofhsps (see Section 1.7.3).
1.3.8 Global cerebral ischaemia
Global cerebral ischaemia (as opposed to focal cerebral ischaemia) was chosen to 
investigate the influence of hsp 70i in ischaemia in this thesis for two reasons. First, and 
most importantly, hsp 70i transgene expression in the transgenic mice used was driven by 
the rhombotin-1 promoter (also known as promoter 1 of the LMO-1 gene, Greenburg et al., 
1990) meaning hsp 70i was over-expressed in several brain regions known to be 
selectively vulnerable to global cerebral ischaemia (see Section 2.9 for details). Second,
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global cerebral ischaemia enabled inter-hemispheric comparison of ischaemic neuronal 
damage in mice unilaterally injected with adenovirus (ad) hsp 70i.
1.4 Mechanisms of ischaemic cell death
Following global cerebral ischaemia in a number of species, hippocampus CA1 pyramidal 
neurones display delayed neuronal death (Ito et al., 1975; Pulsinelli and Brierly, 1979; 
Kirino, 1982; Kirino and Sano, 1984a; Smith et al., 1984; Petito et al., 1987; Bonnekoh et 
al., 1990; Horn and Scholte, 1992) while death in other structures, such as the striatum, is 
more rapid (Pulsinelli et al., 1982; Crain et al., 1988). The mechanisms leading to 
ischaemic cell death, be it delayed or rapid, are not yet fully elucidated. One major theory 
involves the release of neurotransmitters (notably glutamate) which leads to neuronal 
calcium overload. Calcium overload is thought to mediate activation of second messenger 
systems, inflammatory genes, production of free radicals, lipases and proteases, and 
induction of genes regulating apoptosis.
1.4.1 Glutamate excitotoxicity and calcium overload
The role of glutamate as a brain neurotransmitter was accepted in the 1980s (Watkins & 
Evans, 1981; Wroblewski & Danysz, 1989). Glutamate is the major fast excitatory 
neurotransmitter in the brain (McCulloch, 1994). However, the action of glutamate upon 
its receptors has been implicated as one of the leading theories contributing to ischaemic 
brain injury. Dialysis studies have indicated that background extracellular concentrations 
of glutamate are maintained between 1 and 5pM, while intracellular concentrations are 
maintained between 5 and lOmM. The differences in extracellular and intracellular 
glutamate are maintained by transmembrane sodium, potassium and charge gradients 
driving glutamate uptake (Attwell et al., 1993). In ischaemic neurones deprived of oxygen 
and glucose high-energy phosphates are lost and the cells depolarise. Depolarisation leads 
to synaptic release of glutamate and reversal of electrogenic transport of glutamate from
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astrocytes (Nicholls & Attwell, 1990). Extracellular glutamate increases and stimulates a- 
amino-2, 3-dihydro-5-methyl-3-oxo-4-isoxalepropanoic acid (AMPA), kainate and N- 
methyl-D-aspartate (NMDA) receptors which leads to an influx of sodium and calcium 
through the channels gated by these receptors. Excessive calcium influx is mediated 
directly and predominantly by NMDA receptors. Calcium influx however, can also be 
effected secondarily by sodium influx through AMPA; kainate and NMDA gated channels 
via activation of voltage gated calcium channels and reverse operation of the 
sodium/calcium exchanger. Sustained, excessive calcium concentrations are thought to 
trigger lethal metabolic derangements (Choi, 1988, Kristian and Siesjo, 1998). Excessive 
concentrations of intracellular calcium mediate cellular injury and death via several 
pathways, including activation of proteases, lipases and endonuleases and the production 
of cytokines and other factors, which directly or indirectly cause cell injury or death 
(Figure 3). Another divalent cation, zinc, has also been postulated to play a role in 
ischaemic cell death (Johansen et al., 1993; Choi and Koh, 1998; Tonder et al., 1998).
1.5 Energy generation in the brain
In an adult human the brain constitutes around 2% of body mass. Despite its relatively 
small size it receives 15% of cardiac output, consumes 20% of total body oxygen and is 
responsible for 25% of total body glucose utilisation (Edvinsson et al., 1993). Glucose 
utilisation in the adult human brain is 30pmole / lOOg / minute. Under normal, non-fasting 
conditions, the brain depends almost exclusively upon glucose as its source of energy 
(Kety, 1948; Sokoloff, 1977; Siesjo, 1978). Brain glucose concentration varies directly 
with plasma glucose concentration, tissue glucose is characteristically 10-15% lower than 
plasma glucose. Glucose is transported into brain cells rapidly by carrier mechanisms with 
greater affinity than those in cerebral endothelium. As much as 90% of brain glucose is 
aerobically catabolised. Hexokinase is responsible for the phosphorylation of glucose in 
the brain. The rate of glucose phosphorylation in the brain is governed only by the product
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of hexokinase, glucose-6-phosphate i.e., negative feedback. Glucose-6-phosphate is in 
turn converted to fructose-6-phosphate by phosphohexose isomerase, which is further 
metabolised by the glycolytic and tricarboxylic acid pathways. Each molecule of glucose 
metabolised in this manner yields 33 high energy phosphates. The remainder of the brain 
glucose fulfils several other important roles within the brain. For instance, glucose 
represents the principle source of carbon in cerebral lipids and is a precursor for 
neurotransmitters such as, y-aminobuteric acid (GABA), glutamate and acetylcholine. 
Only 2% and 0.3% of all cerebral glucose utilisation is used for lipid and protein synthesis, 
respectively. The pentose phosphate pathway is responsible for catabolising a small 
portion of cerebral glucose, estimated at -3%  in the rat and -6%  in non-human primates 
(Siesjo, 1978; Gaitmonde et al., 1983; Clarke et al., 1989). The only other energy 
generating substrates within the brain, besides glucose, is glucose stored in the tissues as 
glycogen and ketone bodies. The levels of both are minimal under normal circumstances. 
The requirement of three grams of water for every gram of glycogen limits the glycogen 
levels in the brain (Cahill & Aoki, 1980). In the absence of glucose, these levels of 
glycogen could only support metabolic activity for a few minutes (Siesjo, 1978). 
Oxidation of ketone bodies in the brain in well-nourished animals is negligible. However, 
after 24 hours of starvation the contribution of ketone bodies to overall oxygen 
consumption rises from less than 1% to 20% (Siesjo, 1978).
1.6 Mapping brain function with 14C-2-deoxyglucose autoradiography
The 14C-2-deoxyglucose autoradiography technique developed by Sokoloff et al., (1977) is 
an excellent tool with which neuroscientists can map brain function in vivo. The 
neurophysiological and neuropharmacological applications of 14C-2-deoxyglucose 
autoradiography are widespread. This is largely due to its ability to enable determination 
of local cerebral glucose utilisation (LCGU) in discrete and functionally diverse brain 
regions in conscious, freely moving animals. The conceptual basis for 14C-2-deoxyglucose
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autoradiography stems from two simple premises: (1) under normal, non-fasting
conditions the energy requirements of the adult brain are derived almost exclusively from 
the aerobic catabolism of glucose (Kety, 1948; Sokoloff, 1977; Siesjo, 1978), and (2) 
functional activity and energy metabolism within any region of the brain is associated 
intimately and directly (Sokoloff, 1977).
1.6.1 Concept
Tower (1958) reported glucose uptake and phosphorylation in brain slices to be inhibited 
by 2-deoxyglucose, an analogue of glucose (Figure 4). This was accompanied by an 
accumulation of 2-deoxyglucose-6-phosphate in the tissue. Bachelard (1971) and 
Oldendorf (1971) reported that the entry of glucose and 2-deoxyglucose into the brain was 
mediated via the same carrier mechanism. Once in the brain tissue, the hexokinase enzyme 
phosphorylates both glucose and 2-deoxyglucose. Glucose becomes glucose-6-phosphate, 
while 2-deoxyglucose becomes 2-deoxyglucose-6-phosphate. At this point glucose-6- 
phosphate is further metabolised via the glycolytic and tricarboxylic acid pathways and / or 
the pentose phosphate pathway (Bachelard, 1971). 2-deoxyglucose-6-phosphate is not a 
substrate for the primary enzymes of the above pathways, instead it is metabolised by 
glucose-6-phosphatase. Glucose-6-phosphatase hydrolyses 2-deoxyglucose-6-phosphate 
into deoxyglucose. In brain tissue glucose-6-phosphatase activity is also extremely low 
(Sokoloff et al., 1977; Sokoloff, 1979). The limited glucose-6-phosphatase concentration 
present within the brain is associated with the cerebral capillaries rather than the tissue 
itself (Goldstein et al., 1975). Accordingly, glucose-6-phosphatase activity is not a major 
concern in the use of 2-deoxyglucose in the brain, except when the measurement period is 
much greater than 45 minutes (Sokoloff, 1979).
By radiolabelling 2-deoxyglucose with I4C, Sokoloff et al., (1977) capitalised on the 
inability of the brains biochemical processes to metabolise 2-deoxyglucose by developing
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Figure 4 Diagrammatic representation of glucose and 2-deoxyglucose
2-deoxyglucose differs from glucose in that it lacks a hydroxyl group on the 2-carbon 
position. Adapted from McCulloch, 1982.
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a theoretical model (Figure 5). This model enabled the rate of glucose utilisation to be 
described mathematically by a single equation (Figure 6). The equation, known as the 
‘operational equation’ (Sokoloff et al., 1977) permits the rate of LCGU to be calculated 
from (1) the levels of plasma glucose and 14C throughout the experimental period, and 
(2) the regional tissue concentration of 14C at the end of the experiment (as derived using 
pre-calibrated standards).
1.6.2 Operational equation
The operational equation describes the rate of cerebral glucose utilisation (R i) in terms of 
the concentration of plasma 14C-2-deoxyglucose (Cp*) and plasma glucose levels (Cp) over 
the experimental time (T) and the concentration of 14C  found within the brain tissue (C i* ). 
The distribution 14C-2-deoxyglucose between plasma and brain tissue is governed by the 
rate constants kj*, k2 * and its phosphorylation to 2-deoxyglucose-6-phosphate k3 *. These 
rate constants are not measured for each experiment. Instead the original values 
determined by Sokoloff et al., (1977) in the original description of the method are used.
1.6.3 Constraints
The 14C-2-deoxyglucose autoradiographic technique is subject to several constraints: (1) 
the composite, lumped constant and the kinetic constants must be known for the region and 
condition being investigated, (2) the rate of glucose utilisation must remain constant over 
the period of measurement, (3) plasma glucose must remain constant over the 
experimental period, and (4) plasma 14C-2-deoxyglucose and glucose must be 
representative of those in the cerebral capillaries. Variation of the lumped constant, which 
is a major determinant of the amount of 14C retained in the brain, is not often altered under 
normal physiologic conditions. The lumped constant is not affected by marked changes in 
glucose utilisation (Sokoloff et al., 1977), changes in cerebral blood flow (Sokoloff, 1979) 
or by moderate hypo or hyperglycaemia (McCulloch, 1982). The lumped constant can
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Figure 5 Theoretical model of 14C-2-deoxy glucose autoradiography
PLASM A BRAIN TISSUE
Precursor Pool I Metabolic Products
[,4C]Oeoxyglucose
(Cp)
Glucose
(Cp)
CO
[,4C|Deoxyglucose 
(C|)
If*
— [14C]Deoxyglucose-6-Phosphate
! (Cm )
C j-  C | *C m
it
Glucose f  Glucose-6-Phosphate
TOTAL TISSUE “C CONCENTRATION 
I
(Ce) (Cm)
CO2 - H 2 O
Cp* and Cp represent the concentrations of 14C-2-deoxyglucose and glucose in arterial 
plasma, respectively; C e*  and C e  represent their respective concentrations in the tissue 
pools that serve as substrates for hexokinase. Cm * represents the concentration of 14C-2- 
deoxyglucose in brain tissue. Ki*, K2* and K 3* are the glucose rate constants. Adapted 
from Sokoloff et al., 1977.
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Figure 6 14C-2-deoxyglucose operational equation
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Figure shows the operational equation of the 14c-2-deoxyglucose method. T  represents the 
time at termination of the experimental period; X equals the ratio of the distribution space 
of deoxyglucose in the tissue to that of glucose; O equals the fraction of glucose. KM*, 
VM* and Km, Vm represents the familiar Michaelis-Menten kinetic constants of hexokinase 
for deoxyglucose and glucose, respectively. The other symbols are the same as those 
defined in Figure 5. Adapted from Sokoloff, 1978.
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however, be altered by severe hypoglycaemia and hyperglycaemia (McCulloch, 1982), and 
structural alteration in brain tissue (Ginsberg & Reivich, 1979). The lumped constant 
displays differences between species (Sokoloff, 1979). The constancy of plasma glucose 
and the rate of glucose utilisation during the period of measurement impose only minor 
restrictions on experimental design (McCulloch, 1982).
1.6.4 Utility
LCGU, as measured by the 14C-2-deoxyglucose autoradiography technique, predominantly 
reflects electrical activity in nerve terminals (Schwartz et al., 1979). As alterations in 
glucose utilisation correspond to the activity in axonal pathways, changes in glucose use 
will not be restricted to receptor localisation, but also to the neuronal pathways connected 
to these regions. In consequence the l4C-2-deoxyglucose autoradiography technique is 
ideal for mapping cerebral function in neuronal circuits. 14C-2-deoxyglucose 
autoradiography has been used extensively to investigate the functional effects of several 
neuropharmacologic and neurophysiologic stimuli (McCulloch, 1982). Many of these 
studies were carried out in the rat, however Nowacyk and Des Rosier (1981) adapted the 
original 14C-2-deoxyglucose technique of Sokoloff et al., (1977) for use in the mouse. 
Browne et al., (1999) employed the fully quantitative 14C-2-deoxyglucose method of 
Nowacyk and Des Rosier (1981) to investigate the consequences of endothelial and 
neuronal nitric oxide deficiency in knockout mice. Fully quantitative 14C-2-deoxyglucose 
autoradiography in mice is technically demanding and very invasive. In this thesis a 
modification of the original ,4C-2-deoxyglucose technique of Sokoloff et al., (1977) was 
established in the mouse (see Sections 2.7.3 and 2.7.5). The semi-quantitative approach 
implemented only required intraperitoneal injection of 14C-2-deoxyglucose and collection 
of a terminal blood sample, meaning it was not technically demanding or overly invasive. 
Using this approach the first reports of LCGU in transgenic mice over-expressing hsp 70i 
(Section 3.4) and ad egfp transfection in the mouse brain (Section 3.5) have been reported.
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1.7 Heat shock proteins
Heat shock proteins (hsps) have been the subject of extensive investigation over the past 
four decades. Approximately 12,500 publications relating to these proteins are cited in the 
Medline database since 1962. The major eukaryotic hsps form a super-family consisting of 
several sub-families (Table 1). Subfamilies are identified by molecular weight and are 
further sub-divided according to cellular localisation, expression pattern and function. The 
70-kilo Dalton family (hsp 70s) are the most abundant and conserved of these sub-families. 
Hsps may be expressed constitutively (e.g., heat shock cognate protein 70, hsc 70) or be 
induced (e.g., heat shock protein 70, hsp 70i). Constitutive proteins can also be induced, 
while some highly inducible proteins can be expressed basally at very low levels. Both 
constitutively expressed and inducible hsps are essential for development and cellular 
function (no hsp 70i null mice have been produced). Hsps can be induced by an array of 
stimuli including ischaemia (Currie and White, 1981; Nowak, 1985; Dienel et al., 1986; 
Jacewizc et al., 1986; Vass et al., 1988; Gonzalez et al., 1989), hyperthermia (Ritossa, 
1962; Heikkila et al., 1979; Heikkila and Brown, 1979a, 1979b; Freedman et al., 1981; 
Cosgrove et al., 1982), heavy metals (Wagner et al., 1990; Lee et al., 2000) and 
pharmacologic agents (Sharp et al., 1991; Planas et al., 1994; Armstrong et al., 1996; 
Kondo et al., 1997) (Figure 7). The balance between constitutively expressed and 
inducible hsps has been hypothesised to play a critical role in cellular homeostasis 
(Latchman, 1998). Hsps are thought to direct repair, refolding and trafficking of abnormal 
intracellular proteins by acting as molecular chaperones (Massa et al., 1995; Morimoto 
1998; Sharp et al., 1999). In view of these activities it has been hypothesised the heat 
shock response may act as some kind of primeval mechanism facilitating cell survival after 
insult.
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1.7.1 The heat shock response: discovery and description
Since the 1950s puffing patterns in diptera polytene chromosomes were known to change 
in a very regular manner during larval development (see Ashbumer, 1982). Beerman 
suggested that chromosome puffs represent actively transcribed genes and were sites of 
active gene loci (Beerman, 1956). Throughout the 1950s there was a great deal of interest 
in the type of nucleic acid synthesised in puffs of the salivary gland chromosomes of 
Drosophila. Clever and Karlson (1960) reported that ecdysteroid hormones mediated 
alterations in chromosome puffing patterns. Ritossa (1962) reported the first description of 
a heat shock response. Ritossa discovered a new puffing pattern in salivary gland polytene 
chromosomes of Drosophila busckii induced by elevated temperature and 2-4 
dinitrophenol treatment. Serendipity had played a part in these discoveries as Ritossa 
identified this new cellular response only after a colleague had mistakenly increased the 
temperature of his incubator. This was the first description that puffing patterns could be 
manipulated by external stimuli. The work of Ritossa (1962, 1964) was complemented 
and extended by Berendes and Holt (1964), Berendes (1965a and 1965b) and Ashbumer 
(1970). These groups investigated the effects of heat shock and other stresses in 
Drosophila hydei and Drosophila melanogaster. By the 1970s the heat shock response in 
diptera had been extensively characterised. First, the heat shock response was transient, 
with puffs reaching maximal size at about 30 minutes post heat shock. Second, heat shock 
puffs occurred in isolated organ preparations, i.e., an intact organism was not required for 
an heat shock response. Third, the heat shock response was not specific to tissue type or a 
particular stage of development.
Tissieres et al., (1974) initiated investigation into the functional relevance of heat shock 
puffs using sodium dodecyl sulphate gel electrophoresis and radiolabelled amino acids. 
Tissieres et al., (1974) reported that heat shock induced synthesis of a small number of 
proteins, but reduced synthesis of most other proteins in Drosophila melanogaster salivary
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glands, brain and malphigian tubules. Lewis et al., (1975) confirmed that these newly 
induced proteins were synthesised by heat shock puffs. McKenzie et al., (1975) and 
Spralding et al., (1975) reported identical heat shock responses in cultured Drosophila 
cells. McKenzie et al., (1977) and Mirault et al., (1978) provided strong in vitro evidence 
that hsps were coded for by the induced puffs. They achieved this by isolating heat shock 
messenger RNA, hybridising it back into polytene chromosomes and observing its 
translation in vitro into hsps. It was not long before the heat shock response was realised 
to be far more complex than originally envisaged. Lis et al., (1978) cloned the first heat 
shock induced transcripts. These transcripts did not however bear the hallmarks of 
messenger RNA. The confusion was heightened by the first genetic correlation 
experiments into heat shock puffs and hsps. Ish-Horowitz et al., (1977, 1979) reported that 
hsps were synthesised in Drosophila melanogaster embryos that had been modified to lack 
sites known to code hsp synthesis. These findings were explained when certain puffs were 
discovered at duplicate loci, both containing multiple hsp coding sequences (see 
Ashbumer, 1982).
In 1978 mammalian and avian hsps were discovered (Kelley & Schlesinger, 1978; 
Hightower & Smith, 1978). The same proteins had been synthesised following heat shock 
and amino acid analogue (canavanine) treatment. Also in the same year, analogous heat 
shock (stress) responses were reported in bacteria (Lemeaux et al., 1978; Yamamori et al., 
1978), and Tetrahymena (Fink & Zeuthen, 1978). By 1980 hsps had been reported in 
hamster cells (Bouche et al., 1979), yeast (Miller et al., 1979; McAlister et al., 1979), 
Naegleria (Walsh et al., 1980) plants (Barnett et a l , 1980) and rat (White, 1980b). It was 
now apparent that the so-called heat shock response, was not species dependant and could 
be evoked by a variety of stimuli (stresses) and not increased temperature alone. 
Hightower and White (1981) reported that the two proteins they had been working on 
independently in different species, in different systems, were the same protein. They also
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reported the discovery of a constitutive protein they called P73 (now known as hsc 70). 
The same publication was responsible for the introduction of the terms ‘cellular stress 
response’ and ‘stress proteins’ into the literature.
1.7.2 Hsps and the CNS
Hsps in the Drosophila nervous system were discovered by Tissieres et al., (1974). White 
(1980a; 1980b; and 1981) reported hsps in the mammalian CNS. In these publications 
White described a variety of proteins expressed in explanted rat brain slices. He did not 
immediately refer to them as hsps as they had not been classically induced following a heat 
shock. Instead White suggested these proteins were induced by the trauma of brain slicing 
and explantation. White had set about establishing an amenable means of studying normal 
brain protein synthesis in the CNS. The fact that these ‘trauma induced’ proteins in brain 
slices were not observed in vivo meant that this system might be flawed. White however, 
continued his studies of brain protein synthesis by investigating the proteins he had 
uncovered. Currie and White (1981, 1983) described induction of the same protein 
induced by brain slicing (known then as SP71) in vivo after heat shock. Throughout this 
period Browns laboratory in Canada had been investigating the effect of D-lysergic acid 
diethylamide (LSD) and bacterial pyrogen induced hyperthermia in the rabbit CNS 
(Hekkila et al., 1979; Hekkila and Brown, 1979a, 1979b). These studies concluded that 
whole body hyperthermia caused dissagregation of brain polysomes. Freedman et al., 
(1981) and Cosgrove et al., (1982) went on to show that LSD induced messenger RNA 
which coded for a 74 kilo Dalton protein. Brown and co-workers continued throughout the 
early 1980’s to report similar increases in such proteins in the rabbit CNS following 
hyperthermia.
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1.7.3 Hsp 70i and cerebral ischaemia
In the ischaemic brain, protein synthesis is markedly decreased (Dienel et al., 1980; 
Kleihues & Hossman, 1981; Kirino & Sano, 1984; Thilman et al., 1986). While protein 
synthesis decreases there is considerable evidence that mRNA synthesis is less affected 
(Yanagihara, 1976, 1978). Currie & White (1981) first reported induction of hsp 70i in the 
ischaemic brain. This description was somewhat non-comprehensive as they reported 
induction of hsp 70i (known then as P7 1) in the ‘brain’ in a single animal following 30- 
minute occlusion of one common carotid artery. Nowak (1985) provided a comprehensive 
description that transient global cerebral ischaemia in the gerbil (BCCAo) resulted in hsp 
70i expression. Dienel et al., (1986) reported expression of hsp 70i following global 
cerebral ischaemia in the rat soon after (four vessel model, bilateral carotid and vertebral 
artery occlusion). Jacewizc et al., (1986) demonstrated expression of hsp 70i following a 
focal cerebral ischaemic insult (all o f these studies employed protein synthesis assays). 
Although this approach adequately determined the protein content in a defined sample of 
brain tissue, it could not delineate the localisation of hsp 70i. Welch & Suhan (1986) 
developed a monoclonal antibody to hsp 70i. Vass et al., (1988) and Gonzalez et al., 
(1989) were the first to employ this antibody in studies of cerebral ischaemia. The cellular 
distribution of hsp could now be related to ischaemic cell damage following ischaemic 
insult. Vass et al., (1988) employed the BCCAo model of global cerebral ischaemia in 
gerbils. They studied the distribution and time course of hsp 70i and related that to the 
distribution and time course of ischaemic neuronal damage. Vass and colleagues 
concluded that hsp 70i expression was most prevalent in neurons in brain regions which 
survived ischaemic challenge (i.e., the hippocampus CA3, dentate gyrus and entorhinal 
cortex). Brain regions in which cell death was evident (such as the hippocampus CA1) 
expressed only minimal hsp 70i expression. The time course of hsp 70i expression was 
maximal in hippocampus CA3 at 48 hours post insult. Gonzalez et al., (1989) described 
the pattern of hsp 70i following focal cerebral ischaemia. Hsp 70i was located in cells
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within the tissue margin surrounding the infarct core (i.e., in the penumbra). Extensive 
characterisation of the distribution and time course of hsp 70i expression following 
ischaemic insult ensued (see Massa et al., 1996 for review).
In 1990 Nowak reported, in a BCCAo model of global cerebral ischaemia in gerbil, that 
hsp 70i mRNA was strongly expressed in hippocampus CA1 neurones. A new series of 
studies investigating the distribution and time course of hsp 70i mRNA expression 
following various ischaemic insults began (Abe et al., 1991, 1992, 1993; Kawagoe et al., 
1993; Aoki et al., 1993a, 1993b, 1993c). These studies led to the belief that hsp 70i and 
hsp 70i mRNA could be used as markers of neuronal damage. There was however, 
growing evidence that stress induced proteins (including hsp 70i) could function to protect 
neurones and other cell types from ischaemic injury. Efforts to resolve the dichotomy 
utilised two distinct lines of investigation, conditioning studies and cell culture studies. 
The classic conditioning studies of Chopp et al., (1989) and Kirino et al., (1991) took 
advantage of the fact hsp 70i was induced by transient hyperthermia and ischaemia, 
respectively. Chopp et al., (1989) subjected rats to global cerebral ischaemia (BCCAo 
with hypotension) 24 hours after elevating the body temperature of rats to 41.5°C. A 
significant reduction in ischaemic neuronal damage compared with that of non-heat treated 
animals was observed. Kirino et al., (1991) pre-treated gerbils with two-minutes of 
BCCAo; one day later the same animals were subjected to five minutes of BCCAo. Kirino 
and colleagues, like Chopp et al., (1989), reported a significant decrease in the subsequent 
ischaemic neuronal damage, compared with untreated animals. This phenomenon, known 
as ischaemic tolerance, may involve hsp 70i as it is detected after such pre-treatments. 
However, many other stress-related proteins can also be detected in vivo following such 
interventions. Where cells in culture were manipulated to study the remedial effects of hsp 
70i on simulated ischaemia, this doubt was less evident. In many of these studies neurones 
and other cell types were expressing hsp 70i and so were protected from ischaemic insult
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(Lowenstein et al., 1991; Dwyer & Nishimura, 1994; Mailhos et al., 1994; Amin et al., 
1996; Xu & Giffard, 1997).
1.7.4 Regulation of hsp 70i
As hsps play important roles in normal and stressed cells, a complex regulatory process is 
required to ensure the correct expression patterns are maintained. These processes must 
also be operative in early development since hsp 70i and hsp 90 have both been shown to 
be amongst the first genes transcribed from the embryonic genome (Latchman, 1998). 
Heat shock factors (hsfs) essentially regulate the heat shock response. Lower organisms 
such as yeast and drosophila display only one hsf (Sorger & Pelham, 1988; Gallo et al., 
1993), while higher organisms such as plants, mice, chickens and humans exhibit multiple 
hsfs (Sorger et al., 1991; Schuetz et al., 1991; Nakai & Morimoto, 1993; Treuter et al., 
1993; Czamecka-Vemer et al., 1995; Nakai et al., 1997). Vertebrates ubiquitously exhibit 
hsf-1, hsf-2 and hsf-3 with hsf-4 found only in avian species (Morimoto, 1998). Following 
suitable stress in eukaryotic cells, hsf-1 binds to highly conserved regulatory sequences 
known as heat shock elements (hses). Hses are found on the heat shock gene. Once bound 
hsf-1 controls the expression of hsps (Wu, 1984; Sarge et al., 1987; Zimarino &Wu, 1987; 
Larson et al., 1988; Abrayava et al., 1992; Mivechi et al., 1992). Stress causes hsf-1 to 
trimerize enabling it to bind to DNA (i.e., the hses) and phosphorylate (Sarge et al., 1987; 
Kim et al., 1997). In mice and humans this hsf-1 trimerisation, binding and 
phosphorylation can activate the transcription of several hsps following heat shock and 
other stresses (Sarge et al., 1991; Schuetz et al., 1991; Mivechi et al 1992). Hsf-1 is 
readily activated in response to an array of stimuli (generally speaking the same ones as 
hsps, as hsf activation leads to hsp production, Figure 7) (Morimoto et al., 1990, 1994, 
1996; Wu, 1995). In stressed cells nascent protein synthesis is inhibited; these conditions 
lead to hsf-1 activation, which promotes hsp transcription. Hsps then act as molecular 
chaperones repairing, refolding and trafficking damaged proteins. A great deal has yet to
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be established about the regulation of hsf-1. In some organisms hsf-1 is actively repressed 
and exists in the cell nucleus or cytosol in monomeric state. The precise mechanisms by 
which this repression is achieved are unknown. However, there is some evidence that hsp 
90 may have a role in maintaining hsf-1 in this inert state (Ali et al., 1998; Zou et al., 
1998). Moreover, following a heat shock response the subsequently high levels of hsp 70i 
suppress hsf-1 (Mosser et al., 1993). The combined actions of all hsps, hsp 70 and hsp 90 
included, are not sufficient to completely suppress hsf-1 trimerisation (Morimoto, 1998). 
Due to the ease with which hsf-1 is activated, there has been speculation that complex 
systems are in operation, which monitor and control hsf-1 in the activated state (see 
Morimoto, 1998 for details.).
1.8 Genetically modified mice
Around 100 different genes expressed in the CNS have been targeted and phenotyped in 
genetically modified mice (Crawley, 1999). More than 100 studies investigating the 
pathophysiology of ischaemic brain injury employing such mice were reported by mid 
1999 (Ginsberg, 1999). Mice genetically modified to over-express or be deficient of 
certain genes or gene products have been used to investigate their roles in ischaemic brain 
injury. These include hsp 70i (this thesis Section 3.2; Plumier et al., 1997; Radjev et al., 
1999; Yenari et al., 1999), apolipoprotein E (Bart et al., 1998; Sheng et al., 1998; 
Horsburgh et al., 1999), the nitric oxide synthases (Hara et al., 1996; Huang et al., 1994, 
1996; Iadecola et al., 1997; Nagayama et al., 1999), superoxide dismutase (Chan et al., 
1993; Fujimura et al., 1999; Keller et al., 1998; Kinouchi et al., 1991; Murakami et al., 
1998b), adhesion molecules (Connolly et al., 1996, 1997; Kitagawa et al., 1998a; 
Prestigiacomo et al., 1999; Soriano et a l, 1998, 1999), apoptosis, cell damage and survival 
mediating gene products (Eliason et al., 1997; Hara et al., 1997; Kitagawa et al., 1998b), 
early response genes (Panahian et al., 1997), transcription factors (Hata et al., 1998;
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Iadecola et al., 1999; Schneider et al., 1999) and cytokines (Bruce et al., 1996; Schielke et 
a l, 1998).
1.8.1 Evolution and production of genetically modified mice
Mother Nature achieved the first successful introduction of foreign genetic material into 
host genomes in the early days of life on this planet, i.e., viruses, bacteria and spermatozoa. 
In the late twentieth century the tailored invention of genetically modified organisms 
started with the explosion of recombinant DNA technologies and the subsequent ability to 
isolate individual genes in the 1970s. Introduction of foreign genetic material into host 
cells and genomes was viewed as an excellent means by which an understanding of 
organism development and growth could be investigated. Pivotal to all advances in the 
synthesis of genetically modified organisms was the work of mammalian embryologists 
(see Brinster, 1972). For it was the development of techniques such as embryo removal, 
cultivation of embryos in vitro and returning of embryos to mothers for development, 
which enabled many early gene transfer studies.
1.8.2 Adding genetic information to mice
The infectivity of viruses meant these organisms were used extensively to transfer genetic 
information from one organism to another. Graham et a l, (1973) introduced ad 5 DNA 
into human KB cell monolayers. Viruses were again utilised, this time to introduce foreign 
DNA into intact organisms, by injection and infection of pre-implantation blastocysts and 
embryos (Jaenisch & Mintz, 1974; Jaenisch). The virus theme continued throughout the 
1970s where successful introduction of exogenous DNA into cultured cells was becoming 
commonplace (Bachetti & Graham, 1977; Wigler et al., 1977; Maitland & McDougall, 
1977; Minson et al., 1978). Gordon et al., (1980) pioneered the technique of pronuclear 
injection to introduce foreign genetic information into intact mice (Figure 8). The 
pronuclear injection technique was complemented and extended by Gordon & Ruddle
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Figure 8 Pronuclear injection technique of transgenic mouse production
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Single-celled fertilised eggs are extracted from superovulated female mice. Cloned DNA 
(in the case of this thesis human hsp 70i) is then injected into a pronucleus using a 
microneedle. Surviving embryos are then reimplanted into the oviduct of a
pseudopregnant female. Offspring are screened using Southern blotting for DNA
incorporation with an appropriate labelled probe. Positive mice are then back-crossed to 
homozygocity. Adapted from Reventos and Gordon, 1990.
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(1981) who introduced the term ‘transgenic’ (to define: animals which have integrated 
foreign DNA in their germ line as a consequence of the experimental introduction of DNA) 
Brinster et al., (1981); Constantini & Lacy, (1981) and notably, Palmiter et al., (1982). 
Pronuclear injection is the most commonly used technique to produce transgenic animals 
and precipitated a logarithmic growth of transgenic science. During this time Mann et al., 
(1983), Joyner & Bernstein (1983) and Miller et al., (1983) produced recombinant 
retroviruses carrying heterologous genes, meaning the previous technique of Jaenisch et 
al., (1976) could now be used to produce transgenic animals.
Embryonic stem cell lines were derived from pre-implantation embryos (Evans & 
Kaufman, 1981; Martin, 1981). These cells could be maintained in culture for extensive 
periods and could be subjected to various manipulations (Reventos & Gordon, 1990). Re­
implantation of such blastocysts leads to animals with embryonic stem derived cells in all 
lineages (including the germ line) known as chimaeras (Figure 9). Chimaeras occur 
naturally in many species of mammals, including man (Gardner, 1968). Early 
experimental work to produce chimaeras focused primarily on the processes involved in 
mammalian differentiation during development. The first experimental attempt to produce 
a chimaeric animal was made by Nicholas and Hall (1942). Nicholas and Hall fused two 
1-cell rat embryos together and reported that the product went to term. However, the 
results were inconclusive. Nineteen years later Tarkowski (1961) developed experimental 
chimaeras by fusing two embryos together. Tarkowski’s method and that of Mintz (1962) 
were the forerunners to a technique of producing chimaeras, established by Gardner (1968, 
1972). Gardner produced chimaeras by injecting foreign cells into the blastocoleic cavity 
of mouse blastocysts. Mosaicism was verified using genetic markers. Gardner’s work 
bears many similarities to the techniques adopted to make modem day transgenic animals. 
In fact, Gardner and his peers were effectively producing transgenic animals as defined by 
Gordon & Ruddle (1981).
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Figure 9 Production of chimaeric mice
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Chimaeric mice are produced by embryonic stem (ES) cell-mediated gene transfer. ES 
cells can be transfected by DNA-mediated gene transfer (DMTG). Transfected cells are 
then injected into the cavity of a blastocyst. Sperm of chimaeric mice, derived from ES 
cells, which contributes to the germ line produces transgenic mice. Adapted from 
Reventos and Gordon, 1990.
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Brinster (1974) and Mintz & Illmensee (1975) published work investigating the 
transmission of genetic markers from adult mice to offspring. Transmission of genetic 
markers was achieved, in part, by placing malignant pluripotent teratocarcinoma cells into 
blastocysts and injecting these into the mother. Genetic markers highlighted that these 
tumour cells were spread throughout the offspring genome. Furthermore, these cells were 
functioning properly in their new surroundings, e.g., producing immunoglobulins, 
haemaglobin, etc. Evans and Kaufman (1981) and Martin (1981) further developed these 
observations with the characterisation of the mouse embryonic stem cell that could still 
enter the germ line after genetic manipulation in vitro (Gossler et al., 1986; Robertson et 
al., 1986). In 1985 Smithies et al., unlocked the true potential of genetic manipulation of 
embryonic stem cells. Smithies group reported stable insertion of defined DNA sequences 
into the human p-globulin locus in a predictable fashion. This phenomenon was known as 
homologous recombination. Homologous recombination occurs very rarely in all species 
to produce DNA mutations. Smithies and his co-workers had been able to identify this 
process and detect it at a specific locus. Essentially, homologous recombination could be 
used to target specific genes on a chromosome. In the study conducted by Smithies et al., 
correctly targeted cells were obtained at a frequency of one event per 10 million treated 
cells. Despite this apparently low rate of targeted transformation several other groups 
reported encouraging findings. Constantini et al., (1986) used this technology to correct 
murine p-thalassemia by transferring cloned p-globin genes into the mouse germ line. The 
mice in question had spontaneously developed a deletion of the pmaj-globulin gene, 
probably due to exhaustive inbreeding. Having cured P-thalassemia inside a generation, 
Constantini et al., echoed the statements of Williamson (1982), Anderson (1984) and 
Walters (1986) in condemning the transfer of genes into the germ line as ‘not a feasible 
strategy for human gene therapy’.
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Targeted introduction of DNA largely evolved from the generation and use of 
hypoxanthine guanine phosphorybosil transferase (HPRT)-deficient mice. Two British 
groups had established mice deficient in HPRT and coined them animal models for the 
neurological and behavioural disorder Lesch-Nyhan syndrome. Hooper et al., (1987) 
identified and selected variant embryonic stem cells deficient in HPRT and used these cells 
to produce germ line chimaeras. This led to female offspring heterozygous for HPRT- 
deficiency and the generation of HPRT-deficient pre-implantation embryos from these 
females. While Kuehn et al., (1987) mutagenized embryonic stem cells by retroviral 
insertion and selected for loss of HPRT activity to manufacture chimaeric mice, 
Doetshman et al., (1987) corrected the HPRT-deficiency in mice produced by Hooper et 
al., (1987) by homologous recombination in vitro. Several studies of this nature ensued 
and new targeting vectors were investigated. Most of the early studies employed a 
targeting vector containing the bacterial neomycin resistance gene (neor) as a selectable 
marker gene facilitating the isolation of targeted clones (Thomas & Capecchi, 1987; 
Johnson et al., 1989). Mansour et al., (1988) included the herpes simplex virus (hsv) 
thymidine kinase gene (tk). This strategy was employed to select against non-homologous 
integration. Zimmer & Gruss (1989) used microinjection of a maternal gene fragment to 
disrupt the Hoxl. 1 gene in embryonic stem cells.
1.8.3 Removing genetic information from mice
Thompson et al., (1989) first described the combination of gene targeting with germ line 
transfer. They produced male mouse chimaeras, which transmitted HPRT corrected genes 
to their progeny. This however, was associated with an unanticipated deletion, which 
occurred during or after the targeting event. Later that year Roller et al., (1989) reported 
high frequency germ-line transmission of a planned alteration to the HPRT gene by 
homologous recombination in embryonic stem cells. Zijlstra et al., (1989) followed suit a 
couple of months later, reporting germ line transmission of a disrupted P2-microglobulin
39
gene produced by homologous recombination in embryonic stem cells. In both cases, there 
were no dramatic pathologies observed in these mice carrying homozygous deletions in 
their genes (Figure lOi).
The classic approach of generating null mutants i.e., introducing a null mutation into 
embryonic stem cells from which homozygous mutant mice can be derived (described 
above), is somewhat indiscriminate. That is to say, the gene disruption or deletion is 
carried in the germ line. This means it is inserted in all embryonic stem cell lineages and is 
apparent from the onset of development. The characterisation and application of a system, 
known as the Cre-mediated loxP specific recombination system, from the E. coli 
bacteriophage PI (Sternberg & Hamilton, 1981; Austin et al., 1981; Abremski & Hoess, 
1984; Sauer & Henderson 1988, 1989) enabled the inactivation of genes in a conditional 
manner. Cre is a 38-kilo Dalton recombinase protein, encoded by the E. coli 
bacteriophage PI. loxP is a 34 base pair sequence which consists of two 13 base pair 
inverted repeats, separated by an eight base pair spacer. Together these form two binding 
sites for the Cre recombinase (Figure lOi). Cre recombinase was shown to be capable of 
mediating loxP site-specific recombination in embryonic stem cells by Gu et al., (1993) 
and in transgenic animals (Lasko et al., 1992; Orban et al., 1992). Cre-mediated 
recombination at site-specific loxP sites, to create exon specific gene knockouts (Figure 
lOii), allowed scientists to investigate specific gene functions in vivo throughout 
development and maturity.
Conditional or tissue-specific gene deletions can also be engineered using the Cre-loxP 
system (Gu et al., 1994; Di Santo et al., 1995). This approach enables sequence specific 
removal of genetic information in specific tissue types or cell sub-populations. The 
general strategy of this approach is considered in some detail in van der Neut, (1997). 
Briefly, a neor-tk cassette flanked by two loxP sites is placed on one side of the sequence
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Figure 10 Cre loxP recombinase and exon specific gene knockout
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Inactivation of a gene (la) using two different targeting vectors. (Ib) crucial exon(s) can be 
replaced with the targeting vector (neo). (Ic) transcription of the gene is prevented by a 
targeting vector (neo) splitting a crucial exon. Alternative splicing in this way can 
however lead to partially functioning gene products. Exon-specific knockout (Ha) a gene 
contains 6 exons (1-6). Exon 3 has to be removed. (lib) exon 3 is removed by insertion of 
a targeting vector (neo-tk) flanked by loxP (triangles). (lie, lid) homologous 
recombination leads to embryonic stem (ES) cells with one allele (i.e., exon 3 is replaced 
by the neo-tk cassette), transient expression of a plasmid encoding Cre recombinase leads 
to recombination at the loxP sites, removing the neo-tk cassette. (He) ES cells containing 
recombined alleles produced. These can then be injected into blastocysts and introduced 
into pseudopregnant female mice, to produce gene deleted (knockout) mice. Adapted from 
vanderNeut, 1997.
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being deleted, with another loxP site positioned before said sequence. These clones are 
then transiently transfected with a Cre encoding plasmid, and selected using selective 
growth media. The Cre expression leads to three types of site-specific recombination: (1) 
the neor-tk cassette is preserved (these clones do not survive in the selection media) (2) 
only the neor-tk cassette is removed (this produces viable cells with one mutated allele 
flanked by two loxP sites), and (3) the whole insert is removed, i.e., the two extreme loxP 
sites are excised, these cells also survive the selection media. The cells with one mutated 
allele are separated by southern blotting and are injected into blastocysts. The resulting 
chimaeric mice are backcrossed until mice with one loxP flanked mutated allele are 
obtained. The mice are then crossed with transgenic mice containing Cre recombinase 
driven by tissue specific promoters. This results in mice homozygous for the loxP flanked 
mutated allele and the Cre transgene. Cre-mediated recombination ensues, resulting in 
tissue-specific null mice. Several variations of this technique that utilise tissue-specific 
and inducible promoters and also reporter constructs are now in use. These can be utilised 
to further tailor the excision of desired DNA sequences from specific cell subtypes at 
different stages of development and to express marker gene products to locate and identify 
regions of mutation.
In short, genetically modified mice can now be produced to over-express or be deficient of 
genes of interest. Moreover, this over-expression or deletion can be directed at specific 
cell subtypes and can be induced at different stages of development. These developments 
have led to the widespread, almost ubiquitous, use of such mice in most areas of animal 
based biomedical research, including the neurosciences.
1.8.4 Concerns over genetically modified and inbred mice
The use of transgenic and targeted deletion (knockout) mice, particularly in the past five 
years, has undoubtedly led to greater scientific understanding of the processes involved in
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many research fields, including the neurosciences. However, while this field continues to 
grow and prosper, it should be noted that concerns about the field exist. The concerns 
voiced are primarily directed toward animals with gene deletions and abhorrent behaviours 
observed in inbred mouse strains (Choi, 1997; Crawley, 1996, 1999; Crawley et al., 1997; 
Crusio, 1996; Gerlai, 1996a, 1996b; Lathe, 1996; Routtenberg, 1996; Wehner & Silva, 
1996; Zimmer, 1996). This belt of publications led to the convening of a special workshop 
entitled ‘Mutant Mice and Neuroscience’ at Cold Spring Harbor laboratory in December of 
1996 (Banbury conference of genetic background in mice, 1997). This meeting produced a 
series of recommendations and guidelines, which, if adhered to, would improve the power 
of studies employing such mice. Beyond gene deletion, complications stem from the 
spectrum of unique characteristics displayed by individual mouse strains. As far as brain 
function is concerned, inbred strains vary in their responses to many stimuli, including 
pharmacologic agents (Cooper & Francis, 1979; Holsztynska et al., 1991; Seale et al., 
1984; Tolliver & Carney, 1994) and alcohol (Church & Feller, 1979). Major differences in 
brain anatomical structures are also reported in several mouse strains (Crusio et al., 1990; 
Livy & Wahlsten, 1991; Schopke et al., 1991; Wahlsten & Schalomon, 1994; Wainwright 
& Deeks, 1984). These anatomical differences are prevalent in SV129 strain mice. SV129 
strain mice show absence of corpus callosum (Livy & Wahlsten, 1991) and perform poorly 
on memory tasks and stress-related paradigms (Crawley, 1996). During the development 
of reliable systems of embryonic stem cell gene transfer in the 1980’s. The embryonic 
stem cells, which were most efficiently derived and manipulated, were those of SV129 
strain mice (Lathe, 1996). Consequently, most knockout mice are derived from the SV129 
lineage. Attempts to overcome the risk of neurological deficits in such knockout mice 
involved crossing these mice into and injecting SV129 embryonic stem cells into a C57bl/6 
mouse strain background, however, this did not solve the problems (Choi, 1997; Crawley, 
1996, 1999; Crawley et al., 1997; Crusio, 1996; Gerlai, 1996a, 1996b; Lathe, 1996; 
Routtenberg, 1996; Wehner & Silva, 1996; Zimmer, 1996). Moreover, C57bl/6
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strain mice display poor performance on passive avoidance and low levels of anxiety-like 
behaviours (Crawley & Davis, 1982; Mathis et al., 1994, 1995). Added to this uncertainty 
is the argument that deleting a gene does not necessarily delete the function it would have 
performed (Crawley, 1996; Gerlai, 1996a). Crusio (1996) equates this strategy with brain 
lesioning. Crusio suggests that the common assumption in both situations is that the 
‘lesion’ (of the brain or the chromosome) leads to the dysfunction observed in the residual 
organism. Although evidence supporting neurogenesis following brain lesions is now 
reported, (Lui et al., 1998; Zupanc, 1999) ‘genegenesis’ is highly unlikely. Instead a 
process or processes akin to the re-routing principles of synaptic plasticity in the brain may 
well occur at the molecular genetic level i.e., other genes may effect some of the deleted 
genes properties. To further confound these complications, Lathe (1996) reports the 
observations of Wehner, who observed distinct behaviour and learning disabilities between 
the SV129J and SV129ev sub-strains of the SV129 strain.
In summary, the use of genetically modified mice is not without its problems. However, 
many of these problems are primarily peculiar to gene deletion mice, largely because of 
their strain derivation. Other cautionary points pertain mainly to the differences between 
strains and sub-strains in response to a host of different stimuli. In terms of scientific 
rigour the above points must be considered, understood and incorporated as integral 
sources of error in any given experimental paradigm. Furthermore, the recommendations 
of the Banbury conference (1997) should be heeded, and most importantly adequate 
scientific controls applied. A positive note, which can be extracted from strain and sub­
strain differences in response to various stimuli, is the fact mice are not clones of each 
other i.e., they exhibit individual responses. This fact, if considered properly, may well 
add weight to scientific investigation of the human condition, as we too exhibit individual 
responses.
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1.9 Viral vectors
Viruses are sub-microscopic biological entities (ranging from a few to a few hundred 
nanometers), capable of infecting and destroying host organisms. In the twentieth century 
alone smallpox killed an estimated 300 million people, about three-fold as many people as 
all the wars in the twentieth century combined (Oldstone, 1998). Today widespread 
vaccination programs have almost eradicated viral infections such as smallpox and polio in 
the Western world. However, human immunodeficiency virus, for which there is presently 
no vaccine or known cure, is reported to have infected somewhere in the region of 100 
million people. Similarly, the common influenza virus continues to claim the lives of 
people in the United Kingdom, despite extensive vaccination programs.
Although small quantities of virus are used to prevent subsequent viral infections i.e., 
vaccination, until recently it was difficult to envisage the use of these particles in the 
therapy of any other disease states. One man, with what appears to be tremendous 
foresight on this matter, was Frank Herbert (1969). In his novel Dune Herbert wrote of a 
distant future in which physicians would harness deadly viruses and use them to 
therapeutically alter the genetic makeup of humans. His prediction came true in the early 
1990’s when viruses containing desirable gene products were injected into humans, a 
technique commonly known as gene therapy.
1.9.1 Vectors for gene therapy
By definition gene therapy is the introduction of therapeutic nucleic acids into cells with 
the aim of ameliorating or curing disease. There are two targets for gene therapy: (1) the 
germ line, and (2) somatic cells. Gene therapy of the germ line is often the starting point 
for the creation of transgenic and knockout mice (see Sections 1.8.2 and 1.8.3). Gene 
therapy of somatic cells involves the transfer of genetic information into mature cells as 
therapy for disease. In order that desired DNA can be introduced into target cells, a vector
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is required. The most commonly used vectors are naked DNA (usually as a plasmid), 
cationic liposomes, viruses or a combination of the above. The choice of vector depends 
largely upon the target and the modality employed to transfer the genes into said target. 
There are two major approaches for transferring therapeutic genes into cells using the 
aforementioned vectors: (1) transplantation of autologous cells which have been
genetically modified ex vivo, and (2) direct delivery into target tissue in vivo (Figure 11). 
The latter of these approaches has become the most widely used (Marcel & Grausz, 1997).
1.9.2 Viruses as vectors for gene therapy
The optimal vector that performs safe and efficient gene transfer to widespread areas of 
tissue has yet to be discovered. Viruses offer the greatest potential of the several candidate 
vectors presently being investigated. Five viruses in particular have been employed 
extensively in basic and clinical research to evaluate gene therapy, ad, adeno-associated 
virus, hsv, lentivirus and retrovirus. The three principle reasons why viruses are popular 
vectors for gene therapy are: (1) the relevant ease with which viruses can be engineered to 
contain genetic information of interest; (2) their natural propensity to infect; and (3) 
their ability to introduce foreign genetic material into host cells using the indigenous cell 
machinery for survival and replication. A major pre-requisite of all viral vectors is that 
they must be rendered replication defective. Strategies of rendering viruses replication 
defective involve the removal of the viral genes responsible for replication. Another 
measure which, is often required, is to reduce the cytopathogenicity of the virus. This is 
achieved by selective removal of viral genes responsible for eliciting these responses (see 
Hermens and Verhaagen, 1998 for an extensive review of virus recombination). The 
potential of any given virus as a modicum of therapeutic genetic information is very much 
dependant upon its own characteristics, the target tissue and the therapeutic gene. The 
characteristics of individual viruses vary considerably (Table 2). In terms of being used as 
a vector, the primary features are infectivity, immunocytopathogenicty and insert size.
46
Figure 11 In vivo and ex vivo gene transfer with virus vectors
Gene transfer
&' o '*A* *A*
•£> &
Recombinant virus
In vivo
Direct intra-cerebral injection
In situ gene transfer
Ex vivo
Transduction of explanted cells 
in vitro
Transplantation of transduced cells 
(e.g. Intracerebral graft)
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Much of the recent work on viral vectors has investigated the effect of the balance of these 
three features. For instance, the substantial immune response elicited in response to early 
(El deleted) ad vectors (Yang et al., 1994a) led researchers to delete more genes, E2 
(Englehardt et al., 1994; Yang et al., 1994b) and E4 genes (Dedieu et al., 1997). These 
vectors produced increased duration of transgene expression due to a reduction in the 
severity of the immune response (Dedieu et al., 1997). Unfortunately the stability of 
transgene expression was affected by E4 deletion (Armentano et al., 1997). The latest 
generation of ad vectors known as ‘minimal’ or ‘gutless’ vectors have also been developed 
(Fisher et al., 1996; Kochanek et al., 1996). These vectors are devoid of almost all viral 
genes. Subsequently, they can house much larger DNA inserts and elicit diminished 
immune responses. Initial work with these vectors has been fruitful, with stable, long-term 
transgene expression reported (Burcin et al., 1999; Schiedner et al., 1998). Moreover, the 
tetracycline (Tet)-Off system (Gossen & Bujard, 1992), which effectively enables the 
switching on and off of transgene expression, has been successfully applied to ad (Harding 
et al., 1997, 1998), gutless ad (Burcin et al., 1999), hsv (Fotaki et al., 1997; Ho et al., 
1996) and adeno-associated viral vector systems (Rendahl et al., 1998).
1.9.3 Gene therapy for the brain
The classical retroviral vectors, which are widely used to transfer genetic information into 
tissues with a high degree of cell division, cannot be used to transduce non-dividing cells 
such as neurones (Fritsch & Temin, 1977; Miller et al., 1990). Although this discounts 
their use in direct in vivo gene transfer to the brain, retroviruses have been used to modify 
cells ex vivo, and are then transplanted into the nervous system (Gage et al., 1987, 1991; 
Gage and Fisher, 1991; Fisher, 1995; Lisovoski et al., 1997). This approach has however, 
been overtaken by direct in vivo gene transfer to the brain using other viruses. The first 
viral vectors to be directly introduced into the brain were based on the hsv (Andersen et al., 
1992; Fink et al., 1992; Huang et al., 1992). Soon after ad vectors were directly
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introduced into the brain (Akli et al., 1993; Bajocchi et al., 1993; Davidson et al., 1993; le 
Gal le Salle et al., 1993). Similar progress was reported with adeno-associated virus 
(Kaplitt et al., 1994) and lentivirus (Naldini et al., 1996) in subsequent years. The utility 
of each of these viral vectors for gene therapy in the brain has been extensively researched 
over the past seven years or so. The main areas of brain dysfunction that have been 
foremost in these researches are; cerebrovascular disease (such as ischaemia and 
hypotension), neurodegenerative disorders (such as Parkinson’s chorea and Alzheimer’s 
disease), neuroendocrine disorders (such as hypothalamic diabetes insipidus) and brain 
cancers (predominantly gliomas). As the focus of this thesis revolves around ischaemic 
insult, only this category will be discussed in this introductory section.
1.9.4 Gene therapy for cerebrovascular disease
There are two primary targets for gene therapy in cerebrovascular disease. These are the 
cells of the grey and white matter (especially neurones) and cerebral blood vessels. 
Whether the object of gene therapy is to prevent ischaemia (i.e., modulating hypotension) 
or trying to prevent cell loss after ischaemia, the general principles are the same: (1) the 
vector must be delivered to the site of damage, (2) the vector must transfect a suitable 
number of cells at the target site, (3) the expression of the delivered transgene and the 
duration of that expression must be appropriate, and (4) the immune response must be 
minimal. An overview of the use of viruses as vectors of therapeutic genetic information 
toward the therapy of ishaemic brain cells is offered below.
1.9.5 Gene therapy and cerebral ischaemia
Current strategies of viral vector gene therapy for cerebral ischaemia are threefold (1) to 
enhance energy metabolism, (2) to reduce necrotic cell death, and (3) to antagonise 
apoptotic cell death. The pathophysiology and mechanisms of cell death in cerebral 
ischaemia are complex and not completely understood (see Sections 1.3 and 1.4). In brief,
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the major processes occurring in the ischaemic brain are; loss of ion homeostasis, loss of 
high-energy phosphates (i.e., energy failure), increased intracellular calcium, excitotoxicity 
and free radical production. The factors above invariably lead to either necrotic or 
apoptotic cell death.
As energy availability influences excitatory amino acid secretion and calcium mobilisation, 
one of the early attempts of gene therapy in cerebral ischaemia was to deliver the glucose 
transporter (Glut-1). The logic in delivering more glucose transporters was simply that 
more glucose could be transported. Lawrence et al., (1996b) reported that virally mediated 
Glut-1 transporter protected striatal neurons from focal cerebral ischaemia. Several other 
studies in vitro produced similar results (Lawrence et al., 1995; Ho et al., 1995a, 1995b; 
Dash et al., 1996). Kindy et al., (1996) were the forerunners to investigate the viral vector 
gene transfer of a protein called calbindin D28K (a calcium binding protein). The 
principle of delivering calbindin D28K was that it would help overcome the calcium 
overload associated with ischaemic insults. After ad gene transfer Kindy and colleagues 
reported an increase in the number of neurones expressing calbindin D28K surviving 
following global cerebral ischaemia. Yenari et al., (1999) have also recently used virus 
transfection of calbindin D28K to attenuate striatal neuronal death following focal cerebral 
ischaemia. These findings are supported by several other in vivo and in vitro studies 
exploring features of ischaemic cell change, including excitotoxicity and metabolic 
challenges (Meier eta l., 1997, 1998; Phillips eta l., 1999).
One of the peculiarities of cerebral ischaemia is that, due largely to the related calcium 
overload, normal intracellular protein synthesis is ceased. Associated with this reduction 
in nascent protein synthesis are incorrect intracellular targeting of proteins, protein 
malfolding and aggregation. These conditions propagate the induction and synthesis of a 
group of special proteins, the hsps (most notably hsp 70i, the major interest of this thesis).
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The activities of hsp 70i are widely regarded to be of therapeutic value following insults 
such as ischaemia (see Section 1.7). At the outset of this thesis, no investigators had 
studied the in vivo effects of gene transfer of hsp 70i with viral vectors or in transgenic 
mice over-expressing hsp 70i, following cerebral ischaemia. One recent report emphasises 
that viral vector gene transfer of hsp 70i can protect neurones from focal ischaemic and 
excitotoxic insults in vivo (Yenari et al., 1998). Others report virus mediated gene transfer 
of hsp 70i to protect cultured neurones from an array of excitotoxic anoxic and glycaemic 
insults (Papadopoulos et al., 1996; Xu & Giffard, 1997).
Further virus mediated gene transfer approaches of protecting / salvaging neurones from 
ischaemic insult investigate the use of anti-apoptotic genes and cytokine receptor 
antagonists. The models investigated include excitotoxic insults, global and focal cerebral 
ischaemia, hypoxia / glycaemia and reactive oxygen species generation in whole animals 
and in cultured cells. For the most part the results were favourable. Viral vector mediated 
gene transfer of anti-apoptotic genes such as Bcl-2 inferred protection of neurones and 
increased resistance to several ischaemic insults (Jia et al., 1996; Lawrence et al., 1996a; 
Linnik et al., 1995). While other anti-apoptotic genes such as neuronal apoptosis 
inhibitory protein (Xu & Crocker, 1997) and crmA (Roy & Sapolsky, 1999) produced 
similar results. Viral vector mediated gene transfer of interleukin-1 receptor antagonist has 
also been shown to protect neurones following focal cerebral ischaemia (Betz et al., 1995; 
Yang et al., 1997) and excitotoxic seizures (Hagan et al., 1996).
1.9.6 Concerns over viral vectors and gene therapy
In the autumn of 1999, Jesse Gilsenger (an 18-year old man from Arizona) was infused 
with one of the largest doses of ad ever given to a human. He developed influenza-like 
symptoms with a high fever one day after treatment. On the second day he developed liver 
injury (the organ infused) and inappropriate blood clotting. By day three he developed
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trouble breathing and his vital organs were failing. On the fourth day he was taken off life 
support, and died. This chilling reminder of what viruses are capable of created a 
shockwave in the field of gene therapy, and importantly, out with the field of gene therapy. 
A meeting of the recombinant DNA advisory committee was called to discuss this case and 
concluded that death had resulted as a consequence of the ad infusion. It also advised gene 
therapy researchers to increase their safety measures, such as checking sequence integrity 
and closer monitoring of cytokines pre and post vector administration. Moreover, this case 
is now subject to federal investigation. This death and the findings of the committee led to 
the publication of a clutch of editorials and viewpoints on this topic (Fox, 1999, 2000; 
Smaglik, 1999; Ciment, 2000; Commander, 2000; Hollon, 2000). One of the major points 
of conjecture in gene therapy is the lack of standard approaches for measuring and 
comparing the strength and potential toxicity of vectors (Smaglik, 1999). This statement is 
consolidated by the report of Nyberg-Hoffman & Aguiler-Cordova (1999) who report 
instability of viral vectors during shipping in dry ice. These findings suggest that the user 
cannot be sure of the titre at the point of administration. Furthermore, when this is 
combined with variations in different virus production systems, in terms of purity and titre, 
then a significant source of error exists. In the aftermath of the first, and hopefully only 
death resulting solely from gene therapy, these issues are being considered far more 
intensely on the bench and at the bedside.
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1.10 Aims of thesis
This body of work was designed to fulfil three main aims:
(1) To investigate the pathologic and physiologic consequences of global cerebral 
ischaemia on MF1 strain mice. In order to achieve this a mouse model of BCCAo was 
established.
(2) To investigate the influence of hsp 70i over-expression on ischaemic outcome
following BCCAo. Hsp 70i over-expression was explored in two systems, (a) MF1 strain 
hsp 70i over-expressing transgenic mice, and (b) C57bl/6 strain mice intrastriatally
injected with ad hsp 70i.
(3) To investigate the functional consequences of transgenic over-expression of hsp 70i
(in the basal state and following metabolic activation with dizocilpine, 1 mg/kg) and ad-
mediated over-expression of egfp. In order to achieve this a modification of the 14C-2- 
deoxyglucose autoradiography technique of Sokoloff et al., (1977) was established in the 
mouse.
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CHAPTER TWO: METHODS AND MATERIALS
2.1 Mice
MF1 and C57bl/6 strain mice used in this thesis were supplied by Harlan Olac Limited. 
Transgenic mice over-expressing hsp 70i and their wild type littermates (MF1 background, 
see Section 2.9 for detail) were bred and supplied by Dr James Uney from the University 
of Bristol (the original source of founder mice was Harlan Olac Limited). All mice were 
maintained on a 12 hour light / dark cycle and allowed free access to food and water. Male 
mice were used in all studies within this thesis. Female mice were not used in order that 
hormonal fluctuations peculiar to menstruation could be eliminated.
2.2 Global cerebral ischaemia
2.2.1 Experimental groups
Global cerebral ischaemia (BCCAo) was used in four separate studies in this thesis. In the 
first, to investigate the impact of BCCAo on MF1 and C57bl/6 strain mice. Adult male 
MF1 and C57bl/6 strain mice weighing between 30-40 grams were subjected to 10 minutes 
(n=6 MF1; n=6 C57bl/6); 15 minutes (n=6 MF1; n=6 C57bl/6); and 20 minutes (n=6 MF1; 
n=6 C57bl/6) of BCCAo. Sham procedures were also carried out for 10 minutes (n=3 
MF1; n=2 C57bl/6); 15 minutes (n=2 MF1; n=2 C57bl/6); and 20 minutes (n=2 MF1; n=3 
C57bl/6). In the second study, the impact of prolonging the duration of BCCAo on MF1 
strain mice was investigated. Adult male MF1 strain mice weighing between 30-40 grams 
were subjected to 25 minutes (n=6), 30 minutes (n=6), 35 minutes (n=8), 40 minutes (n=6) 
and 45 minutes (n=6) of BCCAo. Sham procedures were also carried out for 25 minutes 
(n=5), 30 minutes (n=5), 35 minutes (n=6), 40 minutes (n=5) and 45 minutes (n=5). In the 
third study, the effect of transgenic over-expression of hsp 70i on pathologic outcome 
following BCCAo investigated. Adult male MF1 strain transgenic mice over-expressing 
hsp 70i (n=10) and their wild type littermates (n=9) weighing between 30-40 grams were 
subjected to 25 minutes of BCCAo. Sham procedures were also carried out in hsp 70i 
transgenic (n=10) and wild type littermate (n=9) mice. In the fourth study, the effect of
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intrastriatally injected ad vectors containing hsp 70i or egfp (reporter gene) were 
investigated. Adult male C57bl/6 strain mice weighing between 30-40 grams were 
subjected to 10 or 20 minutes of BCCAo. These mice had been intrastriatally injected with 
recombinant ad vectors containing hsp 70i or enhanced egfp insert 14-days prior to 
induction of ischaemia. Mice intrastriatally injected with ad vector containing hsp 70i 
were subjected to 20 minutes (n=8) or 10 minutes (n=7) of BCCAo. Mice intrastriatally 
injected with ad vector containing egfp were also subjected to 20 minutes (n=8) or 10 
minutes (n=6) of BCCAo.
2.2.2 Statistical power calculations
In any study when the challenge fails to reveal a significant change, the possibility of a 
type 2 error (i.e., a false negative) needs to be considered. In this thesis post hoc power 
calculations were employed to predict the differences in neuronal damage following 
BCCAo which could be detected. In all studies a difference of approximately 30% could 
be detected with the groups sizes employed:
1. 20-minute BCCAo in MF1 strain mice. Ischaemic neuronal damage in caudate nucleus 
was 1.5 ± 0.4 (mean ± standard deviation, SD) group size was 6. For 80 power, predicted 
detectable difference was 28%.
2. 20-minute BCCAo in C57bl/6 strain mice. Ischaemic neuronal damage in caudate 
nucleus was 2.3 ± 0.6 (mean ± SD) group size was 7. For 80% power, predicted detectable 
difference was 24%.
3. 45-minute BCCAo in MF1 strain mice. Ischaemic neuronal damage in caudate nucleus 
was 14 ± 4.6% (mean ± SD) group size was 6. For 80% power, predicted detectable 
difference was 33%.
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4. 25-minute BCCAo in wild type littermate mice. Ischaemic neuronal damage in caudate 
nucleus was 21 ± 5.8% (mean ± SD) group size was 9. For 80% power, predicted 
detectable difference was 28%.
5. 20-minute BCCAo in ad egfp gene transfer C57bl/6 strain mice. Ischaemic neuronal 
damage in caudate nucleus was 33 ± 10% group size was 8. For 80% power, predicted 
detectable difference was 31%.
2.2.3 Surgical procedure
Global cerebral ischaemia was induced in the mouse by BCCAo. Surgical anaesthesia was 
induced in a perspex chamber with halothane (3%) in a mixture of nitrous oxide and 
oxygen (70:30) for 2.5 minutes. Anaesthesia was maintained throughout the procedure 
with halothane (1.2-1.7%) delivered via a facemask. Core body temperature was recorded 
using a rectal temperature probe and maintained around 37°C using a heating lamp 
throughout the procedure. Via a small skin incision in the neck, the common carotid 
arteries were freed from connecting tissues by blunt dissection. Lengths of surgical silk (4- 
0) were placed around both common carotid arteries. Carotid arteries were occluded by 
applying tension to these silks and placing an aneurysm clip (50-80 gram closing pressure) 
on each vessel. Complete vessel occlusion was observed and the incision site irrigated 
with sterile saline throughout the course of the occlusion. Sham operated mice had 
surgical silks (4-0) placed around both common carotid arteries and the incision site 
irrigated with sterile saline; no tension was applied to the silks. Clips were removed from 
occluded animals according to occlusion duration. Vessel patency was checked and the 
incision site sutured using surgical silk (6-0). Anaesthesia was discontinued. Each mouse 
injected subcutaeneously with sterile saline (0.5ml), was ventilated with 100% oxygen 
until recovery from anaesthesia and returned to its cage. The animals were placed in an 
incubator at 29°C for two hours post-operatively. Thereafter mice were housed in a
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temperature-controlled facility for the remainder of the 72-hour survival period. A 72-hour 
(3-day) survival period was chosen to investigate ischaemic neuronal damage based on 
observations in a pilot study (which indicated that ischaemic neuronal damage at three and 
seven days post-BCCAo was similar).
2.3 Visualisation of circle of Willis anatomy
2.3.1 Experimental groups
The anatomy of the circle of Willis was analysed and recorded in two separate studies 
within this thesis. First, adult male MF1 strain mice (n=16) and C57bl/6 strain mice (n=8) 
weighing between 30-45 grams were investigated. Second, transgenic adult male MF1 
strain mice over-expressing hsp 70i (n=9) and their wild type littermates (n=9) weighing 
between 30-40 grams were investigated.
2.3.2 Surgical procedure
Surgical anaesthesia was induced in a perspex chamber with halothane (3%) in a mixture 
of nitrous oxide and oxygen (70:30) for 2.5 minutes. Anaesthetic was maintained 
throughout the procedure with halothane (1.5%) delivered via a facemask. The heart was 
exposed by making a small incision at the base of the chest, cutting across the diaphragm 
and then through the ribcage bilaterally. A 20 gauge venous catheter connected to a 20ml 
pipette filled with heparinised saline (0.5%) was inserted into the left ventricle and 
clamped in place, the right atrium cut and the heparinised saline perfused through the 
mouse at 3.33ml/min using an infusion pump. After blood had been flushed from the 
animal a syringe containing carbon black ink was connected to the catheter and the ink 
perfused through the mouse at 3.33ml/min using an infusion pump. Carbon black infusion 
was discontinued upon observation of darkened (ink-filled) extremities, including nose, 
ears and mouth. The brains were removed carefully and the anatomy of the circle of Willis
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visualised using a dissecting microscope (magnification X10). The gross structure of the 
circle of Willis and its major arterial branches were recorded diagrammatically.
2.4 Measurement of key physiologic variables
2.4.1 Experimental groups
MABP in mice was measured before, during and following BCCAo in mice in three 
separate studies in this thesis. Arterial pH, carbon dioxide and oxygen tensions were 
measured following BCCAo in these studies. First, key physiologic variables were 
measured in adult, male MF1 (n=8) and C57bl/6 (n=8) strain mice weighing between 30- 
40 grams subjected, to 20 minutes of BCCAo. Second, key physiological variables were 
measured in adult, male MF1 (n=8) strain mice weighing between 35-45 grams, subjected 
to 45 minutes of BCCAo. Third, key physiologic variables were measured in adult, male 
MF1 strain transgenic mice over-expressing hsp 70i (n=9) and their wild type littermates 
(n=9) weighing between 30-40 grams, subjected to 25 minutes of BCCAo.
2.4.2 Surgical procedure
Surgical anaesthesia was induced in a perspex chamber with halothane (3%) in a mixture 
of nitrous oxide and oxygen (70:30) for 2.5 minutes. Anaesthesia was maintained 
throughout the procedure with halothane (1.2-1.7%) delivered via a facemask. Via a small 
skin incision at the junction of hind leg and body, the left femoral blood vessels were 
exposed. The femoral artery and vein were freed of connecting tissues by blunt dissection. 
Three lengths of surgical silk (6-0) were placed around the femoral vessels. The first of 
these silks was tied at the distal end of the exposed vessels and some tension applied. The 
second silk was positioned at the proximal end of the exposed vessels and tension applied 
such that blood flow in the exposed section of the femoral artery was stopped. A small, 
diagonal incision was made in the femoral artery and a polythene cannula (outside 
diameter = 0.61mm; internal diameter = 0.29mm) containing heparinised saline (0.5%)
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was introduced into the lumen of the vessel. The third silk was tied around the vessel to 
hold the cannula in place. Tension was removed from the second silk, the cannula flushed 
and patency observed. The cannula was further secured in place with a small amount of 
general-purpose cyanocrylate glue. Arterial blood pressure was recorded and stored by 
connecting the cannula to a pre-calibrated small bore pressure transducer attached to a 
personal computer running Acknowledge 3.24 software. Blood gas tensions and pH were 
measured from arterial blood samples (circa 50pl) using a blood gas analyser. Core body 
temperature was recorded using a rectal temperature probe and maintained around 37°C 
using a heating lamp throughout the procedure.
2.5 Transcardiac perfusion fixation
Surgical anaesthesic was induced in a perspex chamber with halothane (3%) in a mixture 
of nitrous oxide and oxygen (70:30) for 2.5 minutes. Anaesthetic was maintained 
throughout the procedure with halothane (1.5%) delivered via a facemask. The heart was 
exposed via a small incision at the base of the chest, cutting across the diaphragm and then 
through the ribcage bilaterally. A 20 gauge venous catheter connected to a 20ml pipette 
filled with heparinised saline (0.5%) was inserted into the left ventricle and clamped in 
place, the right atrium cut and heparinised saline perfused through the mouse at 
3.33ml/min using an infusion pump. After blood had been flushed from the animal a 20ml 
syringe containing 4% paraformaldehyde (Appendix A) was connected to the catheter and 
the fixative perfused through the animal at 3.33ml/min using an infusion pump. Mice were 
decapitated and their heads immersed in paraformaldehyde (4%) for 24 hours at 4°C. The 
brains were then removed and stored in phosphate buffer for 24 hours at 4°C before being 
processed.
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2.6 Tissue processing and staining
2.6.1 Tissue processing
Paraformaldehyde fixed brains were cut into three coronal blocks (3mm thick) using a 
rodent brain matrix. Individual blocks were placed into labelled embedding cassettes. The 
cassettes were placed into a wide necked glass jar and processed for wax embedding as 
follows:
1. Running water 30 min
2. 70% ethanol 2 x 30 min
3. 90% ethanol 2 x 30 min
4. 100% ethanol 2 x 30 min
5. 100% ethanol/xylene (1:1) 30 min
6. Xylene 2 x 30 min
7. Paraffin wax 60°C, 1 hour
8. Paraffin wax 60°C, overnight
Stainless steel moulds were cleaned with xylene, placed on a hotplate and the inside 
surface coated with a thin film of glycerine. The moulds were then filled with liquid wax 
and returned to the hotplate. Individual brain blocks were put into the wax moulds and 
removed from the hotplate. The surface of the wax was allowed to form a skin and the 
embedding cassette attached to it. Dispensing more liquid wax on top of the cassette and 
allowing the wax to solidify securely connected this. Once hardened the moulds were 
stored at 4°C for an hour or so and the wax blocks popped out of the moulds. The paraffin 
blocks produced were sectioned at 6pm on a microtome. Sections were stretched by 
surface tension on a water bath at 40°C and collected on poly-L-lysine coated slides. 
Slides were allowed to dry slowly at room temperature and stored in dust tight slide boxes 
until required.
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2.6.2 Histochemical staining
Steps 1-17 (below) describe haematoxylin and eosin staining of paraffin embedded 4% 
paraformaldehyde fixed sections, while steps 4-17 (below) describe haematoxylin and 
eosin staining of fresh frozen sections. Haematoxylin and eosin stained sections were 
employed to identify ischaemic neuronal damage and structural damage and inflammatory 
responses following ischaemia and intracerebral injection of ad vectors, respectively.
1. Histoclear 2 x 1 0  min (to dewax tissue)
2. Absolute ethanol 2 x 10 min (to dehydrate Sections)
3. Methylated spirit 30 seconds
4. Running tap water 1 min
5. Haematoxylin 1-2 min
6. Running tap water 1 min
7. Hydrochloric acid & methanol 5 seconds
8. Running tap water 1 min
9. Scots tap water substitute 2 min
10. Running tap water 1 min
11. Aqueous eosin 3 min
12. Running tap water 1 min
13. 70% ethanol 2 x 5  min
14. 90% ethanol 2 x 5  min
15. 100% ethanol 2 x 5  min
16. Histoclear 5 min
17. Mount coverslips using DPX leave to dry for 24 hours
2.6.3 Identification and quantification of ischaemic neurones
Ischaemic neuronal damage following BCCAo was determined in 4% paraformaldehyde
fixed, wax embedded coronal sections (6p,m thick). Haematoxylin and eosin staining was
employed to identify ischaemic neurones. Morphologically abnormal neurones exhibiting
features of ischaemic cell change, including shrunken cell bodies, triangulated nuclei and
intensely eosinophilic cytoplasm (Adams & Graham, 1988) were estimated in several brain
regions. Two methods of quantifying ischaemic neurones were used in this thesis. First,
ischaemic neurones in a defined region were scored using the scoring system below.
Second, ischaemic neurones and non-ischaemic neurones in a defined region were counted
and the percentage ischaemic neurones determined. My ability to identify ischaemic
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neuronal change was validated by direct comparison with values recorded by an 
experienced investigator (see Appendix B). Furthermore, my ability to quantify ischaemic 
neuronal damage reproducibly was validated by double-blinded analysis of the same 
material (see Appendix C).
Score % ischaemic neurones
0 0%
1 1-30%
2 31-65%
3 66-100%
2.6.4 Structural and inflammatory responses following intracerebral injection
Haematoxylin and eosin staining was employed to delineate the presence of structural 
deformation and inflammatory response following intrastriatal injection of recombinant ad 
vectors and saline (see Section 2.8). Structural deformation resulting from needle insertion 
through the cortex, subcortical white matter and into the caudate nucleus was clearly 
delineated by haematoxylin and eosin. Local infiltration of inflammatory cells to the site 
of intrastriatal injection was also clearly delineated by haematoxylin and eosin staining 
(see Figure 49).
2.6.5 Immunohistochemical localisation of hsp 70i
Established immunohistochemical detection techniques were employed to identify hsp 70i 
in brain sections prepared from mice. All brains were perfusion fixed with 
paraformaldehyde 4% and paraffin wax embedded. Brains were coronally sectioned at 6 
microns using a microtome with sections collected onto poly-Z-lysine coated glass slides. 
Immunohistochemical staining for hsp 70i was carried out using the standard avidin-biotin 
method (Figure 12).
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Figure 12 Schema of avidin-biotin complex immunodetection method
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Adapted from Jackson and Blythe, 1993.
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Day 1: Paraformaldehyde fixed, wax embedded sections were pre-treated with xylene to 
remove all wax from the tissue ( 2 x 1 5  minutes). Sections were then dehydrated in fresh 
absolute ethanol for 20 minutes ( 2 x 1 0  minutes). For optimal staining of hsp 70i antibody 
(Calbiochem Incorporated) antigenic site retrieval was employed at this stage. Retrieval of 
antigenic sites was achieved by immersing sections in citric acid buffer (0.01 mM, pH 6.0) 
and microwaving (650 watts) for five minutes on full power. The sections were left for 
one minute; additional citric acid buffer was added and the sections were then microwaved 
for a further five minutes. Thereafter, sections were left to cool for 30 minutes in citric 
acid buffer. Endogenous peroxidase activity was then quenched by immersing sections in 
hydrogen peroxide (3%) in methanol for 30 minutes. Slides were then rinsed in running 
tap water for 10 minutes before being rinsed in phosphate buffered saline (50mM) for a 
further 10 minutes. Using a hydrophobic pen, each section was circled in order to create a 
barrier to trap and minimise the volume of reagents required to incubate each section. 
Sections were then incubated with 200pl of blocker, which consisted of normal horse 
serum (10%) and bovine serum albumin (5%) in phosphate buffered saline for one hour at 
normal room temperature. This suppressed non-specific binding of the immunoglobulin. 
The blocker was removed and the sections incubated with 200pi of the optimal 
concentration of hsp 70i primary antibody made up in normal horse serum (1.5%) and 
bovine serum albumin (1%) in phosphate buffered saline (see Appendix D, for details of 
antibody optimisation procedure). Sections were incubated overnight at 4°C.
Day 2: Primary antibody solution was removed and sections were rinsed with phosphate 
buffered saline (2 x 10 minutes). Sections were then incubated with 200pl of secondary 
antibody (mouse anti-IgG) diluted 1:100 in phosphate buffered saline and incubated for 
one hour at room temperature. Sections were again rinsed with phosphate buffered saline 
(2 x 10 minutes) and then incubated with 200pl of avidin-biotin horseradish peroxidase
complex for one hour. The avidin-biotin horseradish complex was prepared 40 minutes
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before use from an Elite kit from Vector Laboratories (1 drop solution A and 1 drop 
solution B in 4.9ml phosphate buffered saline). Sections were then rinsed once more with 
phosphate buffered saline ( 2x10  minutes) and the peroxidase reaction developed using the 
diaminobenzidine chromogen. A standard diaminobenzidine chromogen kit (Vector 
Laboratories) was used where two drops of buffer, four drops of diaminobenzidine and two 
drops of hydrogen peroxide were added and mixed with five millimetres of distilled water 
in that order. Sections were incubated for four minutes with diaminobenzidine; the 
reaction being stopped by adding distilled water. Following incubation with this 
diaminobenzidine mixture cells labelled with primary antibody appeared brown. All hsp 
70i stained sections were then lightly counterstained with haematoxylin and mounted as 
follows:
1. Running tap water 10 minutes
2. Haematoxylin 45 seconds
3. Running tap water 1 minute
4. Hydrochloric acid & methanol 5 seconds
5. Running tap water 1 minute
6. Scots tap water substitute 2 minute
7. Running tap water 1 minute
8. 70% ethanol 2 x 5  minutes
9. 90% ethanol 2 x 5  minutes
10. Absolute ethanol 2 x 5  minutes
11. Histoclear 10 minutes
12. Mount coverslips using DPX leave to dry for 24 hours
2.7 In vivo 14C-2-deoxyglucose autoradiography in mouse
2.7.1 Experimental groups
LCGU was estimated in conscious, freely moving mice by means of a modification of the 
14C-2-deoxyglucose technique originally described by Sokoloff et al., (1977). Two studies 
within this thesis employed this technique. First, relative rates of LCGU were estimated in 
36 brain regions of transgenic mice over-expressing hsp 70i and their wild type littermates. 
Twenty-eight adult, male MF1 strain mice (14 transgenic and 14 wild type littermates) 
weighing between 30-40 grams were used. The mice were divided into four groups (two 
hsp 70i transgenic and two wild type littermate, n=7 per group). Ten minutes prior to the
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start of the 14C-2-deoxyglucose procedure. One group of transgenic and one group of wild 
type mice were intraperitoneally injected with saline. The two remaining groups were 
intraperitoneally injected with dizocilpine (1 mg/kg) dissolved in saline (0.4ml). Second 
relative rates of LCGU were estimated in nine brain regions of mice following intrastriatal 
injection with lpl (O.lpl/minute) of recombinant ad egfp (1.57 x 1010 particle forming 
units/ml) or sterile saline. The impact of ad egfp transfection upon LCGU and the effect of 
delay in needle withdrawal after injection (i.e., 2 mins versus 10 mins) were investigated at 
seven and 28 days post injection. Thirty-two adult, male C57bl/6 strain mice weighing 
between 25-35 grams were used. The mice were divided into six groups: two groups (n=6) 
were injected with saline (2 minute delay in needle withdrawal); two groups (n=6) were 
injected with ad (2 minute delay in needle withdrawal); and two groups (n=5) were 
injected with ad (10 minute delay). In one of each treatment group LCGU was estimated 
at seven days and the other at 28 days post injection.
2.7.2 Statistical power calculations
Data from a pilot study using 14C-2-deoxyglucose autoradiography was used to predict the 
differences in LCGU, which could be detected in the two 14C-2-deoxyglucose 
autoradiography studies in this section. Statistical power calculations predicted that a 
difference of less than 10% would be detected. Post hoc power calculations confirmed this 
prediction:
1. Dizocilpine injected hsp 70i transgenic mice. LCGU in dorsal hippocampus CA1 
stratum lacunosum molecularae was 2.7 ± 0.2 (mean ± SD) group size was 7. For 80% 
power, predicted detectable difference was 7%.
2. Ad egfp gene transfer of C57bl/6 strain mice. LCGU in caudate nucleus was 1.45 ± 0.1 
(mean ± SD) group size was 6. For 80% power, predicted detectable difference was 8%.
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2.7.3 Modified 14C-2-deoxyglucose experimental procedure
Conscious mice were intraperitoneally injected with 5pCi of 14C-2-deoxyglucose in 0.4ml 
saline over a ten second period. Mice were returned to their cages for 42.5 minutes and 
general behaviour observed. At the end of this period each animal was anaesthetised in a 
perspex chamber containing halothane (2.5%) in a mixture of nitrous oxide and oxygen 
(70:30) for a period of exactly 2.5 minutes. At 45 minutes after isotope injection the mice 
were decapitated and a terminal blood sample collected by torso inversion. Plasma was 
prepared by centrifugation and the concentrations of plasma glucose and 14C determined by 
automated enzymatic assay and liquid scintillation counting, respectively. Brains were 
removed rapidly and frozen in chilled isopentane (-42°C) for 10 minutes. The brains were 
then coated in Lipshaw brain matrix, dipped into the chilled isopentane (to harden the 
Lipshaw matrix) and mounted onto cryostat chucks. Mounted brains were stored at -20°C 
for less than 24 hours. Serial coronal sections (20pm thick) were then prepared in a 
cryostat at -20°C sampled every 60pm through the cerebrum. Brain sections were 
collected onto coverslips (20mm x 40mm) and dried rapidly on a hotplate at 60°C. The 
coverslips were then mounted onto standard deoxyglucose cards sequentially. 
Autoradiograms of these sections were produced by exposing them with medical X-ray 
film in light tight X-ray cassettes for three days with pre-calibrated methacrylate standards. 
After three days the films were developed: developer five minutes; stop bath 45 seconds; 
fixer 10 minutes; followed by 30 minutes in cold, running tapwater; and placed in a fan- 
heated cupboard until dry.
2.7.4 Densitometric analysis of 14C-2-deoxyglucose autoradiograms
Densitometric analysis was carried out using a computer based densitometer; micro 
computer imaging device. Briefly, densitometric measurements (in this case taken from 
the X-ray film autoradiogram) represent digital signal. This digital signal is initially 
expressed as grey levels which range from 0 (black) to 255 (white). Grey levels are then
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Figure 13 Densitometric analysis of discrete brain regions
Hippocampus CA1 
^  Stratum oriens
^  Posterior thalamus
_______________________Hypothalamus
.. Anterior thalamus 
_ Globus pallidus
Densitometric analysis o f discrete brain regions such as hippocampus CA1 stratum oriens, 
posterior thalamus, hypothalamus (top), anterior thalamus and globus pallidus (bottom). 
l4C-2-deoxyglucose autoradiograms shown taken from dizocilpine (1 mg/kg) treated mice.
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converted into values of optical density ranging from 0 (white) to 2.4 (black), by the 
densitometer. After calibrating the densitometer to the pre-calibrated methacrylate 
standards of known radioactivity (ranging from 44-2500 nCi/g), 14C concentrations in 
selected brain areas could be determined. Cerebral 14C concentrations were measured in 
discrete brain regions by placing autoradiograms on a light box under a closed circuit 
camera (at the same magnification and light intensity used for calibration) and positioning 
a frame over each brain region of interest (see Figure 13). The size of the frame used to 
capture 14C concentration varied with the size of the region or the point of interest. The 
mean 14C was calculated from readings made in 3-6 (predominantly 6) sections per mouse 
bilaterally (maximum = 12). All anatomic brain structures were defined with reference to 
a stereotactic mouse brain atlas (Franklin & Paxinos, 1997).
2.7.5 Estimation of LCGU
In the original and definitive 14C-2-deoxyglucose technique Sokoloff et al., (1977) 
described the collection of 14 timed arterial blood samples over the 45-minute 
experimental period. These blood samples were assayed to determine plasma 14C and 
glucose concentrations throughout the experimental period. The plasma integral required 
for the operational equation (Section 1.6.2, Figure 6) could then be employed to determine 
LCGU in pmol/1 OOg/minute. In this thesis, only a terminal blood sample was collected 
from each mouse. LCGU was estimate as the ratio of 14C concentration in regions of 
interest versus 14C concentration in cerebellar cortical grey matter:
 Tissue 14C in region of interest_____
Tissue 14C in cerebellar cortical grey matter
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2.8 Stereotaxic intrastriatal injection of ad
2.8.1 Experimental groups
Intrastriatal injection into the right caudate nucleus of mice was carried out in two studies 
within this thesis. First, adult male C57bl/6 strain mice weighing between 25-35 grams 
were intrastriatally injected with recombinant ad hsp 70i (n=17) or ad egfp (n=16). 
Second, adult male C57bl/6 strain mice weighing between 25-35 grams were intrastriatally 
injected with recombinant ad egfp (n=22) or sterile saline (n=12).
2.8.2 Establishing injection coordinates
Stereotaxic coordinates for injection into the centre of the right caudate nucleus were 
derived from the mouse stereotaxic brain atlas (Franklin & Paxinos, 1997). Exact 
coordinates were established and determined by placement studies using indelible ink. The 
coordinates used in all mice were calculated with reference to bregma. The coordinates 
used in all mice were: 0.26mm posterior to bregma, 2.0mm lateral (right) of bregma; and 
3.0mm ventral to the dorsal surface of the brain.
2.8.3 Surgical procedure
Surgical anaesthesia was induced in a perspex chamber with halothane (3%) in a mixture 
of nitrous oxide and oxygen (70:30) for 2.5 minutes. Animals were removed from the 
chamber and connected to a stereotaxic frame using a specially designed facemask. 
Halothane anaesthesia was delivered via the facemask using a small animal ventilator. 
Animals were mechanically ventilated at 110 breaths per minute, tidal volume was 0.15ml 
with 50:50 inspiration / expiration ratio. Via a rostro-caudal midline scalp incision the 
skull was exposed and the bregma landmark visualised. A small burrhole was drilled at 
stereotactic coordinates previously determined to enable injection into the centre of the 
right caudate nucleus (see above). All injectants were delivered via a 30 gauge dental 
needle connected to a lOpl Hamilton syringe by a 2cm piece of cannula. Injection rate was
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controlled and maintained at 0.1 pi per minute using a pre-calibrated microinfusion pump. 
Body temperature was maintained between 36.5 and 37.5°C throughout the procedure 
using a thermostatically controlled heating blanket and a rectal temperature probe. Post 
operatively the animals were housed in a temperature-controlled facility until required.
2.9 Transgenic mice over-expressing hsp 70i
Transgenic mice over-expressing hsp 70i used in this thesis were produced and supplied by 
Dr James Uney from the University of Bristol. MF1 strain mice were used to generate hsp 
70i transgenic mice for three reasons: first, the large numbers of eggs they produce, 
second, the large litter sizes they produce, and third, MF1 strain mice are good mothers. 
The technique used to produce the hsp 70i transgenic mice used in this thesis was based on 
the generation of rhombotin-1 transgenic mice (Greenburg et al., 1990). Briefly, hsp 70i 
was fused with the rhombotin-1 (also known as promoter-1 of the Lmo-1 gene, Hinks et 
al., 1997) and microinjected into fertilised (MF1 X MF1) mouse eggs (see Figure 8). 
Transgenic animals were selected and bred to homozygosity in an MF1 background 
(Figure 14). Transgenic mice over-expressing the firefly luciferase reporter gene under the 
control of the rhombotin-1 promoter were produced at the same time. 
Immunohistochemical detection of the luciferase reporter gene confirmed the region 
specific nature of transgene expression (Figure 15).
2.10 Recombinant ad hsp 70i and ad egfp vectors
All ad vectors used in this thesis were produced and supplied by Dr James Uney from the 
University of Bristol. Recombinant (replication defective) ads containing hsp 70i and egfp 
driven by a cytomegalovirus (CMV) promoter were used. Production of recombinant ad 
hsp 70i and ad egfp can be found in Beaucamp et al., (1998). A simplified schematic 
representation is provided in Figure 16. Transfection of El-deleted ad egfp was visualised
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Figure 14 Confirmation of transgenic hsp 70i expression
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Southern blot analysis confirmed hsp 70i expression in transgenic mice. 
(Courtesy o f Dr James Uney)
73
Figure 15 Distribution of hsp 70i transgene expression
Immunohistochemical detection of the firefly luciferase reporter gene under control of the 
rhombotin-1 promoter delineated the region specific nature of hsp 70i transgene 
expression. Brown regions represent luciferase immunoreactive cells.
(Courtesy of Dr James Uney).
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Figure 16 Production of recombinant ad hsp 70i and ad egfp vectors
Wild type 
adenovirus
] E l a removed
Recombinant 
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transgene
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Hsp70i or egfp 
transgene
Schematic representation of recombinant ad hsp 70i and ad egfp production. Briefly, wild 
type ad particles were rendered replication defective by removal of the El a region of their 
genome. The resultant void was filled with either hsp 70i or egfp transgene, which was 
driven by the cytomegalovirus (CMV) promoter.
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using fluorescence light microscopy. Egfp transfection was analysed at 1 (not shown), 7, 
17 and 28 days post ad injection.
2.11 Statistical analyses
All data in this thesis was collected and expressed using a scoring system or as continuous 
numeric data. Data expressed as a score was analysed using non-parametric statistical 
analyses. Mann-Whitney test was used where two unpaired groups were compared. 
Wilcoxon signed rank test was used where paired groups were compared. Spearman rank 
correlation was used where correlation between groups was investigated. Continuous 
numeric data was separated into normally (parametric) and non-normally (non-parametric) 
distributed groups using GraphPad Incorporated statistical software and analysed 
appropriately. Non-normally distributed continuous numeric data was analysed using non- 
parametric tests as described above. Normally distributed continuous numeric data was 
analysed using parametric statistical analysis. Student’s /-test (paired or unpaired, 
according to source) was employed where two groups were compared. Analysis of 
variance, was used to compare three or more groups followed by Student’s /-test with 
Bonferroni correction. Pearsons correlation was used where correlation between groups 
was investigated. All data throughout this thesis are expressed as mean ± the standard 
error of the mean, with n defined. Data that took the form of contingency table (i.e., 
PcomA data) was analysed using Fishers exact test.
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CHAPTER THREE: RESULTS
3.1 BCCAo in MF1 and C57bI/6 strain mice
BCCAo was established as a model of global cerebral ischaemia in MF1 and C57bl/6 
strain mice. Neuropathologic and physiologic consequences of BCCAo in MF1 strain 
mice were compared with those of C57bl/6 strain mice (as the effects of BCCAo in 
C57bl/6 strain mice had already been reported, Fujii et al., 1997; Yang et al., 1997).
3.1.1 Ischaemic neuronal damage in MF1 and C57bl/6 mice following BCCAo
10-20 minute BCCAo
Ischaemic neuronal damage in MF1 and C57bl/6 strain mice following 10, 15 and 20- 
minute BCCAo was scored using a semi-quantitative scoring system (see Section 2.6.3 for 
details). Following 10-minute BCCAo none of the seven brain regions analysed displayed 
any significant differences in ischaemic neuronal damage between MF1 and C57bl/6 strain 
mice (Table 3, Figure 17). Following 15-minute BCCAo MF1 strain mice displayed
significantly less ischaemic neuronal damage than C57bl/6 strain mice in hippocampus
CA2 (Table 3, Figure 17). Following 20-minute BCCAo MF1 strain mice displayed
significantly less ischaemic neuronal damage than C57bl/6 strain mice in hippocampus
CA1 and CA2 (Table 3, Figures 17, 18 and 19).
25-45 minute BCCAo
MF1 strain mice were subjected to extended durations (25, 30, 35, 40 and 45-minutes) of 
BCCAo. Extended BCCAo in MF1 strain mice was investigated to see if  ischaemic 
neuronal damage in this strain could be increased to match the anatomically widespread 
and extensive damage observed in C57bl/6 strain mice (after 20-minute BCCAo). 
Furthermore, ischaemic neuronal damage was quantified as a percentage, as the semi- 
quantitative scoring system applied in the previous study was considered insensitive for 
low levels of ischaemic neuronal damage.
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Ischaemic neuronal damage in 25-minute BCCAo mice did not differ significantly from 
that in sham-operated mice in any of the five brain regions analysed (Table 4, Figure 20). 
Ischaemic neuronal damage in 30 and 35-minute BCCAo mice was significantly increased 
in caudate nucleus compared to sham-operated mice (Table 4, Figure 20). Ischaemic 
neuronal damage in 40-minute BCCAo mice was significantly increased in hippocampus 
CA1, CA2 and caudate nucleus compared with sham-operated mice (Table 4, Figure 20). 
Ischaemic neuronal damage in 45-minute BCCAo mice was significantly increased in 
hippocampus CA1 and caudate nucleus compared with sham-operated mice (Table 4, 
Figure 20).
These data clearly indicated two important features of BCCAo in MF1 mice. First, 
BCCAo could induce ischaemic neuronal damage in this strain. Second, despite increasing 
BCCAo duration in this strain (to more than double that observed in C57bl/6 strain mice) 
ischaemic neuronal damage was not as extensive or anatomically widespread.
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Figure 17 Ischaemic neuronal damage in MF1 and C57bl/6 strain mice:
semi-quantitative assessment
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MFl strain mice displayed significantly less ischaemic neuronal damage than C57bl/6 
strain mice in hippocampus CA2 (following 15 and 20-minute BCCAo) and in 
hippocampus CA1 (following 20-minute BCCAo). Data are presented as mean ± standard 
error of the mean. *p<0.05; **p<0.01 Mann-Whitney test, (n = 6 per group).
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Figure 18 Ischaemic neuronal damage in hippocampus CA1 of M Fl strain mice
Ischaemic neuronal damage in hippocampus CA1 of MFl strain mice, in sham-operated 
(A) and following 10-minute (B), 15-minute (C) and 20-minute (D) BCCAo. In sham- 
operated mice there were no neurones showing features o f ischaemic cell change. Ten and 
15-minute BCCAo induced ischaemic cell change in a few neurones, while 20-minute 
BCCAo induced ischaemic cell change in a dozen or so neurones.
(Original magnification X200).
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Figure 19 Ischaemic neuronal damage in hippocampus CA1 of C57bI/6 strain mice
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4
Ischaemic neuronal damage in hippocampus CA1 o f C57bl/6 strain mice in sham-operated 
mice (A) and following 10-minute (B), 15-minute (C) and 20-minute (D) BCCAo. In 
sham operated mice no neurones exhibited features of ischaemic cell change, while 10, 15 
and 20-minute BCCAo induced widespread ischaemic neuronal damage in pyramidal 
neurones. (Original magnification X200).
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Figure 20 Ischaemic neuronal damage in MFl mice with extended BCCAo:
quantitative assessment
SHAM 25 30 35 40 45
Duration of Ischaemia (mins)
SHAM 25 30 35 40 45
Duration of Ischaemia (mins)
Caudate nucleus
SHAM 25 30 35 40 45
Duration of Ischaemia (mins)
Ischaemic neuronal damage (percent) in mice subjected to BCCAo was significantly 
different from sham-operated mice in hippocampus CA1, hippocampus CA2 and caudate 
nucleus. Ischaemic neuronal damage in mice subjected to BCCAo of a given duration was 
compared with sham-operated mice of the same duration. Sham groups are consolidated in 
this figure. Data are presented as mean ± standard error of the mean. *p<0.05; **p<0.01 
unpaired Student’s t-test. (n=26 sham, n=6 20, 25, 30, 40, 45 mins; n=8 35 mins).
84
3.1.2 Circle of Willis anatomy in MFl and C57bl/6 strain mice
Vascular anomalies of the circle of Willis have been directly linked with the degree of 
ischaemic neuronal damage following BCCAo (see Section 1.3.6). The most frequent 
anomaly reported in mice is posterior communicating artery (PcomA) hypoplasticity. In 
MFl strain mice studied here (n=16) only one mouse was deficient of both PcomAs 
(Figure 21). In C57bl/6 strain mice studied (n=8) five mice were deficient of both PcomAs 
(Figure 22). Furthermore, 56% of MFl strain mice investigated had both PcomAs, while 
no C57bl/6 strain mice had both PcomAs (Table 5). Forty-four percent of MFl strain mice 
displayed an incomplete circle of Willis, while 100% of C57bl/6strain mice displayed an 
incomplete circle of Willis (Table 5). These data show that MFl strain mice are 
significantly less likely to be deficient of both communicating arteries than C57bl/6 strain 
mice.
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Figure 21 Circle of Willis anatomy in MFl strain mice
ACA
MCA
PCA
SCA
PcomA
BA
The presence of ACA (anterior cerebral arteries), MCA (middle cerebral arteries), PCA 
(posterior cerebral arteries), PcomA (posterior communicating arteries), BA (basilar artery) 
and SCA (superior cerebellar arteries) in individual MFl mice (n=16) is summarised in 
this diagram. The top two rows and the large annotated section represent nine mice, which 
displayed a complete circle of Willis with two PcomAs. The second panel consists of six 
mice, which displayed only one PcomA, and one mouse displayed no PcomA.
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Figure 22 Circle of Willis anatomy in C57bl/6 strain mice
ACA
MCA
PcomA
The presence of ACA (anterior cerebral arteries), MCA (middle cerebral arteries), PCA 
(posterior cerebral arteries), PcomA (posterior communicating arteries), BA (basilar artery) 
and SCA (superior cerebellar arteries) in individual C57bl/6 mice (n=8) is summarised in 
this diagram. None of the eight mice investigated had a complete circle of Willis. Three 
mice had only one PcomA (top panel), while the remaining five mice had no PcomAs.
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Table 5 PcomAs in MFl and C57bl/6 strain mice
Number of posterior 
communicating arteries
MFl
(n = 16)
C57bl/6
(n = 8)
Two (complete) 9 0
One or none (incomplete) 7 8
Incomplete circle of Willis (%) 44* * 100
**p<0.01 Fishers exact test.
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3.1.3 Physiologic variables in MFl and C57bl/6 mice subjected to BCCAo
20-minute BCCAo
MABP and temperature have been directly linked with the degree of ischaemic neuronal 
outcome following BCCAo (see Sections 1.2.1 and 1.3.7). During 20-minute BCCAo 
MABP in MFl strain mice was significantly increased compared to that in C57bl/6 strain 
mice (Table 6). Prior to and following BCCAo MABP in MFl and C57bl/6 strain mice 
was similar (Table 6). A descriptive, temporal profile of MABP recorded every two 
minutes throughout the entire BCCAo procedure highlights the decrease in MABP in 
C57bl/6 strain mice (Figure 23). Upon BCCAo MABP in MFl and C57bl/6 strain mice 
increased to similar levels (Figure 23). MF1 strain mice maintained MABP above baseline 
throughout the entire period of BCCAo. In C57bl/6 strain mice MABP decreased 
progressively, commencing at around eight minutes after BCCAo (Figure 23). Removal 
of the carotid clips produced sharp, transient decreases in MABP in both MFl and C57bl/6 
strain mice, which returned to baseline levels over the next 10 or so minutes (Figure 23). 
Core body temperature was controlled, in both strains of mice; to minimise any 
temperature related effect upon ischaemic outcome or other physiologic variables (Table 
6). Arterial pH, carbon dioxide and oxygen tensions, measured 10 minutes post occlusion 
were similar in MFl and C57bl/6 strain mice (Table 6).
45-minute BCCAo
MABP in MFl strain mice prior to and following 45-minute of BCCAo were similar 
(Table 7). Upon BCCAo MABP was increased, and this increase maintained above 
baseline for the duration of the 45-minute occlusion period (Figure 24). This maintained 
increase in MABP throughout the 45-minute occlusion period was similar to the increase 
in MABP observed over a 20-minute occlusion period in a previous study (Figure 23). 
Together these data highlight the ability of MFl strain mice to increase and maintain 
MABP during BCCAo. Core body temperature was controlled; to minimise any
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temperature related effect upon ischaemic outcome or other physiologic variables. Arterial 
pH, carbon dioxide and oxygen tensions were similar to those observed in MFl mice 
following 20-minute BCCAo (Table 7, although no direct comparisons were made).
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Table 6 Physiologic variables in MFl and C57bl/6 mice: 20-minute BCCAo
MFl
(n = 8)
C57bl/6
(n = 8)
Weight (g) 35 ±1 30 ± 1 30 minutes before procedure
Temperature (°C) 37 ± 0.04 37 ± 0.03 during entire procedure f
MABP (mmHg) 84 ± 1
102 ± 5  
86 ± 5
89 ± 3  
87 ±5* 
84 ± 2
10 minutes before BCCAo J 
during 20-minute BCCAo { 
10 minutes after BCCAo J
Arterial pH 7.25 ± 0.01 7.21 ±0.04 10 minutes after BCCAo
Arterial pC02 (mmHg) 111 ± 9 115 ± 8 10 minutes after BCCAo
Arterial p 02 (mmHg) 52 ± 4 49 ± 4 10 minutes after BCCAo
t  Once stabilised (between 36.8 and 37.2°C) all changes in temperature were recorded 
throughout the entire experimental procedure. Data shown represent the mean temp 
throughout the experimental period. % Following femoral artery cannulation, MABP was 
continuously recorded until ten minutes post-occlusion. Data shown represent the MABP 
measured in the ten-minute period preceding BCCAo, the period of BCCAo, and the ten- 
minute period post BCCAo. All other data are expressed as mean ± standard error of 
mean. * p < 0.05 unpaired Student’s /-test.
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Figure 23 Influence of 20-minute BCCAo on MABP
1 15
/3 d=
B
B
BCCAo
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Data are expressed as mean ± standard error of the mean. Each point represents MABP 
recorded every two minutes throughout the 20-minute BCCAo procedure. (MFl n=8; 
C57bl/6 n=8).
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Table 7 Physiologic variables in MFl mice: 45-minute BCCAo
MFl
(n = 8)
Weight (g) 42 ±3 30 minutes before procedure
Temperature (°C) 37 ± 0.07 during entire procedure t
MABP (mmHg) 91 ± 6 10 minutes before BCCAo J
103 ± 12 during 20-minute BCCAo J
88 ± 8 10 minutes after BCCAo J
Arterial pH 7.28 ± 0.07 10 minutes after BCCAo
Arterial pC02 (mmHg) 121 ±25 10 minutes after BCCAo
Arterial p 0 2 (mmHg) 59 ± 10 10 minutes after BCCAo
t  Once stabilised (between 36.8 and 37.2°C) all changes in temperature were recorded 
throughout the entire experimental procedure. Data shown represent the mean temp 
throughout the experimental period. J Following femoral artery cannulation, MABP was 
continuously recorded until ten minutes post-occlusion. Data shown represent the MABP 
measured in the ten-minute period preceding BCCAo, the period of BCCAo, and the ten- 
minute period post BCCAo. All other data are expressed as mean ± standard error of 
mean.
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Figure 24 Influence of 45-minute BCCAo on MABP
90
PQ
carotid occlusion
0 10 20 30 40 50 60 70
Time (minutes)
Data are expressed as mean ± standard error of the mean. Each point represents MABP in 
MFl mice, recorded every two minutes throughout the 45-minute BCCAo procedure. 
(n=8).
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3.1.4 Hsp 70i immunoreactivity in MFl and C57bl/6 mice following BCCAo
Immunohistochemical localisation of hsp 70i following global cerebral ischaemia has been 
reported in several brain structures (including hippocampus, corpus striatum and cortex) in 
gerbil and rat (see Section 1.7.3). In mouse immunohistochemical localisation of hsp 70i 
following global cerebral ischaemia has not been shown. In this thesis 
immunohistochemical localisation of hsp 70i was observed in MFl and C57bl/6 strain 
mice in several brain structures following BCCAo.
10-20 minute BCCAo
There were no hsp 70i immunoreactive neurones (or any other cell types) observed in any 
sham-operated mice (Figures 26 and 27). However, following BCCAo there was notable 
cellular immunoreactivity to hsp 70i particularly in neurones and processes. Hsp 70i 
immunoreactive neurones in MFl and C57bl/6 strain mice following 10, 15 and 20-minute 
BCCAo were determined in five brain regions (Table 8). In three of these regions, namely 
hippocampus CA1, CA2 and CA3, MFl strain mice displayed significantly fewer hsp 70i 
immunoreactive neurones (Table 8, Figures 25, 26 and 27). This trend was also evident in 
the caudate nucleus, although, the differences failed to achieve statistical significance. 
Neurones in the dentate gyrus displayed hsp 70i immunoreactivity only in a few C57bl/6 
strain mice following 20-minute BCCAo (Table 8). The greatest number of hsp 70i 
immunoreactive neurones were observed in hippocampus CA1, followed by hippocampus 
CA3, caudate nucleus, hippocampus CA2 and dentate gyrus, respectively in both strains. 
Moreover, the number of hsp 70i immunoreactive neurones was not directly correlated 
with duration of occlusion (Table 8, Figure 25).
25-45 minute BCCAo
Hsp 70i immunoreactive neurones in MFl strain mice following 25, 30, 35, 40 and 45 
minutes BCCAo were determined in five brain regions. All five-brain regions analysed
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displayed hsp 70i immunoreactive neurones following BCCAo (Table 9, Figure 28). The 
greatest number of hsp 70i immunoreactive neurones were observed in hippocampus CA1, 
followed by hippocampus CA3, hippocampus CA2, caudate nucleus and dentate gyrus 
(Table 9). The number of hsp 70i immunoreactive neurones was not directly correlated 
with the duration of ischaemia (Table 9, Figure 28). Although direct comparison could not 
be made, the number of hsp 70i immunoreactive neurones observed following 25-45 
minutes of BCCAo was broadly similar to those observed following 10-20 minutes of 
BCCAo.
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Figure 25 Hsp 70i immunoreactive neurones in MFl and C57bl/6 mice
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MFl strain mice displayed significantly fewer hsp 70i immunoreactive neurones than 
C57bl/6 strain mice in hippocampus CA1 and CA3 (all BCCAo durations) and 
hippocampus CA2 (at 10 and 20-minute BCCAo). Data are presented as mean ± standard 
error of the mean. *p<0.05; **p<0.01; ***p<0.001 unpaired Student’s /-test, (n = 5 
C57bl/6 10, 20 mins; n = 6 MFl 10, 15 mins, C57bl/6 15 mins; n = 7 MFl 20 mins).
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Figure 26 Hsp 70i immunoreactive neurones in hippocampus of M Fl mice
B
I *
CA1
D
CA1
CA2 CA3
No hsp 70i immunoreactive neurones in hippocampus CA1 of sham-operated MFl strain 
mice (A). Hsp 70i immunoreactive neurones in hippocampus CA1 (B), CA2 (C) and CA3 
(D) of MFl strain mice subjected to 20-minute BCCAo. (Original magnification X200).
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Figure 27 Hsp 70i immunoreactive neurones in hippocampus of C57bl/6 mice
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No hsp 70i immunoreactive neurones in hippocampus CAl of sham-operated C57bl/6 
strain mice (A). Hsp 70i immunoreactive neurones in hippocampus CAl (B), CA2 (C) and 
CA3 (D) of C57bl/6 strain mice subjected to 20-minute BCCAo. (Original magnification 
X200).
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Figure 28 Hsp 70i immunoreactive neurones in hippocampus MF1 mice with 
extended BCCAo
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Hsp 70i immunoreactivity in MF1 strain mice did not increase with duration of BCCAo. 
Data are presented as mean ± standard error of the mean, (n = 6 25, 30, 40, 45 mins; n = 7
35 mins).
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3.2 BCCAo in transgenic mice over-expressing hsp 70i
Neuropathologic and physiologic consequences of BCCAo in transgenic mice over­
expressing hsp 70i were compared with those of their wild type littermates.
3.2.1 Ischaemic neuronal damage in hsp 70i transgenic mice following BCCAo
Ischaemic neuronal damage in hsp 70i transgenic and wild type littermate mice following 
25-minute BCCAo and 25-minute sham-BCCAo was quantified as a percentage (see 
Section 2.6.3). Four comparisons were made (Tables 10, 11, 12 and 13) hence the 
Bonferroni correction factor four. Ischaemic neuronal damage in sham-operated hsp 70i 
transgenic and wild type littermate mice did not differ significantly in any of the eight 
brain regions analysed (Table 10, Figure 29). In hsp 70i transgenic mice 25-minute 
BCCAo produced significantly increased ischaemic neuronal damage in four of the eight 
brain regions analysed, compared with sham-operated hsp 70i transgenic mice (Table 11, 
Figure 29). In wild type littermate mice, 25-minute BCCAo produced significantly 
increased ischaemic neuronal damage in seven of the eight brain regions analysed, 
compared with sham-operated wild type littermate mice (Table 12, Figure 29). Twenty- 
five minute BCCAo produced significantly less ischaemic neuronal damage in hsp 70i 
transgenic mice in three of the eight brain regions analysed, compared with 25-minute 
BCCAo in wild type littermate mice (Table 13, Figure 29).
These data clearly indicated two important features. First, BCCAo could induce ischaemic 
neuronal damage in hsp 70i transgenic mice and their wild type littermates. Second, 
BCCAo produces significantly less ischaemic neuronal damage in hsp 70i transgenic, mice 
than in wild type littermate mice.
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Figure 29
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Hsp 70i transgenic mice displayed significantly less ischaemic neuronal damage than wild 
type littermate mice in lateral caudate nucleus, medial caudate nucleus and posterior 
thalamus following 25-minute BCCAo. Ischaemic neuronal damage in BCCAo mice was 
significantly increased compared to that in sham-operated mice (not highlighted on graph, 
see Tables 11 and 12 for detaials). Data are presented as mean ± standard error of the 
mean. *p<0.05; **p<0.01 One way analysis of variance followed by unpaired Student’s t- 
test with Bonferroni correction factor of four, (n = 10 hsp 70i transgenic; n = 9 wild type 
littermate).
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Table 10 Ischaemic neuronal damage in hsp 70i transgenic and wild type
littermate mice: sham-operated
hsp 70i wild type
transgenic littermates
SHAM SHAM
Lateral caudate nucleus 3.4 ±0.4 3.2 ±0.3
Medial caudate nucleus 2.7 ±0.3 2.7 ± 0.3
Hippocampus CA1 1.3 ±0.3 1.9 ±0.3
Posterior thalamus 1.0 ±0.2 0.9 ±0.6
Hippocampus CA3 0.2 ±0.1 0.7 ± 0.2
Somatosensory cortex 0.8 ± 0.3 1.1 ±0.2
Hippocampus CA2 1.0 ±0.3 0.7 ± 0.2
Dentate gyrus 0.0 ± 0.0 0.03 ± 0.03
Data are expressed as mean ± standard error of the mean. p>0.05 One way analysis of 
variance followed by unpaired Student’s t-test with Bonferroni correction factor of four. 
(n= 10 hsp 70i transgenic; n = 9 wild type littermates).
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Table 11 Ischaemic neuronal damage in hsp 70i transgenic mice: sham versus
20-minute BCCAo
hsp 70i hsp 70i
transgenic transgenic
SHAM BCCAo
i%) e a
Lateral caudate nucleus 3.4 ±0.4 12.5 ±3.0 *
Medial caudate nucleus 2.7 ± 0.3 7.0 ± 1.6
Hippocampus CA1 1.3 ±0.3 5.4 ± 1.1
Posterior thalamus 1.0 ±0.2 3.4 ±0.5 ***
Hippocampus CA3 0.2 ±0.1 4.4 ± 1.1 **
Somatosensory cortex 0.8 ± 0.3 3.6 ±0.5 ***
Hippocampus CA2 1.0 ±0.3 1.3 ±0.3
Dentate gyrus 0.0 ±0.0 0.2 ±0.1
Data are expressed as mean ± standard error of the mean. *p<0.05; **p<0.01; ***p<0.001 
One way analysis of variance followed by unpaired Student’s Mest with Bonferroni 
correction factor of four. (n= 10 hsp 70i transgenic; n = 9 wild type littermates).
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Table 12 Ischaemic neuronal damage in wild type littermate mice: sham versus
20-minute BCCAo
wild type wild type
littermates littermates 
SHAM BCCAo
(%)___________ (%)
Lateral caudate nucleus 3.2 ±0.3 21.0 ± 3.1 •k ic k
Medial caudate nucleus 2.7 ± 0.3 14.7 ±2.3 ***
Hippocampus CA1 1.9 ±0.3 6.8 ± 1.9 **
Posterior thalamus 0.9 ± 0.6 5.1 ±0.5 ***
Hippocampus CA3 0.7 ± 0.2 4.8 ± 1.2 ***
Somatosensory cortex 1.1 ±0.2 4.1 ±0.3 ***
Hippocampus CA2 0.7 ± 0.2 2.2 ± 0.4 *
Dentate gyrus 0.03 ± 0.03 0.1 ±0.1
Data are expressed as mean ± standard error of the mean. *p<0.05; **p<0.01; ***p<0.001 
One way analysis of variance followed by unpaired Student’s J-test with Bonferroni 
correction factor of four. (n= 10 hsp 70i transgenic; n = 9 wild type littermates).
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Table 13 Ischaemic neuronal damage in hsp 70i transgenic and wild type
littermate mice: 20-minute BCCAo
hsp 70i wild type
transgenic littermates
BCCAo BCCAo
(%) (%)
Lateral caudate nucleus 12.5 ±3.0 21.0 ± 3.1 *
Medial caudate nucleus 7.0 ± 1.6 14.7 ±2.3 **
Hippocampus CA1 5.4 ± 1.1 6.8 ± 1.9
Posterior thalamus 3.4 ±0.5 5.1 ±0.5 *
Hippocampus CA3 4.4 ±1.1 4.8 ± 1.2
Somatosensory cortex 3.6 ±0.5 4.1 ±0.3
Hippocampus CA2 1.3 ±0.3 2.2 ± 0.4
Dentate gyrus 0.2 ±0.1 0.1 ±0.1
Data are expressed as mean ± standard error of the mean. *p<0.05; **p<0.01; One way 
analysis of variance followed by unpaired Student’s /-test with Bonferroni correction factor 
of four. (n= 10 hsp 70i transgenic; n = 9 wild type littermates).
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3.2.2 Circle of Willis anatomy in hsp 70i transgenic mice
In transgenic mice over-expressing hsp 70i (n=9) and their wild type littermates (n=9) no 
animals were deficient of both PcomAs (Figures 30 and 31). No hsp 70i or wild type 
littermate mice were deficient of both PcomAs. Sixty-seven percent of hsp 70i transgenic 
and wild type littermate mice had both PcomAs (Table 14). Thirty-three percent of hsp 70i 
transgenic and wild type littermate mice displayed an incomplete circle of Willis (Table 
14). These results indicate that transgenic mice over-expressing hsp 70i and their wild 
type littermates are as likely as one another to have an incomplete circle of Willis.
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Figure 30 Circle of Willis anatomy in transgenic hsp 70i mice
ACA
MCA
PCA
SCA
PcomA
BA
The presence of ACA (anterior cerebral arteries), MCA (middle cerebral arteries), PCA 
(posterior cerebral arteries), BA (basilar artery) and SCA (superior cerebellar arteries) in 
individual transgenic mice over-expressing hsp 70i (n=9) is summarised in this diagram. 
Six mice presented with both PcomAs (top panel and large annotated section) and three 
presented with only one PcomA (bottom panel). Of the three mice presenting with only 
one PcomA two mice displayed abnormally thin PcomA.
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Figure 31 Circle of Willis anatomy in wild type littermate mice
ACA
MCA
PCA
SCA
PcomA
BA
The presence of ACA (anterior cerebral arteries), MCA (middle cerebral arteries), PCA 
(posterior cerebral arteries), BA (basilar artery) and SCA (superior cerebellar arteries) in 
individual wild type mice (n=9) (littermates of hsp 70i transgenic mice) is summarised in 
this diagram. Six mice presented with both PcomAs (top panel and large annotated 
section) and three presented with only one PcomA (bottom panel). Of the six mice 
presenting with two PcomAs one mouse displayed abnormally thin vessels.
I l l
Table 14 PcomAs in hsp 70i transgenic mice
Number of posterior 
communicating arteries
hsp 701 
transgenic
(n = 9)
wild type 
littermates
(n = 9)
Two (complete) 6 6
One or none (incomplete) 3 3
Incomplete circle of Willis (%) 33 33
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3.2.3 Physiologic variables in hsp 70i transgenic mice: 25-minute BCCAo
Key physiologic variables in transgenic mice over-expressing hsp 70i and their wild type 
littermates with 25-minute BCCAo were investigated. MABP in hsp 70i transgenic and 
wild type littermate mice was broadly similar prior to, during and following BCCAo 
(Table 15). Upon BCCAo MABP in hsp 70i transgenic and wild type littermate mice 
increased to similar levels (Figure 32). In both hsp 70i transgenic and wild type littermate 
mice, increased MABP was maintained above baseline throughout the entire period of 
BCCAo (Figure 32). Removal of carotid clips produced sharp, transient decreases on 
MABP in both hsp 70i transgenic and wild type littermate mice, which returned to around 
baseline levels over the next 10 or so minutes (Figure 32). Core body temperature was 
controlled, in both groups, to minimise any temperature related effect upon ischaemic 
outcome or other physiologic variables. Arterial pH and carbon dioxide and oxygen 
tensions, measured 10 minutes after transient forebrain ischaemia, were broadly similar in 
hsp 70i transgenic and wild type littermate mice (Table 15).
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Table 15 Physiologic variables in hsp 70i transgenic mice: 25-minute BCCAo
hsp 70i 
transgenic
(n = 9)
wild type 
littermates
(n = 9)
Weight (g) 36.5 ± 1 37.6 ± 1 30 minutes before procedure
Temperature (°C) 37.0 ± 0.02 37.0 ± 0.02 during entire procedure f
MABP (mmHg) 90 ± 3 
109 ± 4  
85 ± 2
94 ± 3  
115 ± 3 
92 ± 3
10 minutes before BCCAo % 
during 25-minute BCCAo { 
10 minutes after BCCAo J
Arterial pH 7.34 ± 0.02 7.33 ±0.01 10 minutes after BCCAo
Arterial pC02 (mmHg) 47 ± 3.3 51 ± 2 10 minutes after BCCAo
Arterial p 02 (mmHg) 112 ± 5 104 ± 4 10 minutes after BCCAo
t  Once stabilised (between 36.8 and 37.2°C) all changes in temperature were recorded 
throughout the entire experimental procedure. Data shown represent the mean temp 
throughout the experimental period. J Following femoral artery cannulation, MABP was 
continuously recorded until ten minutes post-occlusion. Data shown represent the MABP 
measured in the ten-minute period preceding BCCAo, the period of BCCAo, and the ten- 
minute period post BCCAo. All other data are expressed as mean ± standard error of 
mean. p>0.05 unpaired Student’s Mest.
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Figure 32 Influence of 25-minute BCCAo on MABP
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Data are expressed as mean ± standard error of the mean. Each point represents MABP 
recorded every two minutes throughout the 25-minute BCCAo procedure, (hsp 70i 
transgenic n=9; wild type littermates n=9).
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3.2.4 Hsp 70i immunoreactivity in hsp 70i transgenic mice following BCCAo
There were no hsp 70i immunoreactive neurones (or any other cell types) observed in any 
sham-operated mice (Figures 34 and 35). However, following BCCAo there was notable 
cellular immunoreactivity to hsp 70i particularly in neurones and processes. Following 25- 
minute BCCAo there were no statistically significant differences in the number of hsp 70i 
immunoreactive neurones in hsp 70i transgenic mice compared with their wild type 
littermates, in any of the eight brain regions analysed (Table 16, Figure 33). The greatest 
number of hsp 70i immunoreactive neurones, in both hsp 70i transgenic and wild type 
mice, were observed in hippocampus CA1, followed by hippocampus CA3 and CA2 
(Table 16, Figures 33, 34 and 35).
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Table 16 Hsp 70i immunoreactive neurones in hsp 70i transgenic and wild type mice
hsp 70i 
transgenic 
SHAM
(n=9)
wild type 
littermates 
SHAM 
(n=9)
hsp 70i 
transgenic 
BCCAo
(n=10)
wild type 
littermates 
BCCAo
(n=10)
Hippocampus CA1 o ± o 0 ± 0 291 ± 87 334 ± 65
Hippocampus CA3 0 ± 0 o ± o 44 ± 11 109 ±35
Hippocampus CA2 0 ± 0 o ± o 30± 11 25 ± 7
Medial caudate nucleus 0 ± 0 0 ± 0 14 ± 6 7 ± 4
Posterior thalamus o ± o 0 ± 0 14 ± 9 6 ± 3
Lateral caudate nucelus 0 ± 0 o ± o 13 ± 8 3 ± 1
Somatosensory cortex 0 ± 0 0 ± 0 8 ± 4 6 ± 3
Dentate gyrus 0 ± 0 o ± o 0.5 ± 0.2 0.2 ± 0.2
Data are expressed as mean ± standard error of the mean. p>0.05 unpaired Student’s /-test 
(hsp 70i transgenic versus wild type littermate with BCCAo only, as sham-operated mice 
had no hsp 70i immunoreactive neurones).
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Figure 33 Hsp 70i immunoreactive neurones in hippocampus CA1, CA2 and CA3
CA1
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The number of hsp 70i immunoreactive neurones in hsp 70i transgenic mice did not differ 
significantly compared with wild type littermate mice following 25 minutes of transient 
forebrain ischaemia. Data are presented as mean ± standard error of the mean, (n = 10 hsp 
70i transgenic; n = 9 wild type littermate).
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Figure 34 Hsp 70i immunoreactive neurones in hippocampus of hsp 70i transgenic
mice
CAl
D
m
f t * ** §
? *  ,
CA2 CA3
No hsp 70i immunoreactive neurones in hippocampus CAl of sham-operated hsp 70i 
transgenic mice (A). Hsp 70i immunoreactive neurones in hippocampus CAl (B), CA2 (C) 
and CA3 (D) of hsp 70i transgenic mice subjected to 25-minute o f BCCAo (Original 
magnification X200).
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Figure 35 Hsp 70i immunoreactive neurones in hippocampus of wild type mice
i
CAl CAl
C D
♦ *
W % w %
m t %
K
CA2 CA3
No hsp 70i immunoreactive neurones in hippocampus CAl of sham-operated wild type 
littermate mice (A). Hsp 70i immunoreactive neurones in hippocampus CAl (B), CA2 (C) 
and CA3 (D) of wild type littermate mice subjected to 25-minute. (Original magnification 
X200).
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3.3 BCCAo in ad hsp70i and ad egfp transfected mice
Neuropathologic consequences of BCCAo in C57bl/6 strain mice intrastriatally injected 
with one microlitre (over ten minutes) of ad hsp 70i and ad egfp were investigated. 
C57bl/6 strain mice were used in this study for two reasons. First, previous studies within 
this thesis had shown them to be more susceptible to BCCAo than MF1 strain mice. 
Second, inter-hemispheric association of ischaemic neuronal damage in C57bl/6 strain 
mice was much stronger than that of MF1 strain mice (particularly in the caudate nucleus, 
Appendix E).
3.3.1 Behaviour following intrastriatal injection of ad hsp 70i and ad egfp
Overt behaviour of mice which received intrastriatal injection of ad hsp 70i (0.75 x 1010 
plaque forming units/ml) was indistinguishable from mice that received intrastriatal 
injection of ad egfp (0.75 x 1010 plaque forming units/ml).
3.3.2 Ad hsp 70i and ad egfp transfection
Direct localisation of hsp 70i transfection following intrastriatal injection in mice was not 
possible in this study as all mice injected were also subjected to BCCAo, which induces 
hsp 70i. Notwithstanding this, hsp 70i immunoreactivity was significantly increased in the 
ad hsp 70i injected hemisphere compared to the contralateral hemisphere, following 10 and 
20-minute BCCAo (see Section 3.3.4). The transfection capacity of ad could however be 
analysed where mice were intrastriatally injected with ad egfp. The extent of ad egfp 
transfection and the cell types transfected can be assumed to correlate well to areas of ad 
hsp 70i transfection. Moreover, a 100% transfection rate of ad egfp in this study (n=16 
mice) and in a previous study (n=22, see Section 3.5) suggested that ad hsp 70i transfection 
did occur. Ad egfp transfection was observed in the caudate nucleus in all mice (Figure 
36). Ad egfp transfection was also frequently observed in fibres of the subcortical white 
matter and white matter bundles within the caudate nucleus (Figures 37 and 38). Several
121
cell types were transfected with ad egfp including, neurones (Figure 39), astrocytes (Figure 
40) and ependymal cells of the right ventricle (Figure 41).
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Figure 37 Ad egfp transfection in subcortical white matter
Intrastriatal injection of ad egfp resulted in extensive transfection of cells and axons within 
ipsilateral subcortical white matter. (Green = egfp). (A, original magnification X200; B, 
original magnification X400).
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Figure 38 Ad egfp transfection of white matter bundles in caudate nucleus
Ad mediated egfp transfection of white matter bundles in the caudate nucleus was a 
common feature of mice intrastriatally injected with ad egfp. (Green = egfp). (A, original 
magnification X200; B ,  original magnification X400).
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Figure 39 Ad egfp transfection of neurones
Ad egfp transfection of a large neuron (A) and a small neuron (B) in the caudate nucleus. 
(Original magnification X400). (Green = egfp).
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Figure 40 Association of ad egfp transfection with astrocytes and activated 
neurofilaments in subcortical white matter and caudate nucleus
Ad egfp transfection was intimately associated with astrocytes (A, original magnification 
X I00 and C, original magnification X400) and activated neurofilaments (A, original 
magnification X200 and D, original magnification X400). Standard immunohistochemical 
detection techniques were employed to detect astrocytes with anti-glial astrocytic fibrillary 
protein antibody and activated neurofilaments H and M with anti-SMI-31 antibody (Dr 
Julia Edgar). The secondary antibody used was labelled with rodamine, which produced 
the red fluorescence. (Green = egfp).
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Figure 41 Ad egfp transfection in ependymal cells
Intrastriatal injection of ad egfp occasionally resulted in transfection of ependymal cells of 
the ipsilateral lateral ventricle. (Green = egfp). (A, original magnification X200; B, 
original magnification X400).
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3.3.3 Ischaemic neuronal damage in ad hsp 70i and ad egfp transfected mice
following BCCAo
20-minute BCCAo
In ad hsp 70i transfected mice, ischaemic neuronal damage in the injected caudate nucleus 
was significantly reduced compared to ischaemic neuronal damage in the contralateral 
caudate nucleus (Figures 42 and 43). Ischaemic neuronal damage did not differ 
significantly between hemispheres in any of the four other brain regions analysed, 
irrespective of ad hsp 70i injection (Table 17). In ad egfp transfected mice, ischaemic 
neuronal damage in the injected caudate nucleus was significantly reduced compared to 
ischaemic neuronal damage in the contralateral caudate nucleus (Figures 42 and 43). 
Ischaemic neuronal damage did not differ significantly between hemispheres in any of the 
four other brain regions analysed, irrespective of ad egfp injection (Table 17).
10-minutes BCCAo
In ad hsp 70i transfected mice, ischaemic neuronal damage in the injected hemisphere did 
not differ significantly compared with ischaemic neuronal damage in the contralateral 
hemisphere in any of the five brain regions analysed (Table 18). In ad egfp transfected 
mice, ischaemic neuronal damage in the injected hemisphere did not differ significantly 
compared with ischaemic neuronal damage in the contralateral hemisphere in any of the 
five brain regions analysed (Table 18).
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Figure 42 Ischaemic neuronal damage in caudate nucleus of ad hsp 70i and ad
egfp transfected mice: 20-minute BCCAo
1 I Ipsilateral 
Contralateral
Ad egfp Ad hsp 70i
Intrastriatal injection of ad hsp 70i and ad egfp significantly reduced ischaemic neuronal 
damage in ipsilateral caudate nucleus (compared with contralateral caudate nucleus) 
produced by 20-minute BCCAo. Data are presented as mean ± standard error of the mean. 
**p<0.01 paired Student’s Mest. (n = 9 ad hsp 70i; n = 8 ad egfp).
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Figure 43 Ischaemic neurones in caudate nucleus of ad hsp 70i and ad egfp
transfected mice: 20-minute BCCAo
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Ischaemic neuronal damage in ipsilateral caudate nucleus of ad hsp 70i (A) and ad egfp (C) 
transfected mice was significantly less than that in contralateral caudate nucleus (B and D7 
respectively). (Original magnification X200).
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Table 17 Ischaemic neuronal damage in ad hsp 70i and ad egfp transfected mice:
20-minute BCCAo
20-minute BCCAo
ADENOVIRUS HSP 70i ADENOVIRUS EGFP
(n=9) (n=8)
IPSI
(%)
CONTRA
(%)
IPSI
(%)
CONTRA
(%)
Hippocampus CA1 18.4 ±8.5 15.5 ±9.6 19.1 ±9.8 20.7 ± 11.3
Hippocampus CA2 26.8 ± 11.0 20.9 ± 9.3 19.0 ± 10.6 11.1 ±7.0
Hippocampus CA3 12.5 ±7.1 5.6 ±2.3 7.7 ±2.3 4.7 ± 2.7
Dentate gyrus 3.7 ±3.2 2.8 ±2.7 0.8 ± 0.3 0.5 ± 0.3
Data are expressed as mean ± standard error of the mean. p>0.05 paired Student’s t-test 
(ipsi versus contra). (IPSI = ipsilateral; CONTRA = contralateral).
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Table 18 Ischaemic neuronal damage in ad hsp 70i and ad egfp transfected mice:
10 minutes ischaemia
10-minute BCCAo
ADENOVIRUS HSP 70i ADENOVIRUS EGFP
(n=7) (n=6)
IPSI
(%)
CONTRA
(%)
IPSI
(%)
CONTRA
(%)
Caudate nucleus 3.4 ±0.9 5.0 ± 1.2 2.8 ± 0.7 3.2 ±1.1
Hippocampus CA1 4.7 ± 3.0 1.8 ±0.4 13.3 ±9.7 4.2 ± 0.8
Hippocampus CA2 3.6 ±2.4 4.7 ±3.4 11.7 ±7.0 14.2 ±7.7
Hippocampus CA3 4.6 ±3.4 12.9 ±8.3 5.1 ±1.9 5.1 ± 1.2
Dentate gyrus 0.2 ± 0.2 0 ± 0 2.6 ±2.4 0.2 ±0.1
Data are expressed as mean ± standard error of the mean. p>0.05 paired Student’s 7-test 
(ipsi versus contra). (IPSI = ipsilateral; CONTRA = contralateral).
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3.3.4 Hsp 70i immunoreactivity in ad hsp 70i and ad egfp transfected mice following
BCCAo
20-minute BCCAo
In ad hsp 70i transfected mice, hsp 70i immunoreactivity in the injected caudate nucleus 
was significantly increased compared with hsp 70i immunoreactivity in the contralateral 
caudate nucleus (Figures 44 and 45). Hsp 70i immunoreactivity did not differ significantly 
between hemispheres in any of the four other brain regions analysed, irrespective of ad hsp 
70i injection (Table 19, Appendix F). In ad egfp transfected mice, hsp 70i 
immunoreactivity in the injected caudate nucleus did not differ significantly from hsp 70i 
immunoreactivity in the contralateral caudate nucleus (Figure 44 and 46). Hsp 70i 
immunoreactivity did not differ significantly between hemispheres in any of the four other 
brain regions analysed, irrespective of ad egfp injection (Table 19).
10-minute BCCAo
In ad hsp 70i transfected mice, hsp 70i immunoreactivity in the injected caudate nucleus 
was significantly increased compared with hsp 70i immunoreactivity in the contralateral 
caudate nucleus (Figures 47 and 48). Hsp 70i immunoreactivity did not differ significantly 
between hemispheres in any of the four other brain regions analysed, irrespective of ad hsp 
70i injection (Table 20). In ad egfp transfected mice, hsp 70i immunoreactivity in the 
injected caudate nucleus did not differ significantly from hsp 70i immunoreactivity in the 
contralateral caudate nucleus (Figure 47 and 48). Hsp 70i immunoreactivity did not differ 
significantly between hemispheres in any of the four other brain regions analysed, 
irrespective of ad egfp injection (Table 20).
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Figure 44 Hsp 70i im mu noreactive neurones in caudate nucleus of ad hsp 70i and
ad egfp transfected mice: 20-minute BCCAo
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Intrastriatal injection of ad hsp 70i displayed significantly increased numbers of hsp 70i 
immunoreactive neurones in ipsilateral caudate nucleus (compared with contralateral 
caudate nucleus) following 20-minute BCCAo. Hsp 70i immunoreactive neurones in 
ipsilateral and contralateral caudate nucleus of ad egfp transfected mice were similar. Data 
are presented as mean ± standard error of the mean. *p<0.05 paired Student’s /-test, (n = 
9 ad hsp 70i; n = 8 ad egfp).
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Figure 45 Hsp 70i immunoreactive neurones in caudate nucleus of ad hsp 70i
transfected mice: 20-minute BCCAo
IPSILATERAL CONTRALATERAL
B
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Significantly more hsp 70i immunoreactive neurones in ipsilateral caudate nucleus o f ad 
hsp 70i transfected mice subjected to 20-minute BCCAo. (A and B, original magnification 
X I00; C and D, original magnification X200; E and F, original magnification X400).
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Figure 46 Hsp 70i immunoreactive neurones in caudate nucleus of ad egfp
transfected mice: 20-minute BCCAo
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Hsp 70i immunoreactive neurones in ipsilateral and contralateral caudate nucleus of ad 
egfp transfected mice subjected to 20-minute BCCAo were similar in number. (A and B, 
original magnification X I00; C and D, original magnification X200, E and F, original 
magnification X400).
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Table 19 Hsp 70i immunoreactive neurones in ad hsp 70i and ad egfp transfected
mice: 20-minute BCCAo
20-minute BCCAo
ADENOVIRUS HSP 70i ADENOVIRUS EGFP
(n=9) (n=8)
IPSI CONTRA IPSI CONTRA
Hippocampus CA1 0.6 ±0.3 0.3 ± 0.2 0.2 ± 0.2 0.5 ± 0.4
Hippocampus CA2 0.6 ± 0.3 0.3 ± 0.2 0 ± 0 0.1 ±0.1
Hippocampus CA3 0.6 ±0.3 0.3 ± 0.2 0.2 ± 0.2 0.5 ± 0.2
Dentate gyrus 0.2 ± 0.2 0 ± 0 0 ± 0 0.1 ±0.1
Semi-quantitative assessment of immunoreactive neurones 0 = no hsp70i immunoreactive 
neurones; 1 = a few hsp 70i immunoreactive neurones; 2 = many hsp 70i immunoreactive 
neurones; and 3 = very many of hsp 70i immunoreactive neurones. Data are expressed as 
mean ± standard error of the mean. p>0.05 paired Student’s Mest (ipsi versus contra). 
(IPSI = ipsilateral; CONTRA = contralateral).
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Figure 47 Hsp 70i immunoreactive neurones in caudate nucleus of ad hsp 70i and
ad egfp transfected mice: 10-minute BCCAo
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Mice intrastriatally injected with ad hsp 70i displayed significantly increased numbers of 
hsp 70i immunoreactive neurones in ipsilateral caudate nucleus (compared with 
contralateral caudate nucleus) following 10-minute BCCAo. Hsp 70i immunoreactive 
neurones in ipsilateral and contralateral caudate nucleus ad egfp transfected mice were 
similar. Data are presented as mean ± standard error of the mean. *p<0.05 paired 
Student’s /-test, (n = 7 ad hsp 70i; n = 6 ad egfp).
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Figure 48 Hsp 70i immunoreactive neurones in caudate nucleus of ad hsp 70i and
ad egfp transfected mice: 10-minute BCCAo
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Significantly more hsp 70i immunoreactive neurones in ipsilateral caudate nucleus o f ad 
hsp 70i transfected mice subjected to 10-minute BCCAo (A and B, original magnification 
X200). Hsp 70i immunoreactive neurones in ipsilateral and contralateral caudate nucleus 
of ad egfp transfected mice were similar in number. (C and D, original magnification 
X400).
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Table 20 Hsp 70i immunoreactive neurones in ad hsp 70i and ad egfp transfected
mice: 10-minute BCCAo
10-minute BCCAo
ADENOVIRUS HSP 70i ADENOVIRUS EGFP
(n=7) (n=6)
IPSI CONTRA IPSI CONTRA
Hippocampus CA1 0.3 ± 0.3 0.4 ±0.2 0.7 ± 0.2 0.5 ± 0.2
Hippocampus CA2 o ± o 0 ± 0 0.2 ± 0.2 0 ± 0
Hippocampus CA3 0.4 ± 0.2 0.6 ± 0.2 0.7 ± 0.2 0.5 ± 0.2
Dentate gyrus o ± o 0 ± 0 0 ± 0 0 ± 0
Semi-quantitative assessment of immunoreactive neurones 0 = no hsp70i immunoreactive 
neurones; 1 = a few hsp 70i immunoreactive neurones; 2 = many hsp 70i immunoreactive 
neurones; and 3 = very many of hsp 70i immunoreactive neurones. Data are expressed as 
mean ± standard error of the mean. p>0.05 paired Student’s /-test (ipsi versus contra). 
(IPSI = ipsilateral; CONTRA = contralateral).
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3.3.5 Structural and inflammatory response following ad injection
Intrastriatal injection of ad hsp 70i and ad egfp produced localised damage in the caudate 
nucleus (Figure 49), cortex and subcortical white matter. Furthermore, intrastriatal 
injection of ad hsp 70i and ad egfp resulted in infiltration of inflammatory cells (Figure 
49). Structural deformation and inflammatory response in ad hsp 70i and ad egfp injected 
mice were similar (Figure 49).
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Figure 49 Needle damage and inflammatory cells after ad injection
a  ■ H 1 H I  I H0MHMI H8
Intrastriatal injection of ad hsp 70i (A) and ad egfp (B) resulted in localised structural 
deformation and infiltration of inflammatory cells o f the caudate nucleus. (Original 
magnification X50).
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3.4 Mapping brain function in transgenic mice over-expressing hsp 70i
LCGU was estimated in transgenic mice over-expressing hsp 70i and their wild type 
littermates using 14C-2-deoxyglucose autoradiography (see Section 2.7 for details). LCGU 
was measured in the basal state (following intraperitoneal injection with sterile saline, 
0.4ml) and following metabolic activation (intraperitoneal injection with dizocilpine 
1 mg/kg dissolved in 0.4ml sterile saline).
3.4.1 Behaviour following intraperitoneal injection with dizocilpine
All mice intraperitoneally injected with dizocilpine displayed overt behavioural changes. 
These changes were predominantly increases in motor activity (typically repetitive 
movement of the head) and elevated excitability. The magnitude of these responses was 
broadly similar in all mice, irrespective of genotype. None of the mice intraperitoneally 
injected with saline displayed abnormal or overt changes in behaviour, irrespective of 
genotype.
3.4.2 Plasma 14C and glucose concentrations
Plasma 14C and glucose concentrations in transgenic mice over-expressing hsp 70i did not 
differ significantly from plasma 14C and glucose concentrations in wild type littermate 
mice, irrespective of dizocilpine or saline injection (Table 21). Moreover, terminal plasma 
14C / glucose ratio correlated well with tissue 14C (cerebellar cortical grey matter), 
irrespective of treatment or genotype (Figure 50).
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Table 21 Plasma 14C and glucose concentrations in hsp 70i transgenic mice
hsp 70i transgenic wild type littermates
SALINE DIZOCILPINE SALINE DIZOCILPINE
________________________ (n=7) (n=7)__________(n=7) (n=7)
Plasma 14C (nCi/g) 35.8 ± 4.4 41.1 ± 3.7 28.9 ± 4.4 41.4 ± 4.0
Plasma glucose (mM) 10.1 ± 0.5 9.7 ± 0.6 8.7 ± 0.8 9.0 ± 0.4
Data are expressed as mean ± standard error of the mean. p>0.05 One way analysis of 
variance followed by unpaired Student’s f-test with Bonferroni correction factor of four.
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3.4.3 LCGU in hsp 70i transgenic and wild type littermate mice
Following intraperitoneal injection o f  saline
LCGU in transgenic mice over-expressing hsp 70i did not differ significantly from LCGU 
in wild type littermate mice in any of the 35 brain regions analysed, following saline 
injection (Table 22, Figures 51, 52, 53 and 54). This was true even of brain regions known 
to over-express the hsp 70i transgene, such as, hippocampus CA1, caudate nucleus and 
anterior thalamus.
Following intraperitoneal injection with dizocilpine
In hsp 70i transgenic mice, intraperitoneal injection of dizocilpine evoked widespread, 
heterogeneous alterations in LCGU compared with intra-peritoneal injection with saline 
(Table 23, Figure 51, 52, 53 and 54). LCGU was markedly increased in 22 brain regions, 
including several regions of the limbic system. LCGU was significantly decreased in two 
brain regions, sensory motor cortex and inferior colliculus. There were no significant 
alterations in LCGU in any of the remaining 11 brain regions analysed (Table 23).
In wild type littermate mice, intraperitoneal injection of dizocilpine evoked widespread, 
heterogeneous alterations in LCGU compared with intraperitoneal injection of saline 
(Table 24, Figures 51, 52, 53 and 54). LCGU was markedly increased in 20 brain regions, 
including several regions of the limbic system. LCGU was significantly decreased in two 
brain regions, sensory motor cortex and inferior colliculus. There were no significant 
alterations in LCGU in any of the remaining brain regions analysed (Table 24).
Intraperitoneal injection of dizocilpine evoked significant alterations in LCGU in five brain 
regions between transgenic mice over-expressing hsp 70i and their wild type littermates 
(Table 25, Figures 51, 52, 53 and 54). LCGU in hsp 70i transgenic mice was significantly 
greater in three brain regions (anterior thalamic nucleus, Hippocampus CA1 stratum oriens
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and hippocampus CA1 stratum lacunosum molecularae, Figures 51, 52 and 53) than in 
wild type littermate mice. LCGU in hsp 70i transgenic mice was markedly lower in two 
brain regions (superior olivary body and nucleus of the lateral lemniscus, Figure 54) than 
in wild type littermate mice. There were no significant differences in LCGU in any of the 
remaining 30 brain regions analysed between hsp 70i transgenic and wild type littermate 
mice following intraperitoneal injection of dizocilpine (Table 25).
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Figure 51 Increased LCGU in hsp 70i transgenic mice: dizocilpine injected
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Following intraperitoneal injection with dizocilpine LCGU in hsp 70i transgenic mice was 
significantly increased in anterior thalamic nucleus, hippocampus CA1 stratum 
laucunosum molecularae and CA1 stratum oriens compared with wild type littermate mice. 
LCGU in dizocilpine injected mice was significantly increased compared to that in saline 
injected mice (not highlighted on graph, see Tables 22 and 23). Data are presented as 
mean ± standard error of the mean. *p<0.05; **p<0.01 One way analysis of variance 
followed by unpaired Student’s /-test with Bonferroni correction factor of four, (n = 7 per 
group; ROI = region of interest)
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Figure 52 Representative 14C-2-deoxyglucose autoradiograms of dorsal hippocampus
Hsp 70i-Saline W ild type-Saline
C D
Hsp 70i-Dizocilpine W ild type-Dizocilpine
Representative examples of l4C-2-deoxyglucose autoradiograms at the level of the dorsal 
hippocampus from hsp 70i transgenic saline injected mice (A), wild type littermate saline 
injected mice (B), hsp 70i transgenic dizocilpine injected mice (C), and wild type 
littermate dizocilpine injected mice (D). Dorsal hippocampus CA1 stratum lacunosum 
(CA1 slm, arrows) in dizocilpine injected mice (C and D) exhibit increased LCGU 
compared to saline injected mice (A and B, respectively). Furthermore, LCGU in CA1 slm 
in dizocilpine injected hsp 70i transgenic mice (C) is increased compared to CA1 slm in 
dizocilpine injected wild type littermate mice (D).
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Figure 53 Representative 14C-2-deoxyglucose autoradiograms of anterior 
thalamic nuclei
H sp 70i-SaIine W ild type-Saline
D
Hsp 70i-Dizocilpine W ild type-Dizocilpine
Representative examples of 14C-2-deoxyglucose autoradiograms at the level of the anterior 
thalamic nucleus from hsp 70i transgenic saline injected mice (A), wild type littermate 
saline injected mice (B), hsp 70i transgenic dizocilpine injected mice (C), and wild type 
littermate dizocilpine injected mice (D). Anterior thalamic nucleus (ATN, arrows) in 
dizocilpine injected mice (C and D) exhibit increased LCGU compared to saline injected 
mice (A and B, respectively). Furthermore, LCGU in ATN in dizocilpine injected hsp 70i 
transgenic mice (C) is increased compared to ATN in dizocilpine injected wild type 
littermate mice (D).
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Figure 54 Decreased LCGU in hsp 70i transgenic mice: dizocilpine injected
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Following intraperitoneal injection with dizocilpine LCGU in hsp 70i transgenic mice was 
significantly decreased in superior olivary body and nucleus of the lateral lemniscus 
compared with wild type littermate mice. Data are presented as mean ± standard error of 
the mean. *p<0.05 One way analysis of variance followed by unpaired Student’s t-test 
with Bonferroni correction factor of four.
(n = 7 per group; ROI = region of interest)
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Table 22 LCGU in hsp 70i transgenic and wild type littermate mice: saline injected
hsp 70i
transgenic
SALINE
(n=7)
wild type
littermates
SALINE
(n=7)
Anterior thalamic nucleus 1.64 ± 0.072 1.66 ± 0.083
Dorsal CA 1 stratum lacunosum moleculare 1.44 ± 0.049 1.44 ± 0.083
Superior olivary body 1.44 ± 0.068 1.52 ± 0.045
Dorsal hippocampus CA 1 stratum oriens 1.01 ± 0.019 0.94 ± 0.023
Nucleus of the lateral lemniscus 0.98 ± 0.042 1.16 ± 0.053
Lateral caudate nucleus 1.54 ± 0.053 1.34 ± 0.034
Hippocampus CA 1 stratum lacunosum moleculare 1.26 ± 0.042 1.24 ± 0.057
Vestibular nucleus 1.77 ± 0.034 1.80 ± 0.045
Superior colliculus 1.40 ± 0.045 1.38 ± 0.049
Lateral ventro dorsal thalamus 1.61 : 0.06 1.69 ± 0.087
Medial beniculate body 1.25 ± 0.049 1.32 ± 0.053
Sensory motor cortex 1.59 ± 0.057 1.51 ± 0.045
Hypothalamus 0.75 ± 0.038 0.69 ± 0.060
Inferior colliculus 2.25 ± 0.260 2.77 ± 0.068
Lateral septal nuclei 0.94 ± 0.038 0.83 ± 0.038
Amygdala 1.15 ± 0.026 1.15 ± 0.030
Substantia nigra pars compacta 1.05 ± 0.030 1.17 ± 0.049
Anterior pyriform cortex 1.73 ± 0.083 1.59 ± 0.068
Dentate gyrus 0.86 ± 0.026 0.79 ± 0.026
Anterior commisure 0.96 ± 0.049 0.91 ± 0.026
Medial caudate nucleus 1.55 ± 0.042 1.31 ± 0.049
Ventromedial thalamus 1.53 ± 0.049 1.57 ± 0.026
Medial mammillary body 1.94 ± 0.064 1.79 ± 0.052
Anterior cingulate cortex 1.62 ± 0.298 1.51 ± 0.057
Anteromedial thalamic nuclei 1.50 ± 0.053 1.53 ± 0.098
Subthalamic nucleus 1.27 ± 0.049 1.32 ± 0.068
Globus pallidus 0.86 ± 0.038 0.85 ± 0.053
Posterior entorhinal cortex 1.05 ± 0.049 1.07 ± 0.049
Lateral habenular nuclei 1.06 ± 0.019 1.04 ± 0.049
Lateral geniculate body 1.21 ± 0.026 1.27 ± 0.068
Mediolateral posterior thalamus 1.62 ± 0.053 1.62 ± 0.042
Substantia nigra pars reticulata 0.81 ± 0.026 0.79 ± 0.034
Nucleus accumbens 0.79 ± 0.042 0.68 ± 0.038
Posterior cingulate cortex 1.86 ± 0.042 1.75 ± 0.049
Pontine reticular formation 1.03 ± 0.026 1.08 ± 0.026
Data are expressed as mean ratio of 14C in region of interest / 14C in cerebellar cortex 
(nCi/g) ± standard error of the mean. p>0.05 One way analysis of variance followed by 
unpaired Student’s Mest with Bonferroni correction factor of four.
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Table 23 LCGU in hsp 70i transgenic mice: saline versus dizocilpine injected
hsp 70i hsp 70i
transgenic transgenic
SALINE DIZOCILPINE
(n=7)___________ (n=7)
Anterior thalamic nucleus 1.64 ± 0.072 3.04 ± 0.136 ***
Dorsal CA 1 stratum lacunosum moleculare 1.44 ± 0.049 2.70 ± 0.079 ***
Superior olivary body 1.24 ± 0.068 1.37 ± 0.090
Dorsal hippocampus CA 1 stratum oriens 1.01 ± 0.019 1.18 ± 0.057 *
Nucleus of the lateral lemniscus 0.98 ± 0.042 1.08 ± 0.410
Lateral caudate nucleus 1.54 ± 0.053 2.56 ± 0.120 ***
Hippocampus CA 1 stratum lacunosum moleculare 1.26 ± 0.042 2.36 ± 0.128 ***
Vestibular nucleus 1.77 ± 0.034 1.66 ± 0.052
Superior colliculus 1.40 ± 0.045 1.39 ± 0.071
Lateral ventro dorsal thalamus 1.61 =t: 0.06 3.08 ± 0.177 ***
Medial beniculate body 1.25 ± 0.049 1.54 ± 0.079 **
Sensory motor cortex 1.59 ± 0.057 1.33 ± 0.053 *
Hypothalamus 0.75 ± 0.038 0.91 ± 0.034 *
Inferior colliculus 2.25 ± 0.260 1.62 ± 0.120 *
Lateral septal nuclei 0.94 ± 0.038 1.43 ± 0.034 ***
Amygdala 1.15 ± 0.026 1.75 ± 0.083 ***
Substantia nigra pars compacta 1.05 ± 0.030 1.36 ± 0.034 *
Anterior pyriform cortex 1.73 ± 0.083 3.50 ± 0.306 ***
Dentate gyrus 0.86 ± 0.026 1.12 ± 0.015 ***
Anterior commisure 0.96 ± 0.049 1.29 ± 0.049 **
Medial caudate nucleus 1.55 ± 0.042 1.79 ± 0.083
Ventromedial thalamus 1.53 ± 0.049 1.95 ± 0.090 **
Medial mammillary body 1.94 ± 0.064 2.24 ± 0.143
Anterior cingulate cortex 1.62 ± 0.298 1.91 ± 0.068
Anteromedial thalamic nuclei 1.50 ± 0.053 1.99 ± 0.060 ***
Subthalamic nucleus 1.27 ± 0.049 1.40 ± 0.019
Globus pallidus 0.86 ± 0.038 1.10 ± 0.034 **
Posterior entorhinal cortex 1.05 ± 0.049 2.22 ± 0.139 ***
Lateral habenular nuclei 1.06 ± 0.019 1.22 ± 0.034
Lateral geniculate body 1.21 ± 0.026 1.45 ± 0.068 *
Mediolateral posterior thalamus 1.62 ± 0.053 2.05 ± 0.087 **
Substantia nigra pars reticulata 0.81 ± 0.026 0.99 ± 0.037 *
Nucleus accumbens 0.79 ± 0.042 0.94 ± 0.038
Posterior cingulate cortex 1.86 ± 0.042 2.15 ± 0.049
Pontine reticular formation 1.03 ± 0.026 1.28 ± 0.037 **
Data are expressed as mean ratio of 14C in region of interest / 14C in cerebellar cortex 
(nCi/g) ± standard error of the mean. *p<0.05; **p<0.01; ***p<0.001 One way analysis
of variance followed by unpaired Student’s /-test with Bonferroni correction factor of four.
Table 24 LCGU in wild type littermate mice: saline versus dizocilpine injected
wild type wild type
littermates littermates
SALINE DIZOCILPINE
(n=7)___________ (n=7)
Anterior thalamic nucleus 1.66 ±0.083 2.22 ±0.211 *
Dorsal CA 1 stratum lacunosum moleculare 1.44 ±0.083 2.12 ±0.162 ***
Superior olivary body 1.52 ±0.045 1.84 ± 0.155
Dorsal hippocampus CA 1 stratum oriens 0.94 ± 0.023 1.02 ±0.045
Nucleus of the lateral lemniscus 1.16 ±0.053 1.28 ±0.068
Lateral caudate nucleus 1.34 ±0.034 2.24 ±0.143 ***
Hippocampus CA 1 stratum lacunosum moleculare 1.24 ±0.057 2.06 ±0.124 ***
Vestibular nucleus 1.80 ±0.045 1.82 ±0.079
Superior colliculus 1.38 ±0.049 1.58 ±0.098
Lateral ventro dorsal thalamus 1.69 ±0.087 2.69 ± 0.226 ***
Medial beniculate body 1.32 ±0.053 1.40 ±0.049
Sensory motor cortex 1.51 ±0.045 1.19 ±0.071 **
Hypothalamus 0.69 ± 0.060 0.82 ± 0.049
Inferior colliculus 2.77 ± 0.068 1.95 ±0.117 **
Lateral septal nuclei 0.83 ± 0.038 1.33 ±0.094 ***
Amygdala 1.15 ±0.030 1.91 ±0.158 ***
Substantia nigra pars compacta 1.17 ±0.049 1.44 ±0.090 **
Anterior pyriform cortex 1.59 ±0.068 3.26 ±0.215 ***
Dentate gyrus 0.79 ± 0.026 1.08 ±0.052 ***
Anterior commisure 0.91 ± 0.026 1.35 ±0.090 ***
Medial caudate nucleus 1.31 ±0.049 1.72 ±0.094 **
Ventromedial thalamus 1.57 ±0.026 2.03 ±0.125 **
Medial mammillary body 1.79 ±0.052 2.13 ±0.177
Anterior cingulate cortex 1.51 ±0.057 2.03 ± 0.094
Anteromedial thalamic nuclei 1.53 ±0.098 1.93 ±0.109 *
Subthalamic nucleus 1.32 ±0.068 1.44 ±0.109
Globus pallidus 0.85 ± 0.053 1.08 ±0.030 **
Posterior entorhinal cortex 1.07 ±0.049 2.18 ± 0.117 ***
Lateral habenular nuclei 1.04 ±0.049 1.20 ±0.087
Lateral geniculate body 1.27 ±0.068 1.43 ±0.086
Mediolateral posterior thalamus 1.62 ±0.042 2.03 ±0.120 **
Substantia nigra pars reticulata 0.79 ± 0.034 1.00 ±0.064 **
Nucleus accumbens 0.68 ± 0.038 0.93 ± 0.038 **
Posterior cingulate cortex 1.75 ±0.049 2.30 ±0.102
Pontine reticular formation 1.08 ±0.026 1.28 ±0.056 *
Data are expressed as mean ratio of 14C in region of interest / 14C in cerebellar cortex 
(nCi/g) ± standard error of the mean. *p<0.05; **p<0.01; ***p<0.001 One way analysis 
of variance followed by unpaired Student’s /-test with Bonferroni correction factor of four.
Table 25 LCGU in hsp 70i transgenic and wild type littermates: dizocilpine injected
hsp 70i wild type
transgenic littermates
DIZOCILPINE DIZOCILPINE
(n=7)___________ (n=7)
Anterior thalamic nucleus 3.04 ± 0.136 2.22 ± 0.211 **
Dorsal CA 1 stratum lacunosum moleculare 2.70 ± 0.079 2.12 ± 0.162 **
Superior olivary body 1.37 ± 0.090 1.84 ± 0.155 *
Dorsal hippocampus CA 1 stratum oriens 1.18 ± 0.057 1.02 ± 0.045 *
Nucleus of the lateral lemniscus 1.08 ± 0.041 1.28 ± 0.068 *
Lateral caudate nucleus 2.56 ± 0.120 2.24 ± 0.143
Hippocampus CA 1 stratum lacunosum moleculare 2.36 ± 0.128 2.06 ± 0.124
Vestibular nucleus 1.66 ± 0.052 1.82 ± 0.079
Superior colliculus 1.39 ± 0.071 1.58 ± 0.098
Lateral ventro dorsal thalamus 3.08 ± 0.177 2.69 ± 0.226
Medial beniculate body 1.54 ± 0.079 1.40 ± 0.049
Sensory motor cortex 1.33 + 0.053 1.19 ± 0.071
Hypothalamus 0.91 ± 0.034 0.82 ± 0.049
Inferior colliculus 1.62 ± 0.120 1.95 ±0.117
Lateral septal nuclei 1.43 ± 0.034 1.33 ± 0.094
Amygdala 1.75 ± 0.083 1.91 ± 0.158
Substantia nigra pars compacta 1.36 ± 0.034 1.44 ± 0.090
Anterior pyriform cortex 3.50 ± 0.306 3.26 ± 0.215
Dentate gyrus 1.12 ± 0.015 1.08 ± 0.052
Anterior commisure 1.29 ± 0.049 1.35 ± 0.090
Medial caudate nucleus 1.79 ± 0.083 1.72 ± 0.094
Ventromedial thalamus 1.95 ± 0.090 2.03 ± 0.125
Medial mammillary body 2.24 ± 0.143 2.13 ± 0.177
Anterior cingulate cortex 1.91 ± 0.068 2.03 ± 0.094
Anteromedial thalamic nuclei 1.99 ± 0.060 1.93 ± 0.109
Subthalamic nucleus 1.40 ± 0.019 1.44 ± 0.109
Globus pallidus 1.10 ± 0.034 1.08 ± 0.030
Posterior entorhinal cortex 2.22 ± 0.139 2.18 ± 0.117
Lateral habenular nuclei 1.22 ± 0.034 1.20 ± 0.087
Lateral geniculate body 1.45 ± 0.068 1.43 ± 0.086
Mediolateral posterior thalamus 2.05 ± 0.087 2.03 ± 0.120
Substantia nigra pars reticulata 0.99 ± 0.037 1.00 ± 0.064
Nucleus accumbens 0.94 ± 0.038 0.93 ± 0.038
Posterior cingulate cortex 2.15 ± 0.049 2.30 ± 0.102
Pontine reticular formation 1.28 ± 0.037 1.28 ± 0.056
Data are expressed as mean ratio of 14C in region of interest / 14C in cerebellar cortex 
(nCi/g) ± standard error of the mean. *p<0.05; **p<0.01; ***p<0.001 One way analysis
of variance followed by unpaired Student’s Mest with Bonferroni correction factor of four.
3.5 Mapping brain function following ad egfp gene transfer
LCGU was estimated in C57bl/6 strain mice seven and 28-days after intrasrtriatal injection 
with ad egfp or saline (one microlitre over a 10-minute period). The impact of two versus 
ten-minute delay in post-injection needle extraction upon egfp transfection and LCGU was 
also investigated. Two densitometric analysis strategies were employed. First, LCGU in 
the entire caudate nucleus was measured. Second, LCGU in circumscribed areas of the 
caudate nucleus was measured (this enabled analysis of ad egfp transfected areas and 
needle damage, see Appendix G for more detail). The remaining eight brain regions were 
analysed using standard densitometric analysis techniques (see Section 2.7.4).
3.5.1 Behaviour following intrastriatal injection with ad
Overt behaviour of mice which received intrastriatal injection of 1 microlitre 
(O.lpl/minute) of ad egfp (1.57 x 1010 plaque forming units/ml) was indistinguishable from 
mice that received intrastriatal injection of sterile saline.
3.5.2 Ad egfp transfection
All of the 22 mice intrastriatally injected with ad egfp displayed transfection. Ad egfp 
transfection was prevalent in three structures in all mice, the caudate nucleus, subcortical 
white matter and white matter bundles within the caudate nucleus. The extent of ad egfp 
transfection was not noticeably different at seven and 28-days post injection (Figure 55). 
Moreover, the delay in post-injection needle extraction did not noticeably affect the extent 
of ad egfp transfection (Figure 56). In some mice, ad egfp transfection was observed in 
ependymal cells of the right ventricle (Figure 56).
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Figure 55 Ad egfp transfection: 7 and 28 days post-injection
Ad egfp transfection in caudate nucleus at seven days post-injection (A) was similar to that 
observed at 28 days post-injection (B). (Original magnification X I00).
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Figure 56 Ad egfp transfection: 2 versus 10-minute delay in needle extraction
Ad egfp transfection in the caudate nucleus, subcortical white matter and ependymal cells 
(of the lateral ventricle) was similar in mice where the needle was extracted two (A) and 10 
(B) minutes after injection (Original magnification X I00).
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3.5.3 Plasma 14C and glucose concentrations
Plasma 14C and glucose concentrations in seven and 28-day ad egfp transfected and saline 
injected mice did not differ significantly (Table 26). Moreover, terminal plasma 14C / 
glucose correlated well with tissue 14C (cerebellar cortical grey matter), irrespective of 
treatment (Figure 57).
3.5.4 LCGU in ad egfp transfected mice
LCGU in entire caudate nucleus
There were no significant inter-hemispheric differences in LCGU where the entire caudate 
nucleus was analysed (Figure 58 and 59). Moreover, there were no significant inter-group 
differences in hemispheric LCGU. LCGU in the entire caudate nucleus was similar in all 
groups irrespective of treatment or survival duration.
LCGU in areas o f ad egfp transfection in caudate nucleus
LCGU was analysed in areas of ad egfp transfection and areas of needle damage on 
autoradiograms (see Appendix F for details on delineation of these areas). In areas of ad 
egfp transfection LCGU was significantly decreased compared to LCGU in the 
contralateral hemisphere at seven and 28-days post-injection (Figures 60 and 61). In saline 
injected mice, there was a significant difference in LCGU between ipsilateral and 
contralateral hemispheres at seven days, but not at 28-days post-injection (Figure 60). 
LCGU in areas of ad egfp transfection was similar in all groups irrespective of treatment or 
survival duration.
LCGU in areas o f needle damage in caudate nucleus
In areas of injection damage, ad egfp transfected mice displayed no significant differences 
in LCGU between hemispheres at seven days post-injection (Figure 61). Ad egfj} 
transfected mice did however display significant decreases in LCGU at 28-days in the
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transfected hemisphere compared to the contralateral hemisphere (Figure 61). In saline 
injected mice, the opposite was observed. LCGU in the saline injected hemisphere was 
significantly increased compared to LCGU in the contralateral hemisphere at seven days 
post-injection (Figure 61). At 28-days post saline injection there were no significant 
differences in LCGU between hemispheres (Figure 61).
LCGU in other brain regions analysed
There were no significant inter-hemispheric differences in LCGU in any of the other eight 
brain regions analysed at seven or 28-days post-injection (Tables 27 and 28).
161
£
§
£
O
PQ
( N
VO
ox) *g g
3  °<  1-1
in
O ;
-H
r -
vdvo
TT
©
-H
CN
£
M
to
£
Q
oo
N
VO
£ W 
<« <N
VO
&
CO
O v
-H
£ ■
O v
VO
in
-H
mwo
£ -
©
-H
wo
d
-H
£ ■
8T3
a
<Z)
' O
<D
•a
&
£
> >x>
T3
<D
£
O
I
0 )o
n
+*
o
<*-»
CAa
£
u .
01)
4 >
’O
£
.9
CA
£o• ■4 
£  
+* 
c
«flo
«
CAo
o
£
ojd
TS
£
£
£
9
CA
£
E
VO
< N
<D
£
H
£
£
£
CA
► »
£
Q
r -
wo
£ B 
CC <N
VOII
£
co
■ " t
-H
coWO
vq
-H
oo
( N
r "
( N
vd
-H
cq
CO
vo
01)
U
f l .
VO
d
-H
wo
o
-H
p
CO
in
d
-H
oo
*  -
o
CA 
• ^
CO
13
*
a>
£
O
woo
d
A
&>
9
<D
a
<4-1o
iHo
&
'O
c3T3
+1
§
<D
CA
CCj
od<D
CA
CA
<Dl-HD.X
<D
<D
U
£
a
Q
£
cS
<4-1
O
of£
£O
'■£o
CD
uoO
Fi
gu
re
 
57 
Re
la
tio
ns
hi
p 
be
tw
ee
n 
tis
su
e 
14C 
an
d 
te
rm
in
al
 p
las
m
a 
14C 
/ g
lu
co
se
 r
at
io
r-~
v o
&
mVO
6X) 60a>
O  < 1 □  •
r o
(S/D«) 
xayoo jqpq9J93
8a
b
O
U>• ^  +-> O d> G<CO<Dti
CO
&
I)
8<D
IJO
COc3
£
<L>
coOOJ3
'3b
UTi­
es
a
CO
cS
'Eh
T3
co
g  • ^a
o
y—H
£
00<D
>0
8
•3
&T31
OOCN
Ohg
I)
<3Oh
vr>
G0
1
(DOao
o
U
cSO
tso
o
co
G
a
CN
£00<L>
0)
I
(L>0
s<L>
1  -s4^  g
£  r'
co 
G O
>0
S
■g
s*
1
OO
CN
CS
CO
&*Gi
00
CN
Figure 58 LCGU in entire caudate nucleus of ad egfp transfected mice
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LCGU measured in entire ipsilateral and contralateral caudate nucleus was similar at seven 
and 28 days post-injection. Data are presented as mean ± standard error of the mean. 
P>0.05 Paired Student’s Mest. (n=6 7 and 28-day saline, 7 and 28-day adenovirus egfp: 2 
mins; n=5 per group 7 and 28-day adenovirus egfp: 10 mins). (ROI = region of interest).
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Figure 59 Representative 14C-2-deoxyglucose autoradiograms of injected caudate 
nucleus
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Representative examples of 14C-2-deoxyglucose autoradiograms of the site of injection in 
the caudate nucleus of saline injected (A and C), ad egfp with 2 minutes needle extraction 
(C and D) and ad egfp with 10 minutes needle extraction (E and F). Areas o f ad egfp 
transfection (red arrows) and areas of needle damage (yellow arrows) are highlighted.
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Figure 60 LCGU in areas of ad egfp transfection in caudate nucleus
7 Day survival
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LCGU in areas of ad egfp transfection was significantly decreased compared with 
contralateral hemisphere at seven and 28 days post injection (irrespective of 2 or 10-minute 
needle extraction delay). LCGU was similar in saline injected and contralateral 
hemisphere at seven and 28 days post injection. Data are presented as mean ± standard 
error of the mean. *p<0.05 paired Student’s /-test. (n=6 7 and 28-day saline, 7 and 28- 
day adenovirus egfp: 2 mins; n=5 per group 7 and 28-day adenovirus egfp: 10 mins). 
(ROI = region of interest).
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Figure 61 LCGU in areas of needle damage in caudate nucleus
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LCGU in areas of needle damage in intrastriatally injected mice was significantly 
decreased compared with contralateral hemisphere at 28 days post injection (at both 2 and 
10-minute needle extraction delay). LCGU was increased in areas of needle damage in 
saline injected mice at 7 days. LCGU in ad egfp transfected mice at 7 days post-injection 
and saline injected mice at 28 days was similar to that in contralateral hemisphere. Data 
are presented as mean ± standard error of the mean. *p<0.05; **p<0.01 paired Student’s t- 
test. (n=6 7 and 28-day saline, 7 and 28-day adenovirus egfp: 2 mins; n=5 per group 7 
and 28-day adenovirus egfp: 10 mins). (ROI = region of interest).
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CHAPTER FOUR: DISCUSSION
Recent research has shown that hsp 70i may ameliorate ischaemic neuronal damage 
induced by cerebral ischaemia. Moreover, genetically modified mice and viral vectors are 
increasingly being employed as research tools to gain insight into the processes and 
mechanisms involved in cerebral ischaemia. The studies of this thesis were designed to 
address two major themes. First, the influence of hsp 70i upon ischaemic outcome 
following global cerebral ischaemia (BCCAo) was investigated using transgenic mice 
over-expressing hsp 70i and ad hsp 70i gene transfer in the caudate nucleus. Second, the 
functional consequences of transgene over-expression in the brain were investigated, in 
transgenic mice over-expressing hsp 70i and following ad egfp gene transfer in the caudate 
nucleus.
4.1 BCCAo in mice
To investigate the influence of hsp 70i in cerebral ischaemia a murine model of cerebral 
ischaemia had to be established. Global cerebral ischaemia was chosen on the basis of the 
over-expression pattern of hsp 70i in the transgenic mice available. In these transgenic 
mice, hsp 70i over-expression was driven by the rhombotin 1 promoter (see Section 2.9 for 
details), meaning hsp 70i was over-expressed in several brain regions selectively 
vulnerable to global cerebral ischaemia (including, hippocampus and striatum). However, 
the background strain of the hsp 70i transgenic mice (MF1) had not been described in any 
ischaemic paradigm. Furthermore, no mouse ischaemia models had been established in my 
laboratory. The first aim of this thesis was therefore, to establish a mouse model of global 
cerebral ischaemia and describe its effects on MF1 strain mice. Global cerebral ischaemia 
was induced by BCCAo. BCCAo had been reported to induce ischaemic neuronal damage 
in several other mouse strains, including C57bl/6 and SV129 (the most commonly 
employed strains for producing genetically modified mice) by Yang et al., (1997) and Fujii 
et al. (1997). Employing different occlusion durations and anaesthesia paradigms, Yang et 
al., (1997) and Fujii et al., (1997) both observed C57bl/6 strain mice to be the most
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susceptible to BCCAo. C57bl/6 strain mice were employed in this thesis to compare the 
effects of BCCAo on MF1 mice and to ensure BCCAo could induce ischaemic neuronal 
damage with the methodology used.
4.1.1 Susceptibility of mouse strain to BCCAo
Ischaemic neuronal damage in seven brain regions was determined histologically following 
BCCAo of 10, 15 and 20 minutes duration in MF1 and C57bl/6 strain mice, and compared 
(see Table 3, Figure 17). MF1 strain mice were observed to display significantly less 
ischaemic neuronal damage than C57bl/6 strain mice following 15 and 20-minute BCCAo. 
These data corroborated the previous findings of Yang et al., (1997) and Fujii et al., (1997) 
in that BCCAo (of short duration, 10-20 minutes) produced widespread ischaemic neuronal 
damage in C57bl/6 strain mice. In MF1 mice however, BCCAo of short duration (10-20 
minutes) did not produce widespread ischaemic neuronal damage. Instead only minimal to 
moderate ischaemic neuronal damage was observed in brain areas selectively vulnerable to 
global cerebral ischaemia. In an attempt to increase the ischaemic neuronal damage in 
MF1 mice, BCCAo duration was extended (25-45 minutes). A similar ploy had been 
adopted by Fujii et al., (1997) who reported only minimal ischaemic neuronal damage in 
SV129 strain mice following short durations of BCCAo, compared to C57bl/6 strain mice. 
In this thesis however, ischaemic neuronal damage in MF1 strain mice was investigated at 
several durations of extended BCCAo and was assessed quantitatively (as percentage 
ischaemic neurones, not as a semi-quantitative score). By investigating several durations 
of extended BCCAo and assessing ischaemic neuronal damage quantitatively, an accurate 
profile of the effect of increasing BCCAo duration was obtained (see Table 4, Figure 20). 
There was a trend of increased ischaemic neuronal damage with increased BCCAo 
duration versus sham-operated mice (see Figure 20). However, ischaemic neuronal 
damage in 25-minute BCCAo mice was similar to 45-minute BCCAo mice in all five-brain 
regions analysed (see Table 4). Moreover, the ischaemic neuronal damage observed in
MF1 mice following extended duration BCCAo was similar to that in MF1 mice following 
10-20 minute BCCAo (see Table 3) and was not as extensive or widespread as that 
observed in C57bl/6 strain mice following 10-20 minute BCCAo (see Table 3). In short, 
BCCAo induced ischaemic neuronal damage in MF1 strain mice, but the degree of 
ischaemic neuronal damage was moderate in comparison to that induced in C57bl/6 strain 
mice.
4.1.2 Hierarchy of ischaemic neuronal damage in MF1 and C57bl/6 mice
Differences in the rank order of ischaemic neuronal vulnerability following global cerebral 
ischaemia in gerbil and rat have been well documented (Kirino, 1982; Kirino and Sano, 
1984a; Pulsinelli et al., 1982; Smith et al., 1984). In mice, the rank order of ischaemic 
neuronal vulnerability has been shown to be quite different from that in gerbil and rat 
(Yang et al., 1997; Fujii et al., 1997; Murakami et al., 1998). In gerbil and rat models 
ischaemic neuronal damage was predominantly observed in hippocampus CA1, CA4 and 
subiculum. The major differences in mouse relate to the incidence of ischaemic neuronal 
damage in hippocampus CA2, caudate nucleus and cerebral cortex as well as hippocampus 
CA1. In this thesis, BCCAo produced ischaemic neuronal damage of varying degrees 
throughout the hippocampus, caudate nucleus, cortex and thalamus in MF1 and C57bl/6 
strain mice (see Tables 3 and 4). The regional hierarchy of ischaemic neuronal 
vulnerability in MF1 strain mice was different to that of C57bl/6 strain mice (Table 29).
Table 29 Hierarchy of ischaemic neuronal damage in MF1 and C57bl/6 mice 
Most damaged area
Least damaged area
MF1 rs7hi/6
Caudate nucleus Hippocampus CA2
Somatosensory cortex Caudate nucleus
Posterior thalamus Posterior thalamus
Hippocampus CA1 Somatosensory cortex
Hippocampus CA2 Hippocampus CA1
Hippocampus CA3 Hippocampus CA3
Dentate gyrus Dentate gyrus
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4.1.3 Factors influencing ischaemic neuronal damage following BCCAo
The increased susceptibility of C57bl/6 strain mice to BCCAo has been suggested to be 
due to their increased likelihood of circle of Willis hypoplasticity. Yang et al., (1997) and 
Fujii et al., (1997) both reported a high incidence of PcomA hypoplasticity in C57bl/6 
strain mice. The first report of PcomA hypoplasticity in any mouse strain was Barone et 
al., (1993). Barone and colleagues (1993) suggested that PcomA hypoplasticity in balb-c 
strain mice might render this strain susceptible to BCCAo as a murine model of global 
cerebral ischaemia. BCCAo in the Mongolian gerbil had been (and remains) widely 
employed as a model of global cerebral ischaemia, as they lack anastomoses between 
anterior and posterior cerebral circulations (Levine and Sohn, 1969; Ito et al., 1975). 
Murakami et al., (1998) have also correlated increased ischaemic neuronal damage in CD- 
1 strain mice with PcomA hypoplasticity. In this thesis, hypoplasticity of the PcomAs in 
C57bl/6 and MF1 strain mice were significantly different (see Figures 21 and 22, Table 5). 
No C57bl/6 strain mouse investigated displayed a complete circle of Willis (i.e., no 
C57bl/6 mice had two PcomAs). In contrast, more than half of MF1 strain mice 
investigated displayed a complete circle of Willis (i.e., nine MF1 mice from 16 had two 
PcomAs). Moreover, five of eight C57bl/6 strain mice had no PcomAs, whereas only one 
from 16 MF1 strain mice had no PcomAs. Therefore, a lack of PcomA hypoplasticity in 
MF1 strain mice could be a major factor why only minimal to moderate ischaemic 
neuronal damage was observed following BCCAo thus, reducing ischaemic neuronal 
damage. That is to say, collateral blood flow via the vertebro-basilar arterial branches may 
help overcome reduced blood flow to the forebrain during BCCAo in MF1 strain mice. In 
C57bl/6 mice increased PcomA hypoplasticity, and therefore reduced collateral blood 
flow, is most likely a major factor why BCCAo produces extensive and widespread 
ischaemic neuronal damage in this study and others (Yang et al., 1997; Fujii et al., 1997). 
Another feature of ischaemic neuronal damage, particularly in MF1 strain mice, was its 
unilateral distribution. That is to say, only one brain hemisphere displayed ischaemic
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neuronal damage in many of the MF1 mice subjected to BCCAo (see Appendix E). A 
likely cause of unilateral ischaemic neuronal damage could be unilateral PcomA 
hypoplasticity. Of MF1 strain mice investigated, six had one PcomA compared with only 
three C57bl/6 strain mice displaying unilateral PcomA hypoplasticity.
The influence of systemic hypotension upon ischaemic neuronal damage during BCCAo 
was elegantly illustrated in the rat by Smith et al, (1984). Smith and colleagues employed 
BCCAo in rat with systemic hypotension (circa 60mmHg) to induce global cerebral 
ischaemia. Without accompanying hypotension, BCCAo alone in rat does not induce 
global cerebral ischaemia. This is not the case in gerbils (Levine and Payan, 1966) or mice 
(Barone et al., 1993). In this thesis however, MABP in C57bl/6 strain mice was observed 
to decrease progressively (after a transient increase) during 20-minute BCCAo to around 
55mmHg (see Figure 23). In contrast, MABP in MF1 strain mice during 20 and 45-minute 
BCCAo was maintained above baseline (after a transient increase) throughout the entire 
occlusion durations (see Figures 23 and 24). It is entirely likely that the maintained 
increase in MABP in MF1 strain mice during BCCAo coupled with the increased presence 
of PcomAs promotes collateral blood flow to the forebrain thus, reducing the 
neuropathologic impact of BCCAo. In C57bl/6 strain mice, the progressive decrease in 
MABP during BCCAo coupled with the decreased presence of PcomAs does not promote 
collateral blood flow to the forebrain thus, increasing the neuropathologic impact of 
BCCAo.
4.1.4 Hsp 70i and cerebral ischaemia
In normal (unstressed brain), hsp 70i is expressed only in minuscule amounts (Latchman,
1998). Cerebral ischaemia however can induce hsp 70i such that it is expressed in several 
brain regions. Global cerebral ischaemia has been shown to induce hsp 70i in gerbil 
(Nowak, 1985; Vass et al., 1988; Aoki et al., 1993a, 1993b; Soriano et al., 1994; Ferrer et
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al., 1995) and rat (Dienel et al., 1986; Gaspary et al., 1995). Hsp 70i induction and 
expression varies with the severity of the ischaemic insult. In gerbils BCCAo induces 
significant hsp 70i expression in CA3, but not hippocampus CA1 (Vass et al., 1988; Aoki 
et al., 1993a). Nowak et al., (1990) however, reported significant hsp 70i mRNA 
expression in hippocampus CA1 neurones following BCCAo in the gerbil. Similar results 
have been reported in rat models of global cerebral ischaemia (Kawagoe et al., 1993). 
Moreover, in focal cerebral ischaemia in rat, hsp 70i immunoreactive neurones are located 
within the margin of viable tissue surrounding the infarct core (penumbra) and not within 
the infarcted core (Gonzalez et al., 1989). These data imply that while hsp 70i is induced 
by ischaemia, hsp 70i protein transcription can also be disrupted by ischaemia if severe 
enough. In mice, hsp 70i expression following ischaemia has only been detected by 
Southern and Western blot analysis (Plumier et al., 1997; Radjev et al., 1999). In this 
thesis, hsp 70i expression following BCCAo was immunohistochemically detected in 
neurones in several brain regions (notably hippocampus CA1 and CA3) in MF1 and 
C57bl/6 strain mice. MF1 strain mice displayed significantly fewer hsp 70i 
immunoreactive neurones than C57bl/6 strain mice following BCCAo (see Tables 8 and 
9). That is to say, C57bl/6 strain mice displayed greater numbers of hsp 70i 
immunoreactive neurones and more extensive ischaemic neuronal damage than MF1 strain 
mice. These findings suggest that the severity of the ischaemic insult produced by BCCAo 
in C57bl/6 strain mice was not sufficient to obliterate the translation of hsp 70i mRNA into 
hsp 70i protein in hippocampus CA1. Whereas, the severity of the ischaemic insult 
produced by BCCAo in MF1 mice was not sufficient to produce hsp 70i expression to the 
same extent as that observed in C57bl/6 strain mice.
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4.2 BCCAo in transgenic and viral vector transfected mice
The benefits of genetically modified (transgenic) mice in the understanding of the 
pathophysiology of cerebral ischaemia have been substantial. The roles of numerous genes 
and gene products in cerebral ischaemia have been further elucidated using such mice (see 
Section 1.8). Viral vectors have also been beneficially employed to investigate the role of 
specific genes in the pathophysiology of cerebral ischaemia (see Section 1.9.5). The 
second aim of this thesis was to investigate the influence of hsp 70i over-expression on 
ischaemic outcome following BCCAo. Directed over-expression of hsp 70i was 
investigated in two systems, first, in transgenic mice over-expressing hsp 70i, and second, 
in mice with ad hsp 70i gene transfer into the caudate nucleus.
4.2.1 Neuroprotection in hsp 70i transgenic mice
The hsp 70i transgenic mice used in this thesis were produced in an MF1 strain
background. The initial study of this thesis described the effects of BCCAo on MF1 strain 
mice (see Section 3.1). BCCAo in MF1 strain mice was shown to evoke only minimal to 
moderate ischaemic neuronal damage. Furthermore, ischaemic neuronal damage in MF1 
strain mice was similar following 25 and 45-minute BCCAo (circa 15% in caudate nucleus 
and 25% in hippocampus CA1, see Table 4). On the basis of these findings 25-minute 
BCCAo was chosen to investigate the ischaemic outcome in hsp 70i transgenic mice and 
their wild type littermates. Following 25-minute BCCAo, wild type littermate mice
displayed similar values of ischaemic neuronal damage in the caudate nucleus,
hippocampus CA3 and dentate gyrus to MF1 strain mice subjected to 25-minute BCCAo in 
a previous study (see Section 3.1). In hippocampus CA1 and CA2 however, wild type 
littermate mice displayed much lower levels of ischaemic neuronal damage than those 
observed in MF1 strain mice. Hsp 70i transgenic mice displayed markedly reduced 
ischaemic neuronal damage compared to wild type littermate mice in three of eight brain 
regions analysed (lateral caudate nucleus, medial caudate nucleus and posterior thalamus,
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see Figure 29). In the initial study in this thesis, significant differences in the susceptibility 
of MF1 and C57bl/6 strain mice to BCCAo were attributed to differences in PcomA 
hypoplasticity and MABP during BCCAo. In the present study, markedly reduced 
ischaemic neuronal damage in hsp 70i transgenic mice compared to wild type littermate 
mice were unlikely to be attributable to inter-group differences in PcomA hypoplasticity or 
MABP. In hsp 70i transgenic and wild type littermate mice investigated the incidence of 
PcomA hypoplasticty was identical (see Figures 30 and 31, Table 14). Whereas, MABP 
prior to, during and following BCCAo in hsp 70i transgenic and wild type littermate mice 
was similar (and was marginally lower throughout in hsp 70i transgenic mice, see Figure 
32). Moreover, there were no statistically significant differences between hsp 70i 
transgenic and wild type littermate mice in any of the other physiologic variables measured 
(see Table 15). Therefore over-expression of hsp 70i might be the major factor 
contributing to the marked reduction in ischaemic neuronal damage in hsp 70i transgenic 
mice. However, hsp 70i immunoreactivity was not significantly different in hsp 70i 
transgenic mice compared to wild type littermate mice in any brain region analysed 72 
hours after BCCAo (see Table 16). The best possible explanation for the reduced 
susceptibility of hsp 70i transgenic mice to BCCAo is increased hsp 70i expression, 
quicker in transgenic than wild type littermate mice (see Section 4.2.2).
4.2.2 Hsp 70i expression and promoter activity
Where transgenic over-expressing mice are used the nature of the over-expression is very 
important. Increased basal expression of a given transgene may have an immediate impact 
upon cellular function following an ischaemic insult. Likewise, stimulation of increased 
transgene expression elicited by up-regulation of specific transgene promoters may also 
increase the expression of a given transgene following ischaemic insult. These features are 
of utmost importance in the study of gene products in the pathophysiology of cerebral 
ischaemia. The phenomenon of delayed neuronal death following global cerebral
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ischaemia has been described in several species (Ito et al., 1975; Pulsinelli and Brierly, 
1979; Kirino, 1982; Kirino and Sano, 1984; Smith et al., 1984; Petito et al., 1987; 
Bonnekoh et al., 1990; Horn and Scholte, 1992). The mechanisms, which mediate this 
type of cellular death, are not fully understood. Several theories, which may be inter­
related, have been hypothesised: (1) glutamate mediated excitotoxicity (Rothman &
Olney, 1986; Choi et al., 1988; Danysz et al., 1995; Choi et al., 1999,; Dimagi et al.,
1999); (2) disruption of mitochondrial synthesis due to dismpted axonal transport (Abe et 
al., 1987); (3) inflammatory attack, mediated by calcium and / or free radicals
(MacManus et al., 1993; Chan, 1994; Nitatori et al., 1995). The array of processes evoked 
in ischaemic brain provide a multitude of candidates which may trigger cell survival or cell 
death cascades (necrotic or apoptotic). Irrespective of the mechanism, the point at which 
one or more of these processes is triggered in individual cells or cell populations, impacts 
upon the utility of potentially protective agents.
The temporal profile of endogenous hsp 70i expression varies with severity of stimulus and 
vulnerability of brain cells within a given region. Hsp 70i mRNA translation and 
subsequent transcription to protein occurs over a period of hours. Transcription deficits (of 
hsp 70i expression) have been reported in neurones destined to die following BCCAo in 
gerbil (Nowak et al., 1990). Therefore the point at which cell death processes are triggered 
is paramount. Here, transgenic mice over-expressing hsp 70i are observed to have 
increased neuronal survival following BCCAo compared with their wild type littermates 
(see Table 13, Figure 29). These neurones may have been saved primarily by increased 
basal levels of hsp 70i acting to preserve intracellular protein integrity from the point of 
ischaemic insult. Furthermore stimulation of the rhombotin 1 promoter regulating hsp 70i 
expression by ischaemia (or a by-product of ischaemia) may have enabled increased and 
quicker expression of hsp 70i.
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The rhombotin 1 promoter is up-regulated by kainate receptor activation (Hinks et al., 
1997) and kainate receptors are activated during ischaemia (Choi et al., 1999; Dirnagl et 
al., 1999). It is likely both of these processes occurred following BCCAo, meaning early 
cell death mechanisms may be ameliorated by pre-existing and speedy increases in hsp 70i 
transgene expression in transgenic mice employed. The endogenous hsp 70i response, 
which is evident from wild type littermate MF1 strain mice (see Table 16) (and has been 
previously shown previously in MF1 strain mice a separate study, see Table 8), may 
ameliorate late or less severe ischaemic cell damage. In this way hsp 70i transgenic mice 
may have three phases of hsp 70i expression to combat ischaemic cell changes, immediate 
and intermediate (driven by hsp 70i transgene over-expression) and an endogenous hsp 70i 
response to BCCAo. While wild type littermate mice only exhibit endogenous hsp 70i 
expression which may occur after ischaemic cell death has been triggered in some cells. 
The hypothesis that germ-line transgenic over-expression of hsp 70i is neuroprotective in 
cerebral ischaemia is consolidated by recent reports of decreased infarct volumes following 
focal cerebral ischaemia (Radjev et al., 1999; Yenari et al., 1999).
4.2.3 Further studies using genetically modified mice
In two further studies within the laboratory, apoE-deficient and IL-18-deficient mice were 
employed to investigate their roles in BCCAo (Appendices H and I). A role for apoE in 
regulating the response to and outcome following brain injury (including ischaemic brain 
injury) has been suggested following numerous reports (Teasdale et al., 1997; Sheng et al., 
1998; Horsburgh et al., 1999; McCarron et al., 1999). The role of IL-18 in cerebral 
ischaemia is not yet known (Touzani et al., 1999). ApoE-deficient mice were more 
susceptible to BCCAo than their wild type littermates. IL-18-deficient mice were also 
more susceptible to BCCAo than their wild type littermates. These results suggested that 
apoE and IL-18 genes modified the pathophysiological response following BCCAo. 
Furthermore, intraventricular infusion of exogenous apoE (prior to, during and following
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BCCAo) was shown to significantly reduce ischaemic neuronal damage (Horsburgh et al.,
2000). A similar rhetoric, whereby exogenous IL-18 was intracerebrally injected into IL- 
18-deficient mice, did little to ameliorate ischaemic brain damage (and in fact may have 
been toxic, appendix J). The apparent success of intraventricular infusion of apoE in 
reducing ischaemic neuronal damage in apoE-deficient mice strongly supported a 
beneficial role for apoE in the brain response to ischaemia. The failure of intracerebral IL- 
18 injection to ameliorate ischaemic neuronal damage suggests IL-18 may not be so 
important in the pathophysiology of ischaemic brain damage. However, these studies 
highlight a design flaw. For example, following brain injury apoE is markedly increased 
and secreted (predominantly from astrocytes) into the extracellular space (Poirier, 1994). 
ApoE mRNA has not been found in neurones to date (Horsburgh et al., 1999), although 
several investigators have identified apoE in vulnerable neurones following ischaemia 
(Hall et al., 1995; Horsburgh and Nicholl, 1996). These findings suggest a mechanism for 
neuronal apoE uptake from the extracellular space (i.e., intraventricularly infused apoE 
could be taken up by neurones). The cellular source of IL-18 in the brain has only recently 
been identified in vitro (Conti et al., 1999; Prinz and Hanisch, 1999). The cell types 
implicated are microglia and astrocytes. An antibody to IL-18 has not yet been produced 
and furthermore, only one study upon the role of IL-18 in cerebral ischaemia has been 
undertaken (Appendix I). Therefore intracerebral injection of IL-18 might not necessarily 
lead to increased neuronal IL-18, as no mechanism has been postulated. Sophisticated 
systems of directly injecting or infusing molecules into the brain have been developed. 
These systems include the use of vectors (such as viral vectors, see below), which, can be 
targeted to specific cell types including neurones and glial cells (Hermens and Verhaagan, 
1997; Weihl, 1999; Sapolsky and Steinberg, 1999).
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4.2.4 Ad hsp 70i gene transfer is neuroprotective
Ad hsp 70i gene transfer was hypothesised to ameliorate ischaemic neuronal damage 
following BCCAo. Ad egfp gene transfer was hypothesised to have no biological effect 
upon ischaemic neuronal damage following subsequent BCCAo. These assumptions were 
based on previous findings. Several studies employing ad vector transfection of a number 
of different therapeutic genes have been shown to ameliorate ischaemic neuronal damage 
in vivo and in vitro (see Section 1.9.5). Moreover, ad gene transfer of P-galactosidase (a 
commonly used reporter gene, like egfp) has been reported to have no significant effect 
upon ischaemic outcome (Betz et al., 1995; Kindy et al., 1996; Yang et al., 1999). In this 
thesis, both ad hsp 70i and ad egfp significantly reduced ischaemic neuronal damage in 
ipsilateral caudate nucleus compared to contralateral caudate nucleus in mice subjected to 
20-minute BCCAo (see Figure 42). While it is entirely unlikely that ad hsp 70i and ad 
egfp reduce ischaemic neuronal damage of striatal neurones by the same mechanism, the 
data of the present study cannot clarify this.
4.2.5 Impact of injecting ad vectors into the brain
First generation ad vectors (El-deleted, used in this thesis) have many advantages 
including efficient and relatively safe gene transfer into dividing and quiescent cells 
(Breakfield, 1993; Heistad and Faraci, 1996; Verma & Somia, 1997). El-deleted ad 
vectors however, induce innate cellular and humeral immune responses in the periphery 
(Yang et al., 1994a, 1994b, 1995; Simon et al., 1993; Dai et al., 1995) and in brain (Byrnes 
et a l, 1995, 1996a; Kajiwara et al., 1997, 2000). In peripheral organs, such as the liver, 
the immune response eliminates El-deleted ad particles and transduced cells within 14-21 
days (Elkon et al., 1997). In brain, El-deleted ad mediated transgene expression persists 
for somewhat longer durations (Wood et al., 1996). Geddes et al., (1997) report stable 
reversion of diabetes insipidus phenotype in Brattleboro rats transfected with ad vectors 
containing vasopressin four months after injection. The stability of El-deleted ad
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transgene expression is, however, significantly reduced where the subject is subsequently 
exposed peripherally to the same ad vector (Byrnes et al., 1996b). Moreover, the 
anatomical site of ad vector injection into the brain significantly affects the immune 
response. Using replication competent influenza virus Stevenson et al., (1997a) reported 
that immune response priming in the brain occurred following infection of the 
cerebrospinal fluid, but not the parenchyma. Stevenson et al., (1997b) subsequently 
suggested that immune responses in the brain could be region specific.
The immune response consists of two aspects, the cellular immune response and the 
humeral immune response. In the periphery, cellular immunity to ad vectors is believed to 
be the predominant mechanism limiting the duration of transgene expression by killing 
virus infected cells (Kajiwara et al., 2000). Humeral immunity is believed to be the 
predominant mechanism limiting secondary ad transduction (Kay et al., 1995). In brain, 
the inflammatory and immune responses to ad vectors are not well understood. Recent 
studies using ad vectors have shown involvement of the cellular and humeral immune 
responses. Intracerebroventricular (i.e., into the cerebrospinal fluid and not the 
parenchyma) injection of E1/E3 deleted ad vectors was reported to induce rapid release of 
tumour necrosis factor-a, interleukin-ip and interleukin-6 pro-inflammatory cytokines 
(Cartmell et al., 1999). While, intrastriatal injection of El-deleted ad vectors containing p- 
galactosidase gene has been shown to produce a humoral immune response (Kajiwara et 
al., 2000). Thus anti-ad antibodies and anti-P-galactosidase antibodies were produced.
4.2.6 Hsp 70i expression following ad vector injection into brain
Kitagawa et al., (1998) reported expression of hsp 70i following intrahippocampal and
intraventricular injection of E1/E3 deleted ad vectors containing the p-galactosidase gene.
Expression of hsp 70i was local to the site of virus injection and P-galactosidase
transfection in the hippocampus and lateral ventricle. In this thesis, hsp 70i expression was
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observed in mice injected with ad hsp 70i and ad egfp subjected to 10 and 20-minute 
BCCAo. BCCAo of these durations had been shown previously to induce hsp 70i 
expression in large numbers of neurons in several brain regions of C57bl/6 strain mice, 
including the caudate nucleus (see Table 8). In the present study, hsp 70i expression was 
also abundant in several brain regions, including the caudate nucleus (see Tables 19 and 
20). Unfortunately it was not possible to attribute hsp 70i expression observed here to ad 
or BCCAo alone. However, hsp 70i expression in ipsilateral ad injected caudate nucleus 
was significantly greater than that in contralateral caudate nucleus in mice subjected to 10 
and 20-minute BCCAo (see Figures 44, 45, 46, 47 and 48). This suggests that ad hsp 70i 
transfection may be a significant factor in attenuating ischaemic neuronal damage in these 
mice. Hsp 70i expression in ipsilateral ad egfp injected caudate nucleus was not 
significantly greater than that in contralateral caudate nucleus in mice subjected to 10 and 
20-minute BCCAo. The levels of hsp 70i expression in ad egfp transfected mice subjected 
to 20-minute BCCAo were; however, very similar to those in ad hsp 70i transfected mice. 
This suggests that ad egfp gene transfer may induce hsp 70i expression, which could 
ameliorate ischaemic neuronal damage.
4.2.7 Immune responses to ischaemia: effect on ad transgene expression
The expression of the pro-inflammatory cytokines interleukin-1, interleukin-6 and tumour 
necrosis factor-a in normal physiologic conditions are very low (Touzani et al., 1999). 
However, these cytokines are up-regulated in the brain following injury, including 
ischaemia (Stoll et al., 1998; Touzani et al., 1999). The paradigm for the study being 
discussed here involved intrastriatal injection of ad hsp 70i or ad egfp followed by BCCAo 
of 10 or 20 minutes duration 14-days later. The impact of ad vector injection into the brain 
has already been discussed (section 4.2.5) and it is realised that the cellular immune 
response is believed to limit the duration of transgene expression (Kajiwara et al., 2000). 
Given the severity of the ischaemic insult (produced in C57bl/6 strain, used here), it is not
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unreasonable to assume some inflammatory response may have been elicited in the brain 
following reperfusion (not tested). If such a response did occur, transfected ad particles 
and transgene expression might have declined. Comparison of 10 and 20-minute BCCAo 
mice indicated that there were no significant differences in the level of transgene 
expression between ischaemic durations.
4.2.8 Importance of mouse strain
The strain of mouse chosen for experiments such as the present is also very important. 
Mouse strain has been reported to affect vector transgene expression rate (Christenson et 
al., 1998), immune response (Ohmoto et al., 1999) and susceptibility to BCCAo (Yang et 
al., 1997; Fujii et al., 1997). C57bl/6 strain mice (used here) have been shown to exhibit 
increased susceptibility to BCCAo (see Section 3.1). Inter-hemispheric association of 
ischaemic neuronal damage was also a very important feature of the study at hand, as ad 
vectors were injected unilaterally and the effects compared to the contralateral hemisphere. 
C57bl/6 strain mice displayed significant inter-hemispheric association of ischaemic 
neuronal damage (Appendix E) enabling meaningful comparison between ischaemic 
neuronal damage between in ipsilateral (ad injected) and in contralateral hemispheres 
could be made.
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4.3 Functional consequences of transgene introduction in mice
Having observed the neuroprotective effects of hsp 70i transgene over-expression (in hsp 
70i transgenic mice and in mice with intrastriatal ad hsp 70i gene transfer). The third aim 
of this thesis was to investigate the impact of transgene over-expression on brain function. 
Changes in LCGU were measured using 14C-2-deoxyglucose autoradiography. Directed 
over-expression of transgenes was investigated in two systems. First, transgenic mice 
over-expressing hsp 70i from birth (i.e., hsp 70i was introduced in the germ-line) were 
investigated. Second, adult mice were intrastriatally injected with ad egfp (producing 
transfection of all cell types with egfp) were investigated.
4.3.1 Utility of 14C-2-deoxyglucose autoradiography
14C-2-deoxyglucose autoradiography can be used to determine LCGU in discrete and 
functionally diverse brain regions simultaneously in conscious, freely moving animals. 
The 14C-2-deoxyglucose autoradiographic technique has been extensively employed to 
map functional consequences of various environmental, neuropharmacologic and 
neurophysiologic interventions. These investigations have been carried out predominantly 
in the rat (Sokoloff et al., 1977 published their description of the technique in rat). 
However, the technique has been adapted and used in a range of species, including mouse 
(Nowaczyk and Des Rosiers, 1981). Moreover, a number of modifications to the Sokoloff 
et al., (1977) technique have also been reported (Schwartz , 1978a, 1978b; Brown and 
Wolfson, 1978). In this thesis, a modification of the Nowaczyk and Des Rosier, (1981) 
approach was used to investigate the functional consequences of germ-line and ad 
mediated transgene expression in the mouse brain.
Two major modifications to the approach of Nowaczyk and Des Rosier, (1981) were 
implemented. First, 14C-2-deoxyglucose was injected intraperitoneally (not intravenously). 
Second, only a terminal blood sample was collected (as opposed to 14 timed arterial
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samples throughout the 45-minute experimental period). These modifications were driven 
by two main concerns. First, the impact of hypovolaemic effects of withdrawing blood 
from mice. Second, increases in motor function and hyperexcitability elicited by 
dizocilpine injection in mice. The route of 14C-2-deoxyglucose administration 
significantly affects the uptake and clearance of the isotope from the blood (Kelly and 
McCulloch, 1983). The absence of any plasma I4C and plasma glucose data from the 
experimental period precluded the use of the operational equation of Sokoloff et al., (1977) 
(see Figure 6). However tissue 14C concentration was measured densitometrically and 
plasma 14C and glucose concentration were determined from a terminal blood sample. 
Tissue 14C in a region of interest could therefore be normalised to an area in which 14C 
uptake was notionally unaltered (in this case the cerebrellar cortical grey matter, Figure 
62). Thus the relative rates of 14C-2-deoxyglucose uptake from plasma in individual mice, 
in individual brain regions could be accounted for. Moreover, because terminal plasma 14C 
and glucose concentrations were measured, the relationship between tissue 14C and glucose 
could be explored. In this way tissue 14C (cerebellar cortical grey matter) was observed to 
correlate well with plasma 14C / glucose (see Figures 50 and 57). While this approach does 
not offer precise values of LCGU it does provide a reliable estimate without the 
complications of invasive surgical procedures.
4.3.2 LCGU in hsp 70i transgenic mice
LCGU in transgenic mice over-expressing hsp 70i did not differ significantly compared to 
wild type littermate mice, in any of the 35 brain regions analysed (see Table 22). 
Following metabolic activation (produced by dizocilpine injection) there were widespread 
marked, heterogeneous alterations in LCGU between hsp 70i transgenic and wild type 
littermate mice in the basal state (see Tables 23 and 24). The patterns of the alterations in 
LCGU evoked in mouse by dizocilpine were broadly similar to those reported in the rat 
(Nehls e ta l., 1988, 1990; Kurumaji e ta l., 1989). These alterations in LCGU which
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encompass the Papez circuit (entorhinal cortex —» hippocampus —» mammillary body -> 
anterior thalamus —> entorhinal cortex) (Nehls et al., 1988) are accompanied by a range of 
neurophysiologic events. Among these neurophysiologic events are immediate early gene 
induction (Dragunow and Faull, 1990; Gass et al., 1993), ionic homeostasis / cell swelling 
(Olney et al., 1989) and hsp 70i expression (Sharp et al., 1991).
Metabolic activation with dizocilpine produced significantly altered LCGU in transgenic 
mice over-expressing hsp 70i compared with wild type littermates, in five of 35 brain 
regions analysed (see Table 25, Figures 51, 52, 53 and 54). Three of these regions 
(anterior thalamic nucleus, hippocampus CA1 stratum lacunosum molecularae and 
hippocampus CA1 stratum oriens) displayed marked increases in LCGU in hsp 70i 
transgenic mice compared wild type littermate mice. Anterior thalamic nucleus and 
hippocampus are components of the Papez circuit (which is activated by dizocilpine) and 
are known to chronically over-express hsp 70i (as the rhombotin 1 promoter is present in 
these regions, Hinks et al., 1997). Hence the increases in LCGU could be attributed to hsp 
70i over-expression. However, this does not explain why other transgene rich areas, 
activated by dizocilpine, such as caudate nucleus, do not display similar increases in 
LCGU compared with wild type littermate mice. One hypothesis that could explain this is 
that dizocilpine activation produces maximal increases in LCGU in areas such as the 
caudate nucleus, which cannot be influenced by hsp 70i transgene over-expression. 
Whereas, in areas such as anterior thalamic nucleus, dizocilpine evoked marked increases 
in LCGU which could be further increased by the presence of hsp 70i transgene. Given 
hsp 70i is an ATPase, which operates to ameliorate intracellular protein malfolding and 
trafficking caused by insult or injury, then hsp 70i may enable increased cellular function 
reflected by increased LCGU.
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The two other regions (superior olivary body and nucleus of the lateral lemniscus) 
displayed marked decreases in LCGU in hsp 70i transgenic mice compared with wild type 
littermate mice. The reason why LCGU in the superior olivary body and the nucleus of the 
lateral lemniscus was significantly decreased in transgenic mice over-expressing hsp 70i 
compared with wild type littermate mice is less clear. It is unlikely that dizocilpine 
effected these changes in LCGU. While, dizocilpine has effects on some auditory nuclei, 
no effect was seen relative to vehicle (see Tables 22 and 25) or previously in rat (Kurumaji 
et al., 1989). It is also unlikely that hsp 70i transgene effected these changes in LCGU. As 
the rhombotin 1 promoter is not prevalent in these regions (Hinks et al., 1997). In short, it 
remains unclear why LCGU should decrease significantly in these brain regions.
4.3.3 LCGU in IL-18 deficient mice
In a further study within the laboratory, IL-18 deficient mice were employed to investigate 
the impact of IL-18 deficiency upon LCGU. The precise role IL-18 in the brain is not yet 
known (Touzani et al., 1999). In the present study IL-18 deficient mice displayed 
significantly increased LCGU (compared to their wild type littermates) in 14 of 18 brain 
regions analysed (Appendix K). Increases in LCGU were observed throughout the 
forebrain in striatal, cortical and hippocampal structures. These data clearly show that IL- 
18 deficient mice display widespread heterogeneous increases in LCGU. This suggests 
that IL-18 may have an inhibitory role in the brain or that IL-18 deficiency stimulates 
increased cerebral function.
4.3.4 LCGU following intrastriatal ad egfp gene transfer
Two approaches of measuring LCGU in the caudate nucleus following ad egfp gene 
transfer were employed (see Appendix F). LCGU was measured in the entire caudate 
nucleus and in circumscribed areas of ad egfp transgene expression and needle damage 
(see Appendix F). These approaches produced different findings in the same groups of
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mice. Where LCGU in the entire caudate nucleus was measured, ad egfp gene transfer had 
no significant effect (see Figure 58). Where LCGU was measured in circumscribed areas 
of the caudate nucleus, ad egfp expression effected significant alterations in LCGU (see 
Figure 60).
Ads bind to an as yet unidentified cell surface receptors (Hermens and Ver Haagen, 1997). 
The ad then becomes internalised, the viral nucleocapsid is released from endosomes and 
transported to the nucleus (Greber et al., 1993; Figure 63). Once inside the nucleus the ad 
replicates to produce daughter virions. Infection with wild type ad results in cell death and 
release of daughter virions (Figure 64). Whereas, infection with replication-deficient 
(recombinant, El-deleted vectors) produces expression of transgene only (Figure 64, 
although some inflammatory and immune responses have been reported, see Section 
4.2.5). In the present study, brain areas in which ad egfp transfection was observed 
displayed significantly reduced LCGU compared to the contralateral hemisphere at seven 
and 28-days (see Figure 61). There were no differences in LCGU between hemispheres in 
saline injected mice. These data suggest that ad egfp gene transfer reduce cerebral 
function. The mechanisms by which ad egfp transfection leads to these reductions remain 
unclear at present.
Intrastriatal needle insertion and injection of fluid causes localised structural damage in the 
caudate nucleus (see Figure 49, Appendix F). In some mice needle insertion also produced 
small bleeds. On 14C-2-deoxyglucose autoradiograms structural damage and associated 
bleeding appeared as intense, dark regions, mimicking increased LCGU (Figure 65). Dark 
regions were observed almost exclusively at 7 days post-injection in mice in which needle 
extraction was performed at 2 minutes after injection. These regions were considered to be 
artefacts and represent a major source of error in 14C-2-deoxyglucose densitometry in such 
experiments. In ad egfp transfected mice a second intriguing feature was observed. LCGU
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Figure 65 Needle damage on autoradiograms: seven and 28 days post-injection
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Needle damage at seven days appeared on autoradiograms as dark areas (red arrows; saline 
A, ad egfp 2 min needle extraction B, ad egfp 10 min needle extraction C). Needle damage 
at 28 days appeared as dark areas only in saline injected mice (D , yellow arrow). Needle 
damage at 28 days in ad egfp (2 min and 10 min needle extraction) did not appear as dark 
areas (E and F, blue arrows).
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(measured at 28 days post-injection) in the ipsilateral caudate nucleus was significantly 
decreased compared to contralateral caudate nucleus (in mice in which needle extraction 
was performed at two and ten minutes, see Figure 61). While LCGU in saline injected 
mice was not significantly different between hemispheres at 28 days post-injection. On 
this occasion it is likely that the areas of reduced LCGU are areas of irreversibly damaged 
tissue, lacking in functional synapses. This also represents a major source of error in 14C- 
2-deoxyglucose densitometry in this type of experiment.
4.3.5 LCGU following intrastriatal hsv p-galactosidase gene transfer
In a further study within the laboratory, hsv vectors containing p-galactosidase (reporter 
gene) were intrastriatally injected into mice to investigate the effect on LCGU. In mice 
intrastriatally injected with wild type hsv p-galactosidase, LCGU in the ipsilateral caudate 
nucleus (in regions of P-galactosidase transfection) was not significantly altered compared 
to LCGU in the contralateral hemisphere at three days post injection (Appendix L). 
Similarly, in mice intrastriatally injected with attenuated hsv (McKie et al., 1998) P- 
galactosidase, LCGU in the ipsilateral caudate nucleus (in regions of transfection) was also 
not significantly altered compared to LCGU in the contralateral hemisphere at three days 
post-injection (Appendix L). One striking feature of this study was, the compelling 
difference in the extent of P-galactosidase transfection produced by wild type hsv 
compared to attenuated hsv (Appendix L). The area of wild type hsv p-galactosidase 
transfection (at three days post-injection) was similar in magnitude to that observed with 
attenuated ad egfp transfection at seven and 28 days post-injection (see Figures 55) and 17 
days post-injection with BCCAo (see Figure 36).
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4.4 Conclusions
The data presented within this thesis clearly fulfil the three main aims proposed at the 
outset. In fulfilling these aims five major conclusions could be drawn from this work. 
First, MF1 strain mice are less susceptible to BCCAo than C57bl/6 strain mice. Second, 
transgenic mice over-expressing hsp 70i display significantly less ischaemic neuronal 
damage than their wild type littermates following BCCAo. Third, ad gene transfer of hsp 
70i ameliorates ischaemic neuronal damage in C57bl/6 strain mice subjected to BCCAo. 
Fourth, LCGU in transgenic mice over-expressing hsp 70i is unchanged in the basal state, 
but is altered significantly following metabolic activation with dizocilpine, compared with 
wild type littermates. Fifth, ad mediated transfection of egfp significantly decreases 
LCGU in areas of egfp transfection.
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APPENDICES
Appendix A Stock solutions
Phosphate Buffer (50 millimolar; pH 7.4)
Stock solutions:
A sodium dihydrogen orthophosphate (NaH2PC>4 2 H2 0 ) 24 g/1 distilled water
B disodium hydrogen orthophosphate (Na2HPC>4 2 H2 0 ) 28.5 g /1 distilled water
Add 95ml stock A and 405ml stock B to 1.5 litres of distilled water and mix
Phosphate buffered saline (50 millimolar; pH 7.4)
Stock solutions:
A sodium dihydrogen orthophosphate (NaH2P0 4 2 H2 0 ) 24 g/1 distilled water
B disodium hydrogen orthophosphate (Na2HPO4 2 H2 0 ) 28.5 g /1 distilled water
Add 95ml stock A and 405ml stock B to 1.5 litres of 0.9% saline and mix
4% paraformaldehyde
In a fiime hood gently heat two litres of phosphate buffer to 65°C. To this add 80g of 
paraformaldehyde and mix until completely dissolved. Chill mixture to 4°C and filter 
before use. Fresh fixative was freshly prepared as required.
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Appendix B Identification of ischaemic cell change: validation
My ability to identify and score ischaemic cell change following BCCAo in MF1 
C57bl/6 strain mice was compared directly to values obtained by Dr Karen Horsburgh.
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Appendix C Identification of ischaemic cell change: consistancy
My ability to consistently identify and score (semi-quantitatively and quantitatively) 
ischaemic cell change following BCCAo in MF1 and C57bl/6 strain mice (two months 
apart) was excellent.
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Appendix D Optimising anti-hsp 70i antibody
The optimal concentration of anti-hsp 70i antibody was determined for each study in which 
hsp 70i immunohistochemical detection was required. A range of anti-hsp 70i antibody 
concentrations (0% A, 0.02% B, 0.04% C, 0.1% D, 0.2% E, 0.4% F and 1% G) was run on 
each occasion. Zero percent anti-hsp 70i antibody was run as a negative control. In the 
first study using anti-hsp 70i antibody all dilutions were run on ischaemic tissue (positive 
control) and non-ischaemic (sham, negative control). Moreover, another established and 
commonly used monoclonal antibody (anti-synaptophysin antibody) was run on these 
tissues to ensure the proper procedure was followed. Where zero percent anti-hsp 70i 
antibody was incubated on ischaemic and non-ischaemic tissue there was no 
immunohistochemical detection of hsp 70i. Where anti-hsp 70i was incubated on non- 
ischaemic tissue there was also no immunohistochemical detection of hsp 70i. Where anti- 
hsp 70i was incubated on ischaemic tissue immunohistochemical detection of hsp 70i at all 
concentrations. Using a light microscope, each concentration of anti-hsp 70i antibody was 
analysed. One part anti-hsp 70i in 1000 (0.1%, D) offered the best contrast of 
immunohistochemical staining of neurones and fibres with minimal or no background in 
all studies.
Brown stain = hsp 70i immunoreactive cells; purple stain = haematoxylin counterstain
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Appendix E Inter-hemispheric association of ischaemic neuronal damage
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Inter-hemispheric association of ischaemic neuronal damage in MF1 strain mice: 25-45 
minute BCCAo. P>0.05 Spearman rank correlation.
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Appendix F Delineation of ad egfp transfection and needle damage
Densitometric analysis of circumscribed regions o f ad egfp transfection and of needle 
damage was required to gain an accurate reflection o f the effect of ad gene upon LCGU. 
Defined regions of decreased and increased optical density could be observed 
macroscopically on all autoradiograms (A). These areas were correlated to areas of ad 
egfp transfection and of needle damage on adjacent sections using fluorescence light 
microscopy (B) and light microscopy of haematoxylin and eosin stained sections (C). 
Once confirmed, optical density readings of each zone were calculated using a micro 
computer imaging device
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Appendix G Hsp 70i immunoreactivity in white matter, thalamus and cortex
of ad hsp 70i transfected mice: 20-minute BCCAo
Hsp 70i was detected in several brain regions other than caudate nucleus in ad hsp 70i 
transfected mice subjected to 20-minute BCCAo. These regions included, subcortical 
white matter (A), white matter bundle in the caudate nucleus (B), anterior thalamus (C), 
somatosensory cortex (D). (X 400 original magnification A and B, X200 original 
magnification C, X I00 original magnification D).
Brown stain = hsp 70i immunoreactive cells
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Appendix I Increased ischaemic neuronal damage in IL-18 deficient mice
Interleukin-18 deficient mice displayed significantly increased ischaemic neuronal damage 
than their wild type littermates following 25-minute BCCAo, in 2 of 4 brain regions 
analysed.
IL-18 deficient Wild type
<L>
4=!O
JO
Hippocampus
CA1
Hippocampus
CA2
Hippocampus
<DW)
1
4=1O>53
CA310-i
J&y&
ON
Caudate nucleus
Data are presented as mean ± standard error of the mean (n = 6 per group). 
*p<0.05; **p<0.01 Student’s t-test.
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Appendix J Intrastriatal injection of IL-18 has no effect on ischaemic neuronal
damage in caudate nucleus
Intrastriatal injection of one microlitre of IL-18 (0.5pM, 5.0pM, and 50pM) had no 
significant effect upon ischaemic neuronal following 25-minute BCCAo compared with 
saline. However, 2 out of 2 mice intrastriatally injected with 500pM of IL-18 deficient 
mice died shortly after injection. This suggests that increased concentrations of IL-18 may 
be neurotoxic.
Recombinant IL-18
Saline 0.5p M 5.0p M 50p M
Data are expressed as mean ± standard error of the mean. p>0.05 unpaired Student’s ?-test. 
(n = 6 per group).
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Appendix K Increased LCGU in IL-18 deficient mice
IL-18 deficient mice displayed significantly increased LCGU than their wild type 
littermates in 14 of 18 brain regions analysed.
interleukin-18 wild type 
deficient littermates
(n=6) (n=6)
Caudate nucleus 2.10 ± 0.02 2.57 ± 0.14 ***
Sensory motor cortex 2.76 ± 0.19 3.65 ± 0.26 ***
Dorsal CA1 stratum lacunosum molecularae 2.63 ± 0.19 3.05 ± 0.17 kkk
Dorsal hippocampus CA1 1.76 ± 0.06 2.27 ± 0.22 'kick
Hippocampus CA2 1.69 ± 0.04 2.64 ± 0.17 kkk
Hippocampus CA3 1.82 ± 0.07 2.09 ± 0.13 kkk
Parietal cortex 2.81 ± 0.13 3.61 ± 0.35 ***
Auditory cortex 2.93 ± 0.18 3.62 dh0.18 •kkk
Dentate gyrus 1.80 ± 0.21 2.35 ± 0.29 kkk
Substantia nigra pars compacta 2.52 ± 0.11 2.85 ± 0.22 kk
Substantia nigra pars reticulata 1.65 ± 0.16 1.99 ± 0.20 k k
Subthalamic nucleus 2.62 ± 0.12 2.81 ± 0.08 k
Medial geniculate body 2.12 ± 0.23 2.45 ± 0.24 k
Red nucleus 2.14 ± 0.17 2.50 ± 0.17 k
Genu 0.92 ± 0.02 0.92 ± 0.07
Globus pallidus 1.97 ± 0.13 2.01 ± 0.31
Ventral thalamus 2.13 ± 0.21 2.16 ± 0.20
Corpus callosum 0.98 ± 0.03 0.95 ± 0.08
Data are expressed as mean 14C region of interest / 14C hypothalamus ± standard error of 
the mean. *p<0.05; **p<0.01; ***p<0.001 Student’s/-test.
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Appendix L No change in LCGU following intrastriatal hsv p-galactosidase gene 
transfer
Intrastriatal injection of hsv (wild type and attenuated, 1716) did not significantly alter 
LCGU in the caudate nucleus or any of the other eight brain regions analysed.
________________ 3 Day survival__________________
Wild type Attenuated (1716)
HSV p-galactosidase HSV P-galactosidase
(n=4) (n=4)
IPSI CONTRA IPSI CONTRA
Caudate nucleus 1.28 ± 0.05 1.27 ± 0.06 1.26 ± 0 .01 1.24 ± 0.10
Globus pallidus 0.74 ± 0.03 0.74 ± 0.02 0.77 db 0 11 0 .78 ± 0.09
Substantia nigra pars compacta 0.96 ± 0.13 0.98 ± 0.17 0.98 ± 0 .05 0 .97 ± 0.03
Substantia nigra pars reticulata 0.59 ± 0.05 0.59 ± 0.05 0.71 ± 0 05 0 .71 ± 0.07
Hippocampus CA1 1.09 ± 0.10 1.06 ± 0.08 1.10 ± 0 .05 1 08 ± 0.05
Genu of corpus callosum 0.59 ± 0.05 0.61 ± 0.02 0.68 ± 0.05 0 .71 ± 0.07
Thalamus 1.34 ± 0.03 1.31 ± 0.03 1.45 ± 0. 12 1 46 ± 0.14
Sensory motor cortex 1.55 ± 0.09 1.42 ± 0.12 1.54 ± 0 11 1 54 ± 0.13
Hypothalamus 0.81 ± 0.01 0.87 ± 0.01 0.93 ± 0 13 0 92 ± 0.13
Data are expressed as mean ratio of 14C region of interest / 14C cerebellar cortex ± standard 
error of the mean. (HSV = herpes simplex virus). p>0.05 paired Student’s /-test (ipsilateral 
versus contralateral).
P-galactosidase transfection produced by wild type hsv was much greater than produced by 
attenuated (1716) hsv.
Attenuated hsv
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